US20060195183A1 - Apparatus and methods for replacing a cardiac valve - Google Patents

Apparatus and methods for replacing a cardiac valve Download PDF

Info

Publication number
US20060195183A1
US20060195183A1 US11/357,485 US35748506A US2006195183A1 US 20060195183 A1 US20060195183 A1 US 20060195183A1 US 35748506 A US35748506 A US 35748506A US 2006195183 A1 US2006195183 A1 US 2006195183A1
Authority
US
United States
Prior art keywords
valve
support member
wing members
annulus
cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/357,485
Inventor
Jose Navia
Carlos Oberti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cleveland Clinic Foundation
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Priority to US11/357,485 priority Critical patent/US20060195183A1/en
Assigned to CLEVELAND CLINIC FOUNDATION, THE reassignment CLEVELAND CLINIC FOUNDATION, THE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NAVIA, JOSE A., OBERTI, CARLOS, NAVIA, JOSE L.
Publication of US20060195183A1 publication Critical patent/US20060195183A1/en
Priority to US12/828,991 priority patent/US8685086B2/en
Priority to US14/048,987 priority patent/US10583001B2/en
Priority to US14/230,216 priority patent/US10010416B2/en
Priority to US16/025,977 priority patent/US10939999B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2409Support rings therefor, e.g. for connecting valves to tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2454Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
    • A61F2/2457Chordae tendineae prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A61F2002/8483Barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped

Definitions

  • the present invention relates to an apparatus and methods for treating a diseased cardiac valve, and is particularly directed to an apparatus and methods for the correction of mitral valve and tricuspid valve disorders via a minimally invasive or percutaneous approach.
  • the left side atrio-ventricular valve is the mitral valve and the right side atrio-ventricular
  • the mitral and tricuspid valves differ significantly in anatomy. While the annulus of the mitral valve is generally D-shaped, the annulus of the tricuspid valve is more circular. The effects of the valvular dysfunction vary between the mitral valve and the tricuspid valve. Mitral valve regurgitation has more severe physiological consequences to the patient than does tricuspid valve regurgitation, a small amount of which is tolerable.
  • the valve leaflets do not fully close and a certain amount of blood leaks back into the left atrium when the left ventricle contracts.
  • the heart has to work harder by pumping not only the regular volume of the blood, but also the extra volume of blood that regurgitated back into the left atrium.
  • the added workload creates an undue strain on the left ventricle. This strain can eventually wear out of the heart and result in morbidity when the conditions are prolonged and severe enough. Consequently, proper function of the mitral valve is critical to the pumping efficiency of the heart.
  • Mitral and tricuspid valve disease is traditionally treated by either surgical repair with an annuloplasty ring or surgical replacement with a valve prosthesis.
  • surgical valve replacement or repair is often an exacting operation that is done through a surgical technique where the thoracic cavity is opened.
  • the operation requires use of a heart-lung machine for external circulation of the blood as the heart is stopped and opened during the surgical intervention and the artificial cardiac valves and/or annuloplasty rings are sewed in under direct vision. This operation exposes the patient to many risks especially in the elderly population.
  • an apparatus for replacing a diseased atrioventricular valve using a minimally invasive, percutaneous approach would be very helpful to provide additional opportunities to treat patients with severe valvular insufficiency, end stage heart failure, atrial fibrillation, and/or other associated arrhythmias.
  • an apparatus for replacing a cardiac valve having at least two native valve leaflets comprises an expandable support member having oppositely disposed first and second ends and a main body portion extending between the ends.
  • the main body portion of the support member has an annular shape for expanding into position in the annulus of the cardiac valve.
  • the first end comprises a plurality of upper wing members that extend from the main body portion.
  • Each of the upper wing members is movable from a radially collapsed condition into a radially extended condition for engaging a first section of cardiac tissue surrounding one side of the cardiac valve.
  • the second end comprises a plurality of lower wing members that extend from the main body portion.
  • Each of the lower wing members is movable from a radially collapsed condition into a radially extended condition for engaging a portion of the native valve leaflets to pin the leaflets back against the annulus of the native cardiac valve.
  • the second end of the support member further includes at least two strut members that are spaced apart from each other.
  • the at least two valve leaflets are joined at at least two commissural sections that are spaced apart from each other. Each of the at least two commissural sections are attached to a respective one of the strut members to prevent prolapse of the valve leaflets.
  • a prosthetic valve is secured within the main body portion of the support member.
  • the prosthetic valve has at least two valve leaflets that are coaptable to permit unidirectional flow of blood.
  • At least a portion of the support member is treated with at least one therapeutic agent for eluting into cardiac tissue.
  • a method for replacing a cardiac valve having at least two native valve leaflets is provided.
  • a prosthetic valve having at least two valve leaflets that are coaptable to permit unidirectional flow of blood is provided.
  • the prosthetic valve includes an expandable support member having oppositely disposed first and second ends and a main body portion extending between the ends.
  • the expandable support member further includes a plurality of upper wing members that extend from one end of the main body portion, and a plurality of lower wing members that extend from an opposite end of the main body portion.
  • the second end of the support member further includes at least two strut members.
  • the prosthetic valve includes at least two valve leaflets that are joined together at at least two commissural sections.
  • Each of the at least two commissural sections are attached to a respective one of the strut members to prevent prolapse of the valve leaflets.
  • the main body portion of the prosthetic valve is placed within the annulus of the cardiac valve to be replaced, and is then expanded into engagement with the annulus of the cardiac valve to secure the prosthetic valve in the annulus.
  • the upper wing members are deployed from a radially collapsed condition into a radially extended condition into engagement with a first section of cardiac tissue surrounding one side of the cardiac valve.
  • the lower wing members are deployed from a radially collapsed condition into a radially extended condition into engagement with a portion of the native valve leaflets to pin the leaflets back against the annulus of the native cardiac valve.
  • FIG. 1 is a schematic sectional view of an apparatus for replacing a diseased cardiac valve in accordance with the present invention and illustrating the apparatus being delivered to the diseased valve in a collapsed condition through a percutaneous procedure;
  • FIG. 2 is a perspective view of the apparatus of FIG. 1 in a radially expanded condition
  • FIG. 3 is a perspective view showing an alternative embodiment of the apparatus in FIG. 2 ;
  • FIG. 4 is a perspective view showing another alternative embodiment of the apparatus shown in FIG. 2 ;
  • FIG. 5 is a view similar to FIG. 1 illustrating the placement of the apparatus in the annulus of the cardiac valve in the expanded condition
  • FIG. 6 is a schematic sectional view taken along 6 - 6 in FIG. 5 ;
  • FIG. 7 is a schematic top view taken along line 7 - 7 in FIG. 5 with parts omitted for clarity;
  • FIG. 8 is a schematic bottom view taken along line 8 - 8 in FIG. 5 with parts omitted for clarity;
  • FIG. 9 is a plan view of the apparatus in FIG. 4 illustrating an alternative embodiment of the apparatus.
  • FIG. 10 is a view similar to FIG. 9 illustrating another alternative construction of the apparatus.
  • FIG. 11 is a perspective view showing an alternative embodiment of the apparatus in FIG. 4 having artificial chordae.
  • FIG. 12 is a schematic top view similar to FIG. 7 and illustrating an alternate embodiment of the apparatus.
  • FIGS. 1 and 2 illustrate an apparatus 10 that includes a prosthetic valve 12 for replacing a dysfunctional cardiac valve, such as a mitral valve 14 , by inserting the prosthetic valve over the native mitral valve so that the prosthetic valve assumes the valvular function.
  • a prosthetic valve 12 for replacing a dysfunctional cardiac valve, such as a mitral valve 14 , by inserting the prosthetic valve over the native mitral valve so that the prosthetic valve assumes the valvular function.
  • the apparatus 10 disclosed herein could also be used to replace other cardiac valves, such as a tricuspid, pulmonary, or aortic valve.
  • the mitral valve 14 is located between the left atrium 16 and the left ventricle 18 and functions to prevent the backflow of blood from the left ventricle into the left atrium during contraction.
  • the mitral valve 14 has a D-shaped annulus 20 that defines the opening between the left atrium 16 and the left ventricle 18 .
  • the mitral valve 14 is formed by two leaflets; namely, the anterior leaflet 22 and the posterior leaflet 24 ( FIG. 6 ).
  • the anterior leaflet 22 extends along the generally planar base of the D-shaped valve annulus 20
  • the posterior leaflet 24 extends arcuately around the curved portion of the D-shaped annulus of the mitral valve 14 .
  • Chordae tendinea 26 ( FIG. 1 ) extend between the free edges 28 of both leaflets 22 and 24 to the papillary muscles 30 in the left ventricle 18 .
  • the apparatus 10 for replacing the dysfunctional mitral valve 14 includes an expandable support member 40 ( FIG. 2 ), commonly referred to as a stent, and the prosthetic valve 12 .
  • the support member 40 has a known stent configuration that allows it to be collapsed and expanded.
  • the support member 40 may be made from any suitable medical grade metal or plastic, including shape memory materials such as Nitinol, stainless steel, and/or titanium.
  • the support member 40 is annular in shape and includes oppositely disposed first and second ends 42 and 44 with a main body portion 46 extending between the ends. As shown in FIGS. 2-8 , when the support member 40 is expanded, the main body portion 46 has a concave cross-sectional shape for conforming to the convex shape of the valve annulus 20 .
  • the apparatus 10 may further include a layer 50 ( FIG. 3 ) of biocompatible material covering at least a portion of the support member 40 .
  • the layer 50 of biocompatible material may be a synthetic such as Dacron® (Invista, Wichita, Kans.), Gore-Tex® (W. L. Gore & Associates, Flagstaff, Ariz.), woven velour, polyurethane, polytetrafluoroethylene (PTFE), or heparin-coated fabric.
  • the layer 50 may be a biological material such as bovine or equine pericardium, peritoneal tissue, an allograft, a homograft, patient graft, or a cell-seeded tissue.
  • the layer 50 can cover either the inside surface of the support member 40 , the outside surface of the support member, or can be wrapped around both the inside and outside surfaces.
  • the layer 50 may be attached around the entire circumference of the support member 40 or, alternatively, may be attached in pieces or interrupted sections to allow the support member to more easily expand and contract. As shown in FIG. 3 , for example, only the main body portion 46 of the prosthetic valve 12 may be covered with the layer 50 of biocompatible material. Alternatively, the support member 40 may be entirely covered with the layer 50 of biocompatible material ( FIG. 4 ).
  • the first end 42 of the support member 40 comprises a plurality of upper wing members 60 that extend integrally from the main body portion 46 .
  • there are four upper wing members 60 spaced about the circumference of the support member 40 but it should be understood that more or less than four upper wing members could be used.
  • the upper wing members 60 are movable from the radially collapsed condition of FIG. 1 to the radially extended condition of FIGS. 2-8 .
  • Each upper wing member 60 may also include at least one attachment mechanism 62 , such as a barb 64 or suture, for embedding into a first section of cardiac tissue (e.g., the wall of the left atrium 16 ) to help secure the support member 40 in the annulus 20 of the mitral valve 14 .
  • at least one attachment mechanism 62 such as a barb 64 or suture, for embedding into a first section of cardiac tissue (e.g., the wall of the left atrium 16 ) to help secure the support member 40 in the annulus 20 of the mitral valve 14 .
  • the second end 44 of the support member 40 comprises a plurality of lower wing members 70 that extend integrally from the main body portion 46 .
  • the third and fourth lower wing members 76 and 78 are spaced in-between the first and second lower wing members 72 and 74 , respectively. It is contemplated, however, that more or less than four lower wing members 70 could be used. Further, it is contemplated that the third and fourth lower wing members 76 and 78 positioned over the leaflets 22 and 24 could be omitted completely.
  • Each of the lower wing members 70 is movable from the radially collapsed condition of FIG. 1 to the radially extended condition of FIGS. 2-8 for engaging a portion of the native valve leaflets 22 and 24 to pin the leaflets back against the native valve annulus 20 .
  • the lower wing members 70 may also include at least one attachment mechanism 62 , such as a barb 64 or suture, for embedding into at least one of the native valve leaflets 22 and 24 to help secure the support member 40 in the annulus 20 of the mitral valve 14 .
  • the second end 44 of the support member 40 additionally includes at least two strut members 45 .
  • the valve leaflets of the prosthetic valve 12 are joined together at at least two commissural sections 47 that are spaced apart from each other.
  • Each of the at least two commissural sections 47 are attached to a representative one of the strut members 45 to prevent prolapse of prosthetic valve leaflets 90 and 92 , described in detail below.
  • the strut members 45 are securely attached to, and extend in a generally axial manner from, the support member 40 .
  • the strut members 45 are securely connected to the prosthetic valve 12 by sutures, for example, and may be made from any suitable medical grade metal or plastic, including shape memory materials such as Nitinol, stainless steel, and/or titanium.
  • the strut members 45 have a bare metal configuration and do not extend beyond the length of the prosthetic valve 12 . It is contemplated, however, that the configuration of the strut members 45 may be varied as needed. For example, the strut members 45 may be covered by a layer 50 of biocompatible material and extend beyond the length of the prosthetic valve 12 .
  • the prosthetic valve 12 of the present invention may comprise a stentless prosthetic valve.
  • stentless it is meant that the valve components including the leaflets of the prosthetic valve 12 are not reinforced with a support structure, such as a stent or other similar structure.
  • the prosthetic valve 12 is secured, for example, by sutures or other suitable means within the main body portion 46 of the support member 40 .
  • the prosthetic valve 12 may be fixed and preserved using a variety of known methods.
  • the use of chemical processes for the fixation and preservation of biological tissues have been described and are readily available in the art.
  • glutaraldehyde, and other related aldehydes have seen widespread use in preparing cross-linked biological tissues.
  • Glutaraldehyde is a five carbon aliphatic molecule with an aldehyde at each end of the chain, rendering it bifunctional. These aldehyde groups react under physiological conditions with primary amine groups on collagen molecules resulting in the cross-linking of collagen containing tissues. Methods for glutaraldehyde fixation of biological tissues have been extensively described and are well known in the art. In general, a tissue sample to be cross-linked is simply contacted with a glutaraldeyde solution for a duration effective to cause the desired degree of cross-linking within the biological tissue being treated.
  • the prosthetic valve 12 may also be treated and preserved with a dry tissue valve procedure as described in U.S. Pat. No. 6,534,004, the entire contents of which are hereby incorporated by reference. Furthermore, the prosthetic valve 12 may be treated with anti-calcification solutions, such as XenoLogiX® treatment (Edwards Lifesciences, Irvine, Calif.) or the SynerGraft® (CryoLife, Inc., Kennesaw, Ga.) treatment process, and/or anti-calcification agents, such as alfa-amino oleic acid.
  • anti-calcification solutions such as XenoLogiX® treatment (Edwards Lifesciences, Irvine, Calif.) or the SynerGraft® (CryoLife, Inc., Kennesaw, Ga.) treatment process, and/or anti-calcification agents, such as alfa-amino oleic acid.
  • the prosthetic valve 12 can be made with only one piece of pericardial tissue, for example, as shown in FIG. 9 . Where a single piece of pericardial tissue is used, a seam 96 is formed by suturing the ends of the tissue. Alternatively, the prosthetic valve 12 can be made with two pieces of pericardial tissue, one of which will form the first leaflet 90 and the other forms the second leaflet 92 of the prosthetic valve, as may be seen in FIG. 10 . Where two pieces of pericardial tissue are used ( FIG. 10 ), it is necessary to suture the tissue in two locations, thereby forming two seams 98 and 100 . The seams 96 , 98 , and 100 are always placed at what will be the commissures of the prosthetic valve 12 , where the first leaflet 90 meets the second leaflet 92 .
  • FIG. 11 illustrates an alternative embodiment of the present invention.
  • the apparatus 10 a of FIG. 11 is identically constructed as the apparatus 10 of FIGS. 2-8 , except whereas described below.
  • structures that are identical as structures in FIGS. 2-8 use the same reference numbers, whereas structures that are similar but not identical carry the suffix “a”.
  • the apparatus 10 a includes an expandable support member 40 having a flexible configuration and a prosthetic valve 12 a .
  • the support member 40 is annular in shape and includes oppositely disposed first and second ends 42 and 44 with a main body portion 40 extending between the ends.
  • the apparatus 10 a may further include a layer 50 of biocompatible material covering at least a portion of the support member 40 .
  • the first and second ends 42 and 44 of the support member 40 respectively comprises a plurality of upper and lower wing members 60 and 70 that extend integrally from the main body portion 46 .
  • the upper and lower wing members 60 and 70 are movable from the radially collapsed condition of FIG. 1 to the radially extended condition of FIG. 11 .
  • Each upper wing member 60 may also include at least one attachment mechanism 62 , such as a barb 64 or suture, for embedding into a first section of cardiac tissue (e.g., the wall of the left atrium 16 ) to help secure the support member 40 in the annulus 20 of the mitral valve 14 .
  • the lower wing members 70 may also include at least one attachment mechanism 62 , such as a barb 64 or suture, for embedding into at least one of the native valve leaflets 22 and 24 to help secure the support member 40 in the annulus 20 of the mitral valve 14 .
  • at least one attachment mechanism 62 such as a barb 64 or suture
  • the prosthetic valve 12 a of the apparatus 10 a may comprise a stentless prosthetic valve, for example, having dimensions that correspond to the dimensions of the native mitral valve 14 .
  • the biological material can include a harvested biological material such as bovine pericardial tissue, equine pericardial tissue, porcine pericardial tissue, animal or human peritoneal tissue, or mitral, aortic, and pulmonary xenograft or homograft.
  • the biocompatible material may also include a suitable synthetic material such as polyurethane, expanded PTFE, woven velour, Dacron®, heparin-coated fabric, or Gore-Tex®.
  • the prosthetic valve 12 a further includes first and second leaflets 90 and 92 that mimic the three-dimensional anatomical shape of the anterior and posterior leaflets 22 and 24 , respectively, of the mitral valve 14 .
  • the valve leaflets of the prosthetic valve 12 a are joined together at at least two commissural sections 47 that are spaced apart from each other.
  • the prosthetic valve 12 a also includes a distal end 86 that defines a first annulus 94 at which the first and second leaflets 90 and 92 terminate.
  • the prosthetic valve 12 a includes first and second pairs 102 and 104 , respectively, of prosthetic chordae 106 that project from the first and second leaflets 90 and 92 at the first annulus 94 .
  • Each of the prosthetic chordae 106 comprises a solid uninterrupted extension of biocompatible material.
  • Each of the first pair 102 of prosthetic chordae 106 has a distal end 108 and each of the second pair 104 of prosthetic chordae has a distal end 110 .
  • the second end 44 of the support member 40 may additionally include at least two strut members 45 a spaced apart from each other.
  • Each of the at least two commissural sections 47 of the prosthetic valve 12 a are attached to a respective one of the strut members 45 to prevent prolapse of the valve leaflets 90 and 92 .
  • the strut members 45 a are integrally connected to the support member 40 and extend in a generally axial manner along the prosthetic valve 12 a .
  • the strut members 45 a may be attached to the distal ends 108 of the first pair 102 of the prosthetic chordae 106 by sutures, for example.
  • the strut members 45 a may be attached to the distal ends 110 of the second pair 104 of the prosthetic chordae 106 . It is contemplated that the configuration of the strut members 45 a may be varied as needed. For instance, the strut members 45 a may have a shorter length than the length of the strut members illustrated in FIG. 11 . In this instance, the strut members 45 a may be attached at a position proximal to the distal ends 108 and 110 of the prosthetic chordae 106 , such as at or near the first annulus 94 of the prosthetic valve 12 a .
  • the present invention may be treated with at least one therapeutic agent capable of preventing a variety of pathological conditions including, but not limited to, thrombosis, restenosis and inflammation.
  • the therapeutic agent may include at least one of an anticoagulant, an antioxidant, a fibrinolytic, a steroid, an anti-apoptotic agent, and/or an anti-inflammatory agent.
  • the therapeutic agent may be capable of. treating or preventing other diseases or disease processes such as microbial infections, arrhythmias, and/or heart failure.
  • the therapeutic agent may include an antiarrhythmic agent, an inotropic agent, a chronotropic agent, and/or a biological agent such as a cell or protein. More specific types of these therapeutic agents are listed below, including other types of therapeutic agents not discussed above.
  • therapuetic agents include Coumadin, heparin, synthetic heparin analogues (e.g., fondaparinux), G(GP) II b /III a inhibitors, vitronectin receptor antagonists, hirudin, antithrombin III, drotrecogin alpha; fibrinolytics such as alteplase, plasmin, lysokinase, factor XIIa, factor VIIa, prourokinase, urokinase, streptokinase; thrombocyte aggregation inhibitors such as ticlopidine, clopidogrel, abciximab, dextrans; corticosteroids such as aldlometasones, amcinonides, augmented betamethasones, beclomethasones, betamethasones, budesonides, cortisones, clobetasol, clocortolones, desonides, desoxi
  • therapeutic agents may include digitalis glycosides such as acetyl digoxin/methyldigoxin, digitoxin, and digoxin; heart glycosides such as ouabain and proscillaridin; antihypertensives such as centrally effective antiadrenergic substances (e.g., methyldopa and imidazoline receptor agonists); calcium channel blockers of the dihydropyridine type, such as nifedipine and nitrendipine; ACE inhibitors (e.g., quinaprilate, cilazapril, moexipril, trandolapril, spirapril, imidapril, and trandolapril); angiotensin-II-antagonists (e.g., candesartancilexetil, valsartan, telmisartan, olmesartan medoxomil, and eprosartan); peripherally effective alpha-receptor blockers such
  • Additional therapeutic agents may also include antibiotics and antiinfectives such as ⁇ -lactam antibiotics (e.g., ⁇ -lactamase-sensitive penicillins, including benzyl penicillins (penicillin G) and phenoxymethylpenicillin (penicillin V)); ⁇ -lactamase-resistant penicillins, such as aminopenicillins, which include amoxicillin, ampicillin, and bacampicillin; acylaminopenicillins such as mezlocillin and piperacillin; carboxypenicillines and cephalosporins (e.g., cefazolin, cefuroxim, cefoxitin, cefotiam, cefaclor, cefadroxil, cefalexin, loracarbef, cefixim, cefuroximaxetil, ceftibuten, cefpodoximproxetil, and cefpodoximproxetil); aztreonam, ertapenem, and meropenem; ⁇ -
  • the therapeutic agent may also include a biological agent.
  • the biological agent may include organic substances such as peptides, proteins, enzymes, carbohydrates (e.g., monosaccharides, oligosaccharides and polysacchardies), lipids, phospholipids, steroids, lipoproteins, glycoproteins, glycolipids, proteoglycans, polynucleotides (e.g., DNA and RNA), antisense polynucleotides (e.g., c-myc antisense), antibodies (e.g., monoclonal or polycolonal) and/or antibody fragments (e.g., anti-CD34 antibody), bioabsorbable polymers (e.g., polylactonic acid), chitosan, extracellular matrix modulators, such as matrix metalloproteinases (MMP), which include MMP-2, MMP-9 and Batimastat; and protease inhibitors.
  • MMP matrix metalloproteinases
  • Biological agents may include, for example, agents capable of stimulating angiogenesis in the myocardium.
  • agents may include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), non-viral DNA, viral DNA, and endothelial growth factors (e.g., FGF-1, FGF-2, VEGF, TGF).
  • VEGF vascular endothelial growth factor
  • bFGF basic fibroblast growth factor
  • non-viral DNA e.g., viral DNA
  • endothelial growth factors e.g., FGF-1, FGF-2, VEGF, TGF.
  • growth factors may include erythropoietin and/or various hormones such as corticotropins, gonadotropins, sonlatropin, thyrotrophin, desmopressin, terlipressin, oxytocin, cetrorelix, corticorelin, leuprorelin, triptorelin, gonadorelin, ganirelix, buserelin, nafarelin, and goserelin.
  • hormones such as corticotropins, gonadotropins, sonlatropin, thyrotrophin, desmopressin, terlipressin, oxytocin, cetrorelix, corticorelin, leuprorelin, triptorelin, gonadorelin, ganirelix, buserelin, nafarelin, and goserelin.
  • Additional growth factors may also include cytokines, epidermal growth factors (EGF), platelet derived growth factor (PDGF), transforming growth factors- ⁇ (TGF- ⁇ ), transforming growth factor- ⁇ (TGF- ⁇ ), insulin-like growth factor-I (IGF-I), insulin-like growth factor-II (IGF-II), interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), tumour necrosis factor- ⁇ (TNF- ⁇ ), tumour necrosis factor- ⁇ (TNF- ⁇ ), interferon- ⁇ (INF- ⁇ ), colony stimulating factors (CSFs); monocyte chemotactic protein, and fibroblast stimulating factor 1.
  • EGF epidermal growth factors
  • PDGF platelet derived growth factor
  • TGF- ⁇ transforming growth factors- ⁇
  • TGF- ⁇ transforming growth factor- ⁇
  • IGF-I insulin-like growth factor-I
  • IGF-II insulin-like growth factor-II
  • Still other biological agents may include regulatory peptides such as somatostatin and octreotide; bisphosphonates (e.g., risedronates, pamidronates, ibandronates, zoledronic acid, clodronic acid, etidronic acid, alendronic acid, and tiludronic acid); fluorides such as disodium fluorophosphate and sodium fluoride; calcitonin and dihydrotachystyrene; histamine; fibrin or fibrinogen; endothelin-1; angiotensin II; collagens; bromocriptin; methylsergide; methotrexate; carbontetrachloride and thioacetamide.
  • regulatory peptides such as somatostatin and octreotide
  • bisphosphonates e.g., risedronates, pamidronates, ibandronates, zoledronic acid, clodronic acid, eti
  • the present invention may also be treated (i.e., seeded) with other biological agents, such as cells.
  • Suitable cells may include any one or combination of eukaryotic cells. Additionally or optionally, the cells may be capable of producing therapeutic agents and/or genetically engineered to produce therapeutic agents.
  • Suitable cells for use in the present invention include, for example, progentior cells such as adult stem cells, embryonic stem cells, and umbilical cord blood stem cells.
  • the cells may be autologous or allogenic, genetically engineered or non-engineered, and may include, for example, mesenchymal or mesodermal cells, including, but not limited to, endothelial progenitor cells, endothelial cells, and fibroblasts. Mixtures of such cells can also be used.
  • ex vivo or in vivo methods can be used to deliver a nucleic acid molecule or molecules, such as a gene or genes, to the cells.
  • the cells can be modified (i.e., genetically engineered) to produce or secrete any one or combination of the aforementioned therapeutic agents, including, but not limited to, anticoagulant agents, antiplatelet agents, antifibrinolytic agents, angiogenesis factors, and the like.
  • Ex vivo gene transfer is a process by which cells are removed from the body using well known techniques, genetically manipulated, usually through transduction or transfection of a nucleic acid molecule into the cells in vitro, and the returned to the body for therapeutic purposes. This contrasts with in vivo genetic engineering where a gene transfer vector is administered to a patient resulting in genetic transfer into cells and tissues in the intact patient.
  • Ex vivo and in vivo gene transfer techniques are well known to one of skill in the art.
  • the therapeutic agent can be simply linked to the stent surface, embedded and released from within polymer materials, such as a polymer matrix, or surrounded by and released through a carrier.
  • polymer materials such as a polymer matrix
  • a coating composition typically comprised of at least one polymer and at least one therapeutic agent, is usually used to treat drug-eluting devices.
  • the coating composition ensures retention of the therapeutic agent during deployment and modulates elution kinetics of the therapeutic agent. By altering the release kinetics of different therapeutic agents in the same coating composition, distinct phases of a given disease process may be targeted.
  • the present invention may be treated with a coating composition comprising at least one therapeutic agent and at least one polymer or oligomer material.
  • the polymer(s) and/or oligomer(s) may be of various types and from various sources, including natural or synthetic polymers, which are biocompatible, biodegradable, bioabsorbable and useful for controlled release of the therapeutic agent.
  • synthetic polymers can include polyesters, such as polylactic acid, polyglycolic acid, and/or combinations thereof, polyanhydrides, polycaprolactones, polyhydroxybutyrate valerates, and other biodegradable polymers or mixtures of copolymers thereof.
  • Natural polymeric materials can include proteins such as collagen, fibrin, elastin, extracellular matrix components, other biologic agents, and/or mixtures thereof.
  • the polymer material or mixture thereof of the coating composition can be applied with the therapeutic agent on the surface of the present invention and can comprise a single layer.
  • multiple layers of the polymer material can be applied to form the coating composition.
  • Multiple layers of the polymer material can also be applied between layers of the therapeutic agent.
  • the polymeric layers may be applied sequentially, with the first layer directly in contact with the uncoated surface of the apparatus and a second layer comprising the therapeutic agent and having one surface in contact with the first layer and the opposite surface in contact with a third layer of polymeric material which is in contact with the surrounding tissue. Additional layers of the polymeric material and therapeutic agent can be added as required.
  • the coating composition can be applied as multiple layers comprising one or more therapeutic agents surrounded by polymer material.
  • the coating composition can comprise multiple layers of a single therapeutic agent, one or more therapeutic agents in each layer, and/or differing therapeutic agents in alternating layers.
  • the layers comprising the therapeutic agent can be separated from one another by a layer of polymer material.
  • the coating composition may further comprise at least one pharmaceutically acceptable polymers and/or pharmaceutically acceptable carriers, for example, non-absorbable polymers, such as ethylene vinyl acetate and methylmethacrylate.
  • non-absorbable polymers such as ethylene vinyl acetate and methylmethacrylate.
  • the non-absorbable polymer can aid in further controlling release of the therapeutic agent by increasing the molecular weight of the coating composition and thereby delaying or slowing the rate of release of the therapeutic agent.
  • the coating composition can be applied to the present invention using standard techniques to cover the entire surface of the apparatus, or partially, as a single layer in a dot matrix pattern, for example.
  • the coating composition can be applied using various techniques available in the art, such as dipping, spraying, vapor deposition, an injection-like and/or a dot matrix-like approach.
  • the coating composition can begin to degrade in a controlled manner.
  • the therapeutic agent is slowly released into adjacent tissue and the therapeutic agent is eluted so that the therapeutic agent can have its effect locally.
  • the biological agent can be coated directly onto the surface of the present invention or, alternatively, they can be incorporated into the polymeric material (e.g., into a polymer matrix).
  • Such biological agents may also be included within at least one microscopic containment vehicle (e.g., a liposome, nanocapsule, nanoparticle, micelle, synthetic phospholipid, gas-dispersion, emulsion, microemulsion, nanosphere, and the like) that can be stimulated to release the biological agent(s) and/or that release the biological agent(s) in a controlled manner.
  • the microscopic containment vehicle can be coated onto the surface of the present invention or incorporated into the polymeric material.
  • the biological agent comprises cells
  • the cells can be induced to produce, activate, and/or release their cellular products (including one or more therapeutic agents) by an external stimulation device (e.g., an electrical impulse).
  • an external stimulation device e.g., an electrical impulse
  • cells can constitutively release one or more therapeutic agents at a desired level.
  • the apparatus is positioned about a balloon 120 ( FIG. 1 ) for expanding the main body portion 46 of the support member 40 into full and complete contact with the annulus 20 of the mitral valve 14 .
  • the balloon 120 may have an hourglass shape to conform to the concave cross-sectional configuration of the main body portion 46 .
  • the shape of the balloon 120 is defined by first and second bulb sections 122 and 124 connected by a center section 126 . Each of these sections 122 , 124 and 126 may have a D-shaped diameter (or other shaped diameter) to match the D-shaped diameter of the valve 14 and the prosthetic valve 12 .
  • the center section 126 of the balloon 120 has a smaller diameter than the bulb sections 122 and 124 .
  • the first and second bulb sections 122 and 124 and the center section 126 may be inflated together or separately. Further, the sections 122 , 124 and 126 may have multiple chambers to accommodate multiple fluids (i.e., an inflation fluid and a cooling fluid).
  • releasable constraining wires are used to temporarily hold the upper wing members 60 and the lower wing members 70 in the radially collapsed conditions shown in FIG. 1 during delivery and placement of the apparatus 10 .
  • the constraining wires can be made from a variety of different materials including metals, polymers, synthetics, fabrics, and biological tissues.
  • the apparatus is first sized for the particular mitral valve using fluoroscopic and/or echocardiographic data.
  • the catheter 128 is then introduced into either the right or left jugular vein (not shown), a femoral vein (not shown), or the subclavian vein (not shown) using a known percutaneous technique, such as the Seldinger technique, and is advanced through the superior or inferior vena cava (not shown) to approach the right atrium (not shown).
  • the catheter 128 is passed through the interatrial septum (not shown) to reach the left atrium 16 .
  • the apparatus 10 is then positioned within the annulus 20 of the mitral valve 14 as is shown in FIG. 1 . It should be noted that the angular orientation of the apparatus 10 within the mitral valve 14 is important, so a diagnostic agent or agents, such as radiopaque markers (not shown), may be used to ensure the apparatus is rotated to the proper position prior to deployment.
  • a diagnostic agent or agents such as radiopaque markers (not shown) may be used to ensure the apparatus is rotated to the proper position prior to deployment.
  • the catheter 128 is pulled back so that the support member 40 can expand to the condition shown in FIG. 2 in the annulus 20 of the native mitral valve 14 .
  • the balloon 120 is then inflated, which pushes the main body portion 46 of the support member 40 into engagement with the annulus 20 as shown in FIG. 5 .
  • the constraining wires are then released, which allows the upper wing members 60 and the lower wing members 70 of the support member 40 to spring radially outward toward their expanded conditions illustrated in FIGS. 2-8 .
  • the upper wing members 60 in their radially extended condition, extend transverse to the direction of blood flow through the prosthetic valve 12 , and engage the wall of the left atrium 16 .
  • the attachment mechanism 62 comprises barbs 64 as shown in FIG. 5
  • the barbs embed into the wall of the left atrium 16 to help secure the support member 40 in the annulus 20 of the mitral valve 14 .
  • each of the lower wing members 70 engages a portion of the native valve leaflets 22 and 24 .
  • the first and second lower wing members 72 and 74 engage the commissures of the native mitral valve 14 ( FIG. 5 ), while the third and fourth lower wing members 76 and 78 engage respective central portions of the native valve leaflets 22 and 24 ( FIG. 6 ).
  • the barbs 64 on the lower wing members 70 embed into the native valve leaflets 22 and 24 to help secure the support member 40 in the annulus 20 of the mitral valve 14 .
  • the lower wing members 70 pin the native leaflets 22 and 24 back against the valve annulus 20 so that the prosthetic valve 12 can assume the valvular function.
  • the balloon 120 is deflated and moved out of the valve annulus 20 .
  • the engagement of the main body portion body 46 with the valve annulus 20 , the engagement of the upper wing members 60 with the wall of the left atrium 16 , and the engagement of the lower wing members 70 that pins the native valve leaflets 22 and 24 back against the valve annulus provides a unique three-way locking mechanism for securing the apparatus 10 in the valve annulus.
  • the apparatus 10 could alternatively be placed by a retrograde, percutaneous approach.
  • the apparatus 10 may be urged in a retrograde fashion through a femoral artery (not shown), across the aortic arch (not shown), through the aortic valve (not shown), and into the left ventricle 18 where the apparatus may then be appropriate positioned in the native mitral valve 14 .
  • FIG. 12 illustrates another alternative embodiment of the present invention.
  • the apparatus 10 b of FIG. 12 is identically constructed as the apparatus 10 of FIGS. 2-8 , except whereas described below.
  • structures that are identical as structures in FIGS. 2-8 use the same reference numbers, whereas structures that are similar but not identical carry the suffix “b”.
  • the apparatus 10 b comprises a tri-leaflet prosthetic valve 12 b .
  • tri-leaflet prosthetic valves such as the prosthetic valves disclosed in U.S. Pat. No. 5,156,621, which is hereby incorporated by reference in its entirety, are known in the art.
  • the tri-leaflet prosthetic valve 12 b such as a porcine aortic valve, may be used in either the mitral or tricuspid position.
  • the prosthetic valve 12 b may be made of other biological materials, including, but not limited to, aortic xenografts, bovine pericardial tissue, equine pericardial tissue, porcine pericardial tissue, peritoneal tissue, and a homograft or allograft. Additionally, the prosthetic valve 12 b may be made of any one or combination of biocompatible materials such as polyurethane, PTFE, expanded PTFE, Dacron®, woven velour, Gore-Tex®, and heparin coated fabric.
  • each lower wing member 70 may be used so that a lower wing member is positioned at each native commissure and directly over each native valve leaflet.
  • the support structure 40 of the apparatus 10 b also includes at least three strut members 45 that are spaced apart from each other.
  • the valve leaflets of the prosthetic valve 12 b are joined together at at least three commissural sections 47 .
  • Each of the three commissural sections 47 are attached to a representative one of the strut members 45 to prevent prolapse of the valve leaflets 22 and 24 .
  • the apparatus 10 b with the tri-leaflet prosthetic valve 12 b is deployed and functions as described above with regard to the previous embodiment. It should be understood that more or less than six lower wing members 70 could be used.
  • the present invention thus allows for the apparatus 10 to be delivered in a cardiac catheterization laboratory with a percutaneous approach under local anesthesia using fluoroscopic as well as echocardiographic guidance, thereby avoiding general anesthesia and highly invasive open heart surgery techniques.
  • This approach offers tremendous advantages for high risk patients with severe valvular disease. It should be understood, however, that the present invention contemplates. various other approaches, including standard open heart surgeries as well as minimally invasive surgical techniques. Because the present invention omits stitching of the apparatus 10 in the valve annulus 20 , surgical time is reduced regardless of whether an open, minimally invasive or percutaneous approach is used.

Abstract

An apparatus and method for replacing a cardiac valve includes an expandable support member having oppositely disposed first and second ends, a main body portion extending between the ends, and a prosthetic valve within the main body portion. The main body portion has an annular shape for expanding into position in the annulus of the valve. The first and second ends include a plurality of upper and lower wing members movable from a collapsed condition into an extended condition for respectively engaging a first section of cardiac tissue surrounding the valve and for engaging a portion of the native valve leaflets to pin the leaflets back against the annulus. The second end further includes at least two strut members spaced apart from each other. A respective one of the strut members is attached to at least one commissural section of the prosthetic valve to prevent prolapse of the valve leaflets.

Description

    RELATED APPLICATION
  • This application claims priority from U.S. provisional patent application Ser. No. 60/654,725, filed on Feb. 18, 2005, the subject matter of which is incorporated herein by reference.
  • FIELD OF THE INVENTION
  • The present invention relates to an apparatus and methods for treating a diseased cardiac valve, and is particularly directed to an apparatus and methods for the correction of mitral valve and tricuspid valve disorders via a minimally invasive or percutaneous approach.
  • BACKGROUND OF THE INVENTION
  • There are two atrio-ventricular valves in the heart; one on the left side of the heart and one on the right side of the heart. The left side atrio-ventricular valve is the mitral valve and the right side atrio-ventricular
  • The mitral and tricuspid valves differ significantly in anatomy. While the annulus of the mitral valve is generally D-shaped, the annulus of the tricuspid valve is more circular. The effects of the valvular dysfunction vary between the mitral valve and the tricuspid valve. Mitral valve regurgitation has more severe physiological consequences to the patient than does tricuspid valve regurgitation, a small amount of which is tolerable.
  • In mitral valve insufficiency, the valve leaflets do not fully close and a certain amount of blood leaks back into the left atrium when the left ventricle contracts. As a result, the heart has to work harder by pumping not only the regular volume of the blood, but also the extra volume of blood that regurgitated back into the left atrium. The added workload creates an undue strain on the left ventricle. This strain can eventually wear out of the heart and result in morbidity when the conditions are prolonged and severe enough. Consequently, proper function of the mitral valve is critical to the pumping efficiency of the heart.
  • Mitral and tricuspid valve disease is traditionally treated by either surgical repair with an annuloplasty ring or surgical replacement with a valve prosthesis. However, surgical valve replacement or repair is often an exacting operation that is done through a surgical technique where the thoracic cavity is opened. The operation requires use of a heart-lung machine for external circulation of the blood as the heart is stopped and opened during the surgical intervention and the artificial cardiac valves and/or annuloplasty rings are sewed in under direct vision. This operation exposes the patient to many risks especially in the elderly population. A percutaneous procedure that can be performed under local anesthesia in the cardiac catherization lab, rather than in cardiac surgery, could therefore offer tremendous benefits for these patients, many of whom have no options today. Consequently, an apparatus for replacing a diseased atrioventricular valve using a minimally invasive, percutaneous approach would be very helpful to provide additional opportunities to treat patients with severe valvular insufficiency, end stage heart failure, atrial fibrillation, and/or other associated arrhythmias.
  • SUMMARY OF THE INVENTION
  • In one aspect of the present invention, an apparatus for replacing a cardiac valve having at least two native valve leaflets is provided. The apparatus comprises an expandable support member having oppositely disposed first and second ends and a main body portion extending between the ends. The main body portion of the support member has an annular shape for expanding into position in the annulus of the cardiac valve. The first end comprises a plurality of upper wing members that extend from the main body portion. Each of the upper wing members is movable from a radially collapsed condition into a radially extended condition for engaging a first section of cardiac tissue surrounding one side of the cardiac valve. The second end comprises a plurality of lower wing members that extend from the main body portion. Each of the lower wing members is movable from a radially collapsed condition into a radially extended condition for engaging a portion of the native valve leaflets to pin the leaflets back against the annulus of the native cardiac valve. The second end of the support member further includes at least two strut members that are spaced apart from each other. The at least two valve leaflets are joined at at least two commissural sections that are spaced apart from each other. Each of the at least two commissural sections are attached to a respective one of the strut members to prevent prolapse of the valve leaflets. A prosthetic valve is secured within the main body portion of the support member. The prosthetic valve has at least two valve leaflets that are coaptable to permit unidirectional flow of blood.
  • In another aspect of the present invention, at least a portion of the support member is treated with at least one therapeutic agent for eluting into cardiac tissue.
  • In yet another aspect of the present invention, a method for replacing a cardiac valve having at least two native valve leaflets is provided. According to the inventive method, a prosthetic valve having at least two valve leaflets that are coaptable to permit unidirectional flow of blood is provided. The prosthetic valve includes an expandable support member having oppositely disposed first and second ends and a main body portion extending between the ends. The expandable support member further includes a plurality of upper wing members that extend from one end of the main body portion, and a plurality of lower wing members that extend from an opposite end of the main body portion. The second end of the support member further includes at least two strut members. The prosthetic valve includes at least two valve leaflets that are joined together at at least two commissural sections. Each of the at least two commissural sections are attached to a respective one of the strut members to prevent prolapse of the valve leaflets. The main body portion of the prosthetic valve is placed within the annulus of the cardiac valve to be replaced, and is then expanded into engagement with the annulus of the cardiac valve to secure the prosthetic valve in the annulus. The upper wing members are deployed from a radially collapsed condition into a radially extended condition into engagement with a first section of cardiac tissue surrounding one side of the cardiac valve. The lower wing members are deployed from a radially collapsed condition into a radially extended condition into engagement with a portion of the native valve leaflets to pin the leaflets back against the annulus of the native cardiac valve.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The foregoing and other features of the present invention will become apparent to those skilled in the art to which the present invention relates upon reading the following description with reference to the accompanying drawings, in which:
  • FIG. 1 is a schematic sectional view of an apparatus for replacing a diseased cardiac valve in accordance with the present invention and illustrating the apparatus being delivered to the diseased valve in a collapsed condition through a percutaneous procedure;
  • FIG. 2 is a perspective view of the apparatus of FIG. 1 in a radially expanded condition;
  • FIG. 3 is a perspective view showing an alternative embodiment of the apparatus in FIG. 2;
  • FIG. 4 is a perspective view showing another alternative embodiment of the apparatus shown in FIG. 2;
  • FIG. 5 is a view similar to FIG. 1 illustrating the placement of the apparatus in the annulus of the cardiac valve in the expanded condition;
  • FIG. 6 is a schematic sectional view taken along 6-6 in FIG. 5;
  • FIG. 7 is a schematic top view taken along line 7-7 in FIG. 5 with parts omitted for clarity;
  • FIG. 8 is a schematic bottom view taken along line 8-8 in FIG. 5 with parts omitted for clarity;
  • FIG. 9 is a plan view of the apparatus in FIG. 4 illustrating an alternative embodiment of the apparatus;
  • FIG. 10 is a view similar to FIG. 9 illustrating another alternative construction of the apparatus;
  • FIG. 11 is a perspective view showing an alternative embodiment of the apparatus in FIG. 4 having artificial chordae; and
  • FIG. 12 is a schematic top view similar to FIG. 7 and illustrating an alternate embodiment of the apparatus.
  • DETAILED DESCRIPTION OF EMBODIMENTS
  • The present invention relates to an apparatus and methods for treating a diseased cardiac valve, and is particularly directed to an apparatus and methods for the correction of mitral valve and tricuspid valve disorders via a minimally invasive and/or percutaneous approach. As representative of the present invention, FIGS. 1 and 2 illustrate an apparatus 10 that includes a prosthetic valve 12 for replacing a dysfunctional cardiac valve, such as a mitral valve 14, by inserting the prosthetic valve over the native mitral valve so that the prosthetic valve assumes the valvular function. It should be understood, however, that the apparatus 10 disclosed herein could also be used to replace other cardiac valves, such as a tricuspid, pulmonary, or aortic valve.
  • As shown in FIG. 1, the mitral valve 14 is located between the left atrium 16 and the left ventricle 18 and functions to prevent the backflow of blood from the left ventricle into the left atrium during contraction. The mitral valve 14 has a D-shaped annulus 20 that defines the opening between the left atrium 16 and the left ventricle 18. The mitral valve 14 is formed by two leaflets; namely, the anterior leaflet 22 and the posterior leaflet 24 (FIG. 6). The anterior leaflet 22 extends along the generally planar base of the D-shaped valve annulus 20, while the posterior leaflet 24 extends arcuately around the curved portion of the D-shaped annulus of the mitral valve 14. Chordae tendinea 26 (FIG. 1) extend between the free edges 28 of both leaflets 22 and 24 to the papillary muscles 30 in the left ventricle 18.
  • The apparatus 10 for replacing the dysfunctional mitral valve 14 includes an expandable support member 40 (FIG. 2), commonly referred to as a stent, and the prosthetic valve 12. The support member 40 has a known stent configuration that allows it to be collapsed and expanded. The support member 40 may be made from any suitable medical grade metal or plastic, including shape memory materials such as Nitinol, stainless steel, and/or titanium.
  • The support member 40 is annular in shape and includes oppositely disposed first and second ends 42 and 44 with a main body portion 46 extending between the ends. As shown in FIGS. 2-8, when the support member 40 is expanded, the main body portion 46 has a concave cross-sectional shape for conforming to the convex shape of the valve annulus 20.
  • The apparatus 10 may further include a layer 50 (FIG. 3) of biocompatible material covering at least a portion of the support member 40. The layer 50 of biocompatible material may be a synthetic such as Dacron® (Invista, Wichita, Kans.), Gore-Tex® (W. L. Gore & Associates, Flagstaff, Ariz.), woven velour, polyurethane, polytetrafluoroethylene (PTFE), or heparin-coated fabric. Alternatively, the layer 50 may be a biological material such as bovine or equine pericardium, peritoneal tissue, an allograft, a homograft, patient graft, or a cell-seeded tissue. The layer 50 can cover either the inside surface of the support member 40, the outside surface of the support member, or can be wrapped around both the inside and outside surfaces. The layer 50 may be attached around the entire circumference of the support member 40 or, alternatively, may be attached in pieces or interrupted sections to allow the support member to more easily expand and contract. As shown in FIG. 3, for example, only the main body portion 46 of the prosthetic valve 12 may be covered with the layer 50 of biocompatible material. Alternatively, the support member 40 may be entirely covered with the layer 50 of biocompatible material (FIG. 4).
  • The first end 42 of the support member 40 comprises a plurality of upper wing members 60 that extend integrally from the main body portion 46. In the embodiment illustrated in FIGS. 1-8, there are four upper wing members 60 spaced about the circumference of the support member 40, but it should be understood that more or less than four upper wing members could be used. The upper wing members 60 are movable from the radially collapsed condition of FIG. 1 to the radially extended condition of FIGS. 2-8. Each upper wing member 60 may also include at least one attachment mechanism 62, such as a barb 64 or suture, for embedding into a first section of cardiac tissue (e.g., the wall of the left atrium 16) to help secure the support member 40 in the annulus 20 of the mitral valve 14.
  • The second end 44 of the support member 40 comprises a plurality of lower wing members 70 that extend integrally from the main body portion 46. In the embodiment illustrated in FIGS. 1-8, there are four lower wing members 70 spaced about the circumference of the support member 40. More specifically, there are first and second lower wing members 72 and 74, spaced approximately 180° apart, for positioning at the commissures of the native mitral valve 14, and third and fourth lower wing members 76 and 78 (FIG. 7), spaced approximately 180° apart, for positioning directly over respective central portions of the native leaflets 22 and 24. The third and fourth lower wing members 76 and 78 are spaced in-between the first and second lower wing members 72 and 74, respectively. It is contemplated, however, that more or less than four lower wing members 70 could be used. Further, it is contemplated that the third and fourth lower wing members 76 and 78 positioned over the leaflets 22 and 24 could be omitted completely.
  • Each of the lower wing members 70 is movable from the radially collapsed condition of FIG. 1 to the radially extended condition of FIGS. 2-8 for engaging a portion of the native valve leaflets 22 and 24 to pin the leaflets back against the native valve annulus 20. The lower wing members 70 may also include at least one attachment mechanism 62, such as a barb 64 or suture, for embedding into at least one of the native valve leaflets 22 and 24 to help secure the support member 40 in the annulus 20 of the mitral valve 14.
  • The second end 44 of the support member 40 additionally includes at least two strut members 45. As shown in FIG. 2, the valve leaflets of the prosthetic valve 12 are joined together at at least two commissural sections 47 that are spaced apart from each other. Each of the at least two commissural sections 47 are attached to a representative one of the strut members 45 to prevent prolapse of prosthetic valve leaflets 90 and 92, described in detail below. The strut members 45 are securely attached to, and extend in a generally axial manner from, the support member 40. The strut members 45 are securely connected to the prosthetic valve 12 by sutures, for example, and may be made from any suitable medical grade metal or plastic, including shape memory materials such as Nitinol, stainless steel, and/or titanium. As illustrated in FIG. 2, the strut members 45 have a bare metal configuration and do not extend beyond the length of the prosthetic valve 12. It is contemplated, however, that the configuration of the strut members 45 may be varied as needed. For example, the strut members 45 may be covered by a layer 50 of biocompatible material and extend beyond the length of the prosthetic valve 12.
  • The prosthetic valve 12 of the present invention may comprise a stentless prosthetic valve. By “stentless” it is meant that the valve components including the leaflets of the prosthetic valve 12 are not reinforced with a support structure, such as a stent or other similar structure. The prosthetic valve 12 is secured, for example, by sutures or other suitable means within the main body portion 46 of the support member 40.
  • The prosthetic valve 12 may be fixed and preserved using a variety of known methods. The use of chemical processes for the fixation and preservation of biological tissues have been described and are readily available in the art. For example, glutaraldehyde, and other related aldehydes have seen widespread use in preparing cross-linked biological tissues.
  • Glutaraldehyde is a five carbon aliphatic molecule with an aldehyde at each end of the chain, rendering it bifunctional. These aldehyde groups react under physiological conditions with primary amine groups on collagen molecules resulting in the cross-linking of collagen containing tissues. Methods for glutaraldehyde fixation of biological tissues have been extensively described and are well known in the art. In general, a tissue sample to be cross-linked is simply contacted with a glutaraldeyde solution for a duration effective to cause the desired degree of cross-linking within the biological tissue being treated.
  • Many variations and conditions have been applied to optimize glutaraldehyde fixation procedures. For example, lower concentrations have been found to be better in bulk tissue cross-linking compared to higher concentrations. It has been proposed that higher concentrations of glutaraldehyde may promote rapid surface cross-linking of the tissue, generating a barrier that impedes or prevents the further diffusion of glutaraldehdye into the tissue bulk. For most bioprosthesis applications, the tissue is treated with a relatively low concentration glutaraldehyde solution, e.g., typically between 0.1%-5%, for 24 hours or more to ensure optimum fixation. Various other combinations of glutaraldehyde concentrations and treatment times will also be suitable depending on the objectives for a given application. Examples of such other combinations include, but are not limited to, U.S. Pat. Nos. 6,547,827, 6,561,970, and 6,878,168, all of which are hereby incorporated by reference in their entirety.
  • In addition to bifunctional aldehydes, many other chemical fixation procedures have been described. For example, some such methods have employed polyethers, polyepoxy compounds, diisocyanates, and azides. These and other approaches available to the skilled individual in the art for treating biological tissues are suitable for cross-linking vascular graft tissue according to the present invention.
  • The prosthetic valve 12 may also be treated and preserved with a dry tissue valve procedure as described in U.S. Pat. No. 6,534,004, the entire contents of which are hereby incorporated by reference. Furthermore, the prosthetic valve 12 may be treated with anti-calcification solutions, such as XenoLogiX® treatment (Edwards Lifesciences, Irvine, Calif.) or the SynerGraft® (CryoLife, Inc., Kennesaw, Ga.) treatment process, and/or anti-calcification agents, such as alfa-amino oleic acid.
  • The prosthetic valve 12 can be made with only one piece of pericardial tissue, for example, as shown in FIG. 9. Where a single piece of pericardial tissue is used, a seam 96 is formed by suturing the ends of the tissue. Alternatively, the prosthetic valve 12 can be made with two pieces of pericardial tissue, one of which will form the first leaflet 90 and the other forms the second leaflet 92 of the prosthetic valve, as may be seen in FIG. 10. Where two pieces of pericardial tissue are used (FIG. 10), it is necessary to suture the tissue in two locations, thereby forming two seams 98 and 100. The seams 96, 98, and 100 are always placed at what will be the commissures of the prosthetic valve 12, where the first leaflet 90 meets the second leaflet 92.
  • FIG. 11 illustrates an alternative embodiment of the present invention. The apparatus 10 a of FIG. 11 is identically constructed as the apparatus 10 of FIGS. 2-8, except whereas described below. In FIG. 11, structures that are identical as structures in FIGS. 2-8 use the same reference numbers, whereas structures that are similar but not identical carry the suffix “a”.
  • As shown in FIG. 11, the apparatus 10 a includes an expandable support member 40 having a flexible configuration and a prosthetic valve 12 a. The support member 40 is annular in shape and includes oppositely disposed first and second ends 42 and 44 with a main body portion 40 extending between the ends. The apparatus 10 a may further include a layer 50 of biocompatible material covering at least a portion of the support member 40.
  • The first and second ends 42 and 44 of the support member 40 respectively comprises a plurality of upper and lower wing members 60 and 70 that extend integrally from the main body portion 46. The upper and lower wing members 60 and 70 are movable from the radially collapsed condition of FIG. 1 to the radially extended condition of FIG. 11. Each upper wing member 60 may also include at least one attachment mechanism 62, such as a barb 64 or suture, for embedding into a first section of cardiac tissue (e.g., the wall of the left atrium 16) to help secure the support member 40 in the annulus 20 of the mitral valve 14. The lower wing members 70 may also include at least one attachment mechanism 62, such as a barb 64 or suture, for embedding into at least one of the native valve leaflets 22 and 24 to help secure the support member 40 in the annulus 20 of the mitral valve 14.
  • The prosthetic valve 12 a of the apparatus 10 a (and also the previously described valve 12) may comprise a stentless prosthetic valve, for example, having dimensions that correspond to the dimensions of the native mitral valve 14. Where the prosthetic valve 12 a is comprised of biological material, the biological material can include a harvested biological material such as bovine pericardial tissue, equine pericardial tissue, porcine pericardial tissue, animal or human peritoneal tissue, or mitral, aortic, and pulmonary xenograft or homograft. The biocompatible material may also include a suitable synthetic material such as polyurethane, expanded PTFE, woven velour, Dacron®, heparin-coated fabric, or Gore-Tex®.
  • The prosthetic valve 12 a further includes first and second leaflets 90 and 92 that mimic the three-dimensional anatomical shape of the anterior and posterior leaflets 22 and 24, respectively, of the mitral valve 14. The valve leaflets of the prosthetic valve 12 a are joined together at at least two commissural sections 47 that are spaced apart from each other. The prosthetic valve 12 a also includes a distal end 86 that defines a first annulus 94 at which the first and second leaflets 90 and 92 terminate.
  • Additionally, the prosthetic valve 12 a includes first and second pairs 102 and 104, respectively, of prosthetic chordae 106 that project from the first and second leaflets 90 and 92 at the first annulus 94. Each of the prosthetic chordae 106 comprises a solid uninterrupted extension of biocompatible material. Each of the first pair 102 of prosthetic chordae 106 has a distal end 108 and each of the second pair 104 of prosthetic chordae has a distal end 110.
  • As shown in FIG. 11, the second end 44 of the support member 40 may additionally include at least two strut members 45 a spaced apart from each other. Each of the at least two commissural sections 47 of the prosthetic valve 12 a are attached to a respective one of the strut members 45 to prevent prolapse of the valve leaflets 90 and 92. The strut members 45 a are integrally connected to the support member 40 and extend in a generally axial manner along the prosthetic valve 12 a. The strut members 45 a may be attached to the distal ends 108 of the first pair 102 of the prosthetic chordae 106 by sutures, for example. Alternatively, the strut members 45 a may be attached to the distal ends 110 of the second pair 104 of the prosthetic chordae 106. It is contemplated that the configuration of the strut members 45 a may be varied as needed. For instance, the strut members 45 a may have a shorter length than the length of the strut members illustrated in FIG. 11. In this instance, the strut members 45 a may be attached at a position proximal to the distal ends 108 and 110 of the prosthetic chordae 106, such as at or near the first annulus 94 of the prosthetic valve 12 a.
  • The present invention may be treated with at least one therapeutic agent capable of preventing a variety of pathological conditions including, but not limited to, thrombosis, restenosis and inflammation. Accordingly, the therapeutic agent may include at least one of an anticoagulant, an antioxidant, a fibrinolytic, a steroid, an anti-apoptotic agent, and/or an anti-inflammatory agent.
  • Optionally or additionally, the therapeutic agent may be capable of. treating or preventing other diseases or disease processes such as microbial infections, arrhythmias, and/or heart failure. In these instances, the therapeutic agent may include an antiarrhythmic agent, an inotropic agent, a chronotropic agent, and/or a biological agent such as a cell or protein. More specific types of these therapeutic agents are listed below, including other types of therapeutic agents not discussed above.
  • Examples of acceptable therapuetic agents include Coumadin, heparin, synthetic heparin analogues (e.g., fondaparinux), G(GP) IIb/IIIa inhibitors, vitronectin receptor antagonists, hirudin, antithrombin III, drotrecogin alpha; fibrinolytics such as alteplase, plasmin, lysokinase, factor XIIa, factor VIIa, prourokinase, urokinase, streptokinase; thrombocyte aggregation inhibitors such as ticlopidine, clopidogrel, abciximab, dextrans; corticosteroids such as aldlometasones, amcinonides, augmented betamethasones, beclomethasones, betamethasones, budesonides, cortisones, clobetasol, clocortolones, desonides, desoximetasones, dexamethasones, flucinolones, fluocinonides, flurandrenolides, flunisolides, fluticasones, halcinonides, halobetasol, hydrocortisones, methylprednisolones, mometasones, prednicarbates, prednisones, prednisolones, triamcinolones; fibrinolytic agents such as tissue plasminogen activator, streptokinase, dipyridamole, ticlopidine, clopidine, and abciximab; non-steroidal anti-inflammatory drugs such as salicyclic acid and salicyclic acid derivatives, para-aminophenol derivatives, indole and indene acetic acids (e.g., etodolac, indomethacin, and sulindac), heteroaryl acetic acids (e.g., ketorolac, diclofenac, and tolmetin), arylpropionic acids (e.g., ibuprofen and derivatives thereof), anthranilic acids (e.g., meclofenamates and mefenamic acid), enolic acids (e.g., piroxicam, tenoxicam, phenylbutazone, and oxyphenthatrazone), gold compounds (e.g., auranofin, aurothioglucose, and gold sodium thiomalate), diflunisal, meloxicam, nabumetones, naproxen, oxaprozin, salsalate, celecoxib, rofecoxib; cytostatics such as alkaloids and podophyllum toxins such as vinblastin, vincristin; alkylants such as nitrosoureas and nitrogen lost analogues; cytotoxic antibiotics such as daunorubicin, doxorubicin, and other anthracyclins and related substances, bleomycin, and mitomycin; antimetabolites such as folic acid analogues, purine analogues and related inhibitors (e.g., mercaptopurine, thioguanine, pentostatin, and 2-chlorodeoxyadenosine), pyrimidine analogues (e.g., fluorouracil, floxuridine, and cytarabine), and platinum coordination complexes (e.g., cisplatinum, carboplatinum and oxaliplatinum); tacrolimus, azathioprine, cyclosporine, paclitaxel, docetaxel, sirolimus; amsacrin, irinotecan, imatinib, topotecan, interferon-alpha 2a, interferon-alpha 2b, hydroxycarbamide, miltefosin, pentostatin, porfimer, aldesleukin, bexarotene, and tretinoin; antiandrogens and antiestrogens; antiarrythmics, in particular antiarrhythmics of class I such as antiarrhythmics of the quinidine type (e.g., quinidine, dysopyramide, ajmaline, prajmalium bitartrate, and detajmium bitartrate); antiarrhythmics of the lidocaine type, (e.g., lidocaine, mexiletin, phenyloin, and tocainid); antiarrhythmics of class I C (e.g., propafenone, flecainide (acetate)); antiarrhythmics of class II, including betareceptor blockers such as metoprolol, esmolol, propranolol, metoprolol, atenolol, and oxprenolol; antiarrhythmics of class III such as amiodaron and sotalol; antiarrhythmics of class IV such as diltiazem, and verapamil; and other antiarrhythmics such as adenosine, orciprenaline, and ipratropium bromide.
  • Other types of therapeutic agents may include digitalis glycosides such as acetyl digoxin/methyldigoxin, digitoxin, and digoxin; heart glycosides such as ouabain and proscillaridin; antihypertensives such as centrally effective antiadrenergic substances (e.g., methyldopa and imidazoline receptor agonists); calcium channel blockers of the dihydropyridine type, such as nifedipine and nitrendipine; ACE inhibitors (e.g., quinaprilate, cilazapril, moexipril, trandolapril, spirapril, imidapril, and trandolapril); angiotensin-II-antagonists (e.g., candesartancilexetil, valsartan, telmisartan, olmesartan medoxomil, and eprosartan); peripherally effective alpha-receptor blockers such as prazosin, urapidil, doxazosin, bunazosin, terazosin, and indoramin; vasodilators such as dihydralazine, diisopropyl amine dichloroacetate, minoxidil, and nitropiusside-sodium; other antihypertonics such as indapamide, codergocrin mesilate, dihydroergotoxin methane sulphonate, cicletanin, bosentan, and fludrocortisone; phosphodiesterase inhibitors, such as milrinone and enoximone, as well as antihypotonics (e.g., adrenergics and dopaminergic substances such as dobutamine, epinephrine, etilefrine, norfenefrine, norepinephrine, oxilofrine, dopamine, midodrine, pholedrine, and amezinium methyl) and partial adrenoceptor agonists (e.g., dihydroergotamine); fibronectin, polylysines and ethylene vinyl acetates; and adhesive substances such as cyanoacrylates, beryllium, and silica.
  • Additional therapeutic agents may also include antibiotics and antiinfectives such as β-lactam antibiotics (e.g., β-lactamase-sensitive penicillins, including benzyl penicillins (penicillin G) and phenoxymethylpenicillin (penicillin V)); β-lactamase-resistant penicillins, such as aminopenicillins, which include amoxicillin, ampicillin, and bacampicillin; acylaminopenicillins such as mezlocillin and piperacillin; carboxypenicillines and cephalosporins (e.g., cefazolin, cefuroxim, cefoxitin, cefotiam, cefaclor, cefadroxil, cefalexin, loracarbef, cefixim, cefuroximaxetil, ceftibuten, cefpodoximproxetil, and cefpodoximproxetil); aztreonam, ertapenem, and meropenem; β-lactamase inhibitors such as sulbactam and sultamicillintosilates; tetracyclines such as doxycycline, minocycline, tetracycline, chlorotetracycline, oxytetracycline; aminoglycosides such as gentamicin, neomycin, streptomycin, tobramycin, amikasin, netilmicin, paromomycin, framycetin, and spectinomycin; makrolide antibiotics such as azithromycin, clarithromycin, erythromycin, roxithromycin, spiramycin, and josamycin; lincosamides such as clindamycin and lincomycin; gyrase inhibitors, such as fluoroquinolones, which include ciprofloxacin, ofloxacin, moxifloxacin, norfloxacin, gatifloxacin, enoxacin, fleroxacin, and levofloxacin; quinolones such as pipemidic acid; sulphonamides such as trimethoprim, sulphadiazin, and sulphalene; glycopeptide antibiotics such as vancomycin and teicoplanin; polypeptide antibiotics, such as polymyxins, which include colistin, polymyxin-b, and nitroimidazol derivatives (e.g., metronidazol and tinidazol); aminoquinolones such as chloroquin, mefloquin, and hydroxychloroquin; biguanides such as proguanil; quinine alkaloids and diaminopyrimidines such as pyrimethamine; amphenicols such as chloramphenicol; rifabutin, dapsone, fusidinic acid, fosfomycin, nifuratel, telithromycin, fusafungin, fosfomycin, pentamidindiisethionate, rifampicin, taurolidine, atovaquone, and linezolid; virostatics such as aciclovir, ganciclovir, famciclovir, foscamet, inosine (dimepranol-4-acetamidobenzoate), valganciclovir, valaciclovir, cidofovir, and brivudin; tyrosine kinase inhibitors; anti-apoptotic agents such as caspase inhibitors (e.g., fluoromethylketone peptide derivatives), calpain inhibitors, cathepsin inhibitors, nitric oxide synthase inhibitors, flavonoids, vitamin A, vitamin C, vitamin E, vitamin D, pycnogenol, super oxidedismutase, N-acetyl cysteine, selenium, catechins, alpha lipoic acid, melatonin, glutathione, zinc chelators, calcium chelators, and L-arginine; warfarin; beta-blockers; diuretics; spirolactone; and natural products such as vinca alkaloids (e.g., vinblastine, vincristine and vinorelbine).
  • As noted above, the therapeutic agent may also include a biological agent. The biological agent may include organic substances such as peptides, proteins, enzymes, carbohydrates (e.g., monosaccharides, oligosaccharides and polysacchardies), lipids, phospholipids, steroids, lipoproteins, glycoproteins, glycolipids, proteoglycans, polynucleotides (e.g., DNA and RNA), antisense polynucleotides (e.g., c-myc antisense), antibodies (e.g., monoclonal or polycolonal) and/or antibody fragments (e.g., anti-CD34 antibody), bioabsorbable polymers (e.g., polylactonic acid), chitosan, extracellular matrix modulators, such as matrix metalloproteinases (MMP), which include MMP-2, MMP-9 and Batimastat; and protease inhibitors.
  • Biological agents may include, for example, agents capable of stimulating angiogenesis in the myocardium. Such agents may include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), non-viral DNA, viral DNA, and endothelial growth factors (e.g., FGF-1, FGF-2, VEGF, TGF). Other growth factors may include erythropoietin and/or various hormones such as corticotropins, gonadotropins, sonlatropin, thyrotrophin, desmopressin, terlipressin, oxytocin, cetrorelix, corticorelin, leuprorelin, triptorelin, gonadorelin, ganirelix, buserelin, nafarelin, and goserelin. Additional growth factors may also include cytokines, epidermal growth factors (EGF), platelet derived growth factor (PDGF), transforming growth factors-β (TGF-β), transforming growth factor-α (TGF-α), insulin-like growth factor-I (IGF-I), insulin-like growth factor-II (IGF-II), interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6), interleukin-8 (IL-8), tumour necrosis factor-α (TNF-α), tumour necrosis factor-β (TNF-β), interferon-γ (INF-γ), colony stimulating factors (CSFs); monocyte chemotactic protein, and fibroblast stimulating factor 1.
  • Still other biological agents may include regulatory peptides such as somatostatin and octreotide; bisphosphonates (e.g., risedronates, pamidronates, ibandronates, zoledronic acid, clodronic acid, etidronic acid, alendronic acid, and tiludronic acid); fluorides such as disodium fluorophosphate and sodium fluoride; calcitonin and dihydrotachystyrene; histamine; fibrin or fibrinogen; endothelin-1; angiotensin II; collagens; bromocriptin; methylsergide; methotrexate; carbontetrachloride and thioacetamide.
  • The present invention may also be treated (i.e., seeded) with other biological agents, such as cells. Suitable cells may include any one or combination of eukaryotic cells. Additionally or optionally, the cells may be capable of producing therapeutic agents and/or genetically engineered to produce therapeutic agents. Suitable cells for use in the present invention include, for example, progentior cells such as adult stem cells, embryonic stem cells, and umbilical cord blood stem cells. The cells may be autologous or allogenic, genetically engineered or non-engineered, and may include, for example, mesenchymal or mesodermal cells, including, but not limited to, endothelial progenitor cells, endothelial cells, and fibroblasts. Mixtures of such cells can also be used.
  • A variety of ex vivo or in vivo methods can be used to deliver a nucleic acid molecule or molecules, such as a gene or genes, to the cells. For example, the cells can be modified (i.e., genetically engineered) to produce or secrete any one or combination of the aforementioned therapeutic agents, including, but not limited to, anticoagulant agents, antiplatelet agents, antifibrinolytic agents, angiogenesis factors, and the like. Ex vivo gene transfer is a process by which cells are removed from the body using well known techniques, genetically manipulated, usually through transduction or transfection of a nucleic acid molecule into the cells in vitro, and the returned to the body for therapeutic purposes. This contrasts with in vivo genetic engineering where a gene transfer vector is administered to a patient resulting in genetic transfer into cells and tissues in the intact patient. Ex vivo and in vivo gene transfer techniques are well known to one of skill in the art.
  • To treat the present invention with at least one therapeutic agent, a variety of methods, agents, and compositions may be used. For example, the therapeutic agent can be simply linked to the stent surface, embedded and released from within polymer materials, such as a polymer matrix, or surrounded by and released through a carrier. Several approaches to treating medical devices with therapeutic agents exist. Some therapeutic agents can be loaded directly onto metallic surfaces; however, a coating composition, typically comprised of at least one polymer and at least one therapeutic agent, is usually used to treat drug-eluting devices. The coating composition ensures retention of the therapeutic agent during deployment and modulates elution kinetics of the therapeutic agent. By altering the release kinetics of different therapeutic agents in the same coating composition, distinct phases of a given disease process may be targeted.
  • The present invention may be treated with a coating composition comprising at least one therapeutic agent and at least one polymer or oligomer material. The polymer(s) and/or oligomer(s) may be of various types and from various sources, including natural or synthetic polymers, which are biocompatible, biodegradable, bioabsorbable and useful for controlled release of the therapeutic agent. For example, synthetic polymers can include polyesters, such as polylactic acid, polyglycolic acid, and/or combinations thereof, polyanhydrides, polycaprolactones, polyhydroxybutyrate valerates, and other biodegradable polymers or mixtures of copolymers thereof. Natural polymeric materials can include proteins such as collagen, fibrin, elastin, extracellular matrix components, other biologic agents, and/or mixtures thereof.
  • The polymer material or mixture thereof of the coating composition can be applied with the therapeutic agent on the surface of the present invention and can comprise a single layer. Optionally, multiple layers of the polymer material can be applied to form the coating composition. Multiple layers of the polymer material can also be applied between layers of the therapeutic agent. For example, the polymeric layers may be applied sequentially, with the first layer directly in contact with the uncoated surface of the apparatus and a second layer comprising the therapeutic agent and having one surface in contact with the first layer and the opposite surface in contact with a third layer of polymeric material which is in contact with the surrounding tissue. Additional layers of the polymeric material and therapeutic agent can be added as required.
  • Alternatively, the coating composition can be applied as multiple layers comprising one or more therapeutic agents surrounded by polymer material. For instance, the coating composition can comprise multiple layers of a single therapeutic agent, one or more therapeutic agents in each layer, and/or differing therapeutic agents in alternating layers. Alternatively, the layers comprising the therapeutic agent can be separated from one another by a layer of polymer material.
  • The coating composition may further comprise at least one pharmaceutically acceptable polymers and/or pharmaceutically acceptable carriers, for example, non-absorbable polymers, such as ethylene vinyl acetate and methylmethacrylate. The non-absorbable polymer, for example, can aid in further controlling release of the therapeutic agent by increasing the molecular weight of the coating composition and thereby delaying or slowing the rate of release of the therapeutic agent.
  • The coating composition can be applied to the present invention using standard techniques to cover the entire surface of the apparatus, or partially, as a single layer in a dot matrix pattern, for example. The coating composition can be applied using various techniques available in the art, such as dipping, spraying, vapor deposition, an injection-like and/or a dot matrix-like approach. Upon contact of the coating composition with adjacent tissue where implanted, the coating composition can begin to degrade in a controlled manner. As the coating composition degrades, the therapeutic agent is slowly released into adjacent tissue and the therapeutic agent is eluted so that the therapeutic agent can have its effect locally.
  • Where the therapeutic agent comprises a biological agent, such as cells, the biological agent can be coated directly onto the surface of the present invention or, alternatively, they can be incorporated into the polymeric material (e.g., into a polymer matrix). Such biological agents may also be included within at least one microscopic containment vehicle (e.g., a liposome, nanocapsule, nanoparticle, micelle, synthetic phospholipid, gas-dispersion, emulsion, microemulsion, nanosphere, and the like) that can be stimulated to release the biological agent(s) and/or that release the biological agent(s) in a controlled manner. The microscopic containment vehicle can be coated onto the surface of the present invention or incorporated into the polymeric material. Where the biological agent comprises cells, for example, the cells can be induced to produce, activate, and/or release their cellular products (including one or more therapeutic agents) by an external stimulation device (e.g., an electrical impulse). Alternatively, cells can constitutively release one or more therapeutic agents at a desired level.
  • To enable delivery and deployment of the apparatus 10, the apparatus is positioned about a balloon 120 (FIG. 1) for expanding the main body portion 46 of the support member 40 into full and complete contact with the annulus 20 of the mitral valve 14. The balloon 120 may have an hourglass shape to conform to the concave cross-sectional configuration of the main body portion 46. The shape of the balloon 120 is defined by first and second bulb sections 122 and 124 connected by a center section 126. Each of these sections 122, 124 and 126 may have a D-shaped diameter (or other shaped diameter) to match the D-shaped diameter of the valve 14 and the prosthetic valve 12. The center section 126 of the balloon 120 has a smaller diameter than the bulb sections 122 and 124. The first and second bulb sections 122 and 124 and the center section 126 may be inflated together or separately. Further, the sections 122, 124 and 126 may have multiple chambers to accommodate multiple fluids (i.e., an inflation fluid and a cooling fluid).
  • In addition, releasable constraining wires (not shown) are used to temporarily hold the upper wing members 60 and the lower wing members 70 in the radially collapsed conditions shown in FIG. 1 during delivery and placement of the apparatus 10. The constraining wires can be made from a variety of different materials including metals, polymers, synthetics, fabrics, and biological tissues. With the upper wing members 60, the lower wing members 70, and the main body portion 46 of the support member 40 in their collapsed conditions, the apparatus 10 is then loaded into the end of a 16 to 22 French catheter 128 in a known manner.
  • To replace the mitral valve 14 with the apparatus 10 using a percutaneous (or intravascular) approach, the apparatus is first sized for the particular mitral valve using fluoroscopic and/or echocardiographic data. The catheter 128 is then introduced into either the right or left jugular vein (not shown), a femoral vein (not shown), or the subclavian vein (not shown) using a known percutaneous technique, such as the Seldinger technique, and is advanced through the superior or inferior vena cava (not shown) to approach the right atrium (not shown). The catheter 128 is passed through the interatrial septum (not shown) to reach the left atrium 16. From inside the left atrium 16, the apparatus 10 is then positioned within the annulus 20 of the mitral valve 14 as is shown in FIG. 1. It should be noted that the angular orientation of the apparatus 10 within the mitral valve 14 is important, so a diagnostic agent or agents, such as radiopaque markers (not shown), may be used to ensure the apparatus is rotated to the proper position prior to deployment.
  • Next, the catheter 128 is pulled back so that the support member 40 can expand to the condition shown in FIG. 2 in the annulus 20 of the native mitral valve 14. The balloon 120 is then inflated, which pushes the main body portion 46 of the support member 40 into engagement with the annulus 20 as shown in FIG. 5.
  • The constraining wires are then released, which allows the upper wing members 60 and the lower wing members 70 of the support member 40 to spring radially outward toward their expanded conditions illustrated in FIGS. 2-8. The upper wing members 60, in their radially extended condition, extend transverse to the direction of blood flow through the prosthetic valve 12, and engage the wall of the left atrium 16. Where the attachment mechanism 62 comprises barbs 64 as shown in FIG. 5, the barbs embed into the wall of the left atrium 16 to help secure the support member 40 in the annulus 20 of the mitral valve 14.
  • As the lower wing members 70 move from their radially collapsed condition to their radially extended condition, each of the lower wing members engages a portion of the native valve leaflets 22 and 24. The first and second lower wing members 72 and 74 engage the commissures of the native mitral valve 14 (FIG. 5), while the third and fourth lower wing members 76 and 78 engage respective central portions of the native valve leaflets 22 and 24 (FIG. 6). The barbs 64 on the lower wing members 70 embed into the native valve leaflets 22 and 24 to help secure the support member 40 in the annulus 20 of the mitral valve 14. In their radially extended condition, the lower wing members 70 pin the native leaflets 22 and 24 back against the valve annulus 20 so that the prosthetic valve 12 can assume the valvular function. With the apparatus 10 fully deployed, the balloon 120 is deflated and moved out of the valve annulus 20.
  • It should be noted that the engagement of the main body portion body 46 with the valve annulus 20, the engagement of the upper wing members 60 with the wall of the left atrium 16, and the engagement of the lower wing members 70 that pins the native valve leaflets 22 and 24 back against the valve annulus provides a unique three-way locking mechanism for securing the apparatus 10 in the valve annulus.
  • It is contemplated that the apparatus 10 according to the present invention could alternatively be placed by a retrograde, percutaneous approach. For example, the apparatus 10 may be urged in a retrograde fashion through a femoral artery (not shown), across the aortic arch (not shown), through the aortic valve (not shown), and into the left ventricle 18 where the apparatus may then be appropriate positioned in the native mitral valve 14.
  • FIG. 12 illustrates another alternative embodiment of the present invention. The apparatus 10 b of FIG. 12 is identically constructed as the apparatus 10 of FIGS. 2-8, except whereas described below. In FIG. 12, structures that are identical as structures in FIGS. 2-8 use the same reference numbers, whereas structures that are similar but not identical carry the suffix “b”.
  • As shown in FIG. 12, the apparatus 10 b comprises a tri-leaflet prosthetic valve 12 b. Examples of tri-leaflet prosthetic valves, such as the prosthetic valves disclosed in U.S. Pat. No. 5,156,621, which is hereby incorporated by reference in its entirety, are known in the art. The tri-leaflet prosthetic valve 12 b, such as a porcine aortic valve, may be used in either the mitral or tricuspid position. The prosthetic valve 12 b may be made of other biological materials, including, but not limited to, aortic xenografts, bovine pericardial tissue, equine pericardial tissue, porcine pericardial tissue, peritoneal tissue, and a homograft or allograft. Additionally, the prosthetic valve 12 b may be made of any one or combination of biocompatible materials such as polyurethane, PTFE, expanded PTFE, Dacron®, woven velour, Gore-Tex®, and heparin coated fabric.
  • As may be seen in FIG. 12, in the tricuspid position, six lower wing members 70 may be used so that a lower wing member is positioned at each native commissure and directly over each native valve leaflet. The support structure 40 of the apparatus 10 b also includes at least three strut members 45 that are spaced apart from each other. The valve leaflets of the prosthetic valve 12 b are joined together at at least three commissural sections 47. Each of the three commissural sections 47 are attached to a representative one of the strut members 45 to prevent prolapse of the valve leaflets 22 and 24. Other than this, the apparatus 10 b with the tri-leaflet prosthetic valve 12 b is deployed and functions as described above with regard to the previous embodiment. It should be understood that more or less than six lower wing members 70 could be used.
  • The present invention thus allows for the apparatus 10 to be delivered in a cardiac catheterization laboratory with a percutaneous approach under local anesthesia using fluoroscopic as well as echocardiographic guidance, thereby avoiding general anesthesia and highly invasive open heart surgery techniques. This approach offers tremendous advantages for high risk patients with severe valvular disease. It should be understood, however, that the present invention contemplates. various other approaches, including standard open heart surgeries as well as minimally invasive surgical techniques. Because the present invention omits stitching of the apparatus 10 in the valve annulus 20, surgical time is reduced regardless of whether an open, minimally invasive or percutaneous approach is used.
  • From the above description of the invention, those skilled in the art will perceive improvements, changes and modifications. For example, it should be understood by those skilled in the art that the various portions of the support member 40 could be self-expanding or expanded by a change in temperature (because they are made from a shape memory material). Such improvements, changes and modifications within the skill of the art are intended to be covered by the appended claims.

Claims (30)

1. An apparatus for replacing a cardiac valve having at least two native valve leaflets, said apparatus comprising:
an expandable support member having oppositely disposed first and second ends and a main body portion extending between said ends, said main body portion of said support member having an annular shape for expanding into position in the annulus of the cardiac valve;
said first end of said support member comprising a plurality of upper wing members that extend from said main body portion, each of said upper wing members being movable from a radially collapsed condition into a radially extended condition for engaging a first section of cardiac tissue surrounding one-side of the cardiac valve;
said second end of said support member comprising a plurality of lower wing members that extend from said main body portion, each of said lower wing members being movable from a radially collapsed condition into a radially extended condition for engaging a portion of the native valve leaflets to pin the leaflets back against the annulus of the native cardiac valve;
said second end of said support member further including at least two strut members that are spaced apart from each other; and
a prosthetic valve secured within said main body portion of said support member, said prosthetic valve having at least two valve leaflets that are coaptable to permit unidirectional flow of blood, each of said at least two valve leaflets being joined together at at least two commissural sections that are spaced apart from each other, each of said at least two commissural sections being attached to a respective one of said strut members to prevent prolapse of said valve leaflets.
2. The apparatus of claim 1 wherein said plurality of upper wing members, in their radially extended condition, extend transverse to the direction of blood flow through said prosthetic valve.
3. The apparatus of claim 1 wherein at least one of said plurality of upper wing members includes at least one attachment mechanism for embedding into the first section of cardiac tissue to help secure said support member in the annulus of the cardiac valve.
4. The apparatus of claim 3 wherein said at least one attachment mechanism includes at least one barb.
5. The apparatus of claim 1 wherein at least one of said plurality of lower wing members includes at least one attachment mechanism for embedding into a portion of the native valve leaflets to help secure said support member in the annulus of the cardiac valve.
6. The apparatus of claim 1 wherein said main body portion has a concave cross-sectional shape for conforming to the convex shape of the annulus of the cardiac valve.
7. The apparatus of claim 1 wherein said plurality of lower wing members includes first and second lower wing members for positioning at the commissures of the native cardiac valve.
8. The apparatus of claim 7 wherein said first and second lower wing members are spaced approximately 180° apart.
9. The apparatus of claim 8 wherein said plurality of lower wing members further includes third and fourth lower wing members for positioning directly over respective central portions of the at least two native valve leaflets.
10. The apparatus of claim 9 wherein said third and fourth lower wing members are spaced approximately 180° apart and are located in-between said first and second lower wing members, respectively.
11. The apparatus of claim 1 wherein said plurality of lower wing members includes a first group of lower wing members for positioning at the commissures of the native cardiac valve.
12. The apparatus of claim 11 wherein said plurality of lower wing members further includes a second group of lower wing members for positioning directly over respective central portions of the at least two native valve leaflets, said first and second groups of lower wing members being arranged in an alternating fashion.
13. The apparatus of claim 1 wherein said plurality of lower wing members includes at least two lower wing members for positioning directly over respective central portions of the at least two native valve leaflets.
14. The apparatus of claim 1 further comprising a layer of biocompatible material covering at least a portion of said support member.
15. The apparatus of claim 1 wherein at least a portion of said support member is treated with at least one therapeutic agent for eluting into cardiac tissue.
16. The apparatus of claim 1 wherein a plurality of portions of said support member are separately treated with a different therapeutic agent.
17. A method for replacing a cardiac valve having at least two native valve leaflets, said method comprising the steps of:
providing a prosthetic valve that includes an expandable support member having oppositely disposed first and second ends and a main body portion extending between the ends, a plurality of upper wing members that extend from a one end of the main body portion, and a plurality of lower wing members that extend from an opposite end of the main body portion, the second end of the support member further including at least two strut members, the prosthetic valve having at least two valve leaflets that are joined together at at least two commissural sections, each of the at least two commissural sections being attached to a respective one of the strut members to prevent prolapse of the valve leaflets;
placing the main body portion of the prosthetic valve within the annulus of the cardiac valve to be replaced;
expanding the main body portion into engagement with the annulus of the cardiac valve to secure the prosthetic valve in the annulus;
deploying the upper wing members from a radially collapsed condition into a radially extended condition into engagement with a first section of cardiac tissue surrounding one side of the cardiac valve; and
deploying the lower wing members from a radially collapsed condition into a radially extended condition into engagement with a portion of the native valve leaflets to pin the leaflets back against the annulus of the native cardiac valve.
18. The method of claim 17 wherein said step of placing the main body portion of the prosthetic valve within the annulus of the cardiac valve to be replaced further comprises the steps of:
placing the support member around an inflatable balloon in a secured manner;
inserting the balloon and support member into an atrial chamber;
advancing the balloon until the support member is positioned within the annulus of the cardiac valve to be replaced; and
expanding the support member with the balloon so that the support member engages the annulus of the cardiac valve to secure the support member in the annulus.
19. The method of claim 18 wherein the balloon has an hourglass shape defined by first and second bulb sections connected by a center section having a smaller diameter than the bulb sections, said step of placing the support member around the balloon further comprising the step of positioning the support member about the center section.
20. The method of claim 19 wherein said step of advancing the balloon until the support member is positioned within the valve annulus further includes the step of positioning the first bulb section within the leaflets of the native valve so that when the balloon is inflated the first bulb pushes the valve leaflets back to protect the leaflets during expansion of the support member.
21. The method of claim 18 wherein said step of expanding the support member with the balloon so that the support member engages the annulus of the cardiac valve includes the step of conforming the main body portion to the shape of the valve annulus to help locate and secure the support member in the valve annulus by radially forcing the main body portion into the valve annulus.
22. The method of claim 17 wherein each of the plurality of wing members include at least one attachment mechanism for embedding into cardiac tissue.
23. The method of claim 22 wherein the attachment mechanism includes at least one barb extending from each of the wing members, said method further including the step of embedding the at least one barb into cardiac tissue to further secure the support member in the valve annulus.
24. The method of claim 23 wherein each of the wing members has a concave cross-sectional shape for conforming to the convex shape of the valve annulus, said method further comprising the step of pulling the wing members into a flatter cross-sectional shape with a constraining wire for placement of the support member, the at least one barb extending generally radially when the wing members are being held by the constraining wire.
25. The method of claim 24 further comprising the step of releasing the constraining wire after said step of expanding the support member with the balloon so that the upper wing members spring radially outward to engage the first section of cardiac tissue, and the lower wing members spring radially outward to engage a portion of the native valve leaflets.
26. The method of claim 25 wherein said step of releasing the constraining wire causes the at least one barb to embed into cardiac tissue in the distal direction.
27. The method of claim 17 wherein said step of inserting the balloon and the prosthetic valve into the heart chamber is done percutaneously via an intravascular catheter.
28. The method of claim 27 wherein said step of inserting the balloon and the prosthetic valve into the heart chamber is done via a minimally invasive approach.
29. The method of claim 27 wherein said step of inserting the balloon and the prosthetic valve into the heart chamber is done via an open-chest procedure.
30. The method of claim 17 wherein at least a portion of the support member is treated with at least one therapeutic agent for eluting into cardiac tissue, the method further comprising the step of allowing the at least one therapeutic agent to elute into the cardiac tissue.
US11/357,485 2005-02-18 2006-02-18 Apparatus and methods for replacing a cardiac valve Abandoned US20060195183A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US11/357,485 US20060195183A1 (en) 2005-02-18 2006-02-18 Apparatus and methods for replacing a cardiac valve
US12/828,991 US8685086B2 (en) 2006-02-18 2010-07-01 Apparatus and method for replacing a diseased cardiac valve
US14/048,987 US10583001B2 (en) 2005-02-18 2013-10-08 Methods for replacing a cardiac valve
US14/230,216 US10010416B2 (en) 2006-02-18 2014-03-31 Apparatus and method for replacing a diseased cardiac valve
US16/025,977 US10939999B2 (en) 2005-02-18 2018-07-02 Apparatus and method for replacing a diseased cardiac valve

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65472505P 2005-02-18 2005-02-18
US11/357,485 US20060195183A1 (en) 2005-02-18 2006-02-18 Apparatus and methods for replacing a cardiac valve

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US12/769,593 Continuation-In-Part US20100312333A1 (en) 2005-02-18 2010-04-28 Apparatus and method for replacing a diseased cardiac valve
US12/828,991 Continuation-In-Part US8685086B2 (en) 2005-02-18 2010-07-01 Apparatus and method for replacing a diseased cardiac valve
US14/048,987 Division US10583001B2 (en) 2005-02-18 2013-10-08 Methods for replacing a cardiac valve

Publications (1)

Publication Number Publication Date
US20060195183A1 true US20060195183A1 (en) 2006-08-31

Family

ID=36609618

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/357,485 Abandoned US20060195183A1 (en) 2005-02-18 2006-02-18 Apparatus and methods for replacing a cardiac valve
US14/048,987 Active US10583001B2 (en) 2005-02-18 2013-10-08 Methods for replacing a cardiac valve

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/048,987 Active US10583001B2 (en) 2005-02-18 2013-10-08 Methods for replacing a cardiac valve

Country Status (5)

Country Link
US (2) US20060195183A1 (en)
EP (1) EP1850796B1 (en)
DK (1) DK1850796T3 (en)
ES (1) ES2558534T3 (en)
WO (1) WO2006089236A1 (en)

Cited By (351)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050216079A1 (en) * 2000-09-20 2005-09-29 Ample Medical, Inc. Heart valve annulus device and method of using same
US20060173524A1 (en) * 2003-12-23 2006-08-03 Amr Salahieh Medical Implant Delivery And Deployment Tool
US20060287716A1 (en) * 2005-06-08 2006-12-21 The Cleveland Clinic Foundation Artificial chordae
US20070061008A1 (en) * 2005-09-13 2007-03-15 Amr Salahieh Two-Part Package For Medical Implant
US20080177381A1 (en) * 2007-01-19 2008-07-24 The Cleveland Clinic Foundation Method for implanting a cardiovascular valve
US20080207874A1 (en) * 2004-07-01 2008-08-28 Biosource Pharm, Inc. Peptide Antibiotics and Methods For Making Same
US20090088837A1 (en) * 2007-09-28 2009-04-02 The Cleveland Clinic Foundation Prosthetic chordae assembly and method of use
US20090105751A1 (en) * 2007-10-18 2009-04-23 John Zentgraf Minimally invasive repair of a valve leaflet in a beating heart
US20090216314A1 (en) * 2005-11-10 2009-08-27 Arshad Quadri Balloon-Expandable, Self-Expanding, Vascular Prosthesis Connecting Stent
US20090276040A1 (en) * 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
US20090281618A1 (en) * 2008-04-23 2009-11-12 Medtronic, Inc. Prosthetic Heart Valve Devices and Methods of Valve Replacement
US20090306768A1 (en) * 2006-07-28 2009-12-10 Cardiaq Valve Technologies, Inc. Percutaneous valve prosthesis and system and method for implanting same
US20100036479A1 (en) * 2008-04-23 2010-02-11 Medtronic, Inc. Stented Heart Valve Devices
US20100082094A1 (en) * 2008-09-29 2010-04-01 Arshad Quadri Heart valve
US20100082089A1 (en) * 2008-10-01 2010-04-01 Arshad Quadri Delivery system for vascular implant
US20100100176A1 (en) * 2003-10-06 2010-04-22 Ats Medical, Inc. Anchoring structure with concave landing zone
US7708775B2 (en) 2005-05-24 2010-05-04 Edwards Lifesciences Corporation Methods for rapid deployment of prosthetic heart valves
US20100137979A1 (en) * 2006-09-19 2010-06-03 Yosi Tuval Sinus-engaging Valve Fixation Member
US20100249919A1 (en) * 2009-03-31 2010-09-30 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US20100256751A1 (en) * 2008-06-20 2010-10-07 Edwards Lifesciences Corporation Retaining Mechanisms for Prosthetic Valves
US20100280606A1 (en) * 2009-03-17 2010-11-04 Biomedxl Heart valve prosthesis with collapsible valve and method of delivery thereof
US7951197B2 (en) 2005-04-08 2011-05-31 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US7959673B2 (en) 2007-02-09 2011-06-14 Edwards Lifesciences Corporation Degenerative valvular disease specific annuloplasty rings
US20110147251A1 (en) * 2009-12-18 2011-06-23 Edwards Lifesciences Corporation Prosthetic heart valve packaging and deployment system
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
US7972377B2 (en) 2001-12-27 2011-07-05 Medtronic, Inc. Bioprosthetic heart valve
US7981153B2 (en) 2002-12-20 2011-07-19 Medtronic, Inc. Biologically implantable prosthesis methods of using
US7988724B2 (en) 2003-12-23 2011-08-02 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US20110198244A1 (en) * 2010-02-15 2011-08-18 Edwards Lifesciences Corporation Prosthetic heart valve packaging system
US20110214398A1 (en) * 2010-03-05 2011-09-08 Edwards Lifesciences Corporation Dry Prosthetic Heart Valve Packaging System
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US20110268774A1 (en) * 2008-12-30 2011-11-03 Andrey Stepanovich Bryukhovetskiy preparation of stem cells with reprogrammed cell signalling, a method of producing the preparation and a method of use thereof
US20110270393A1 (en) * 2008-06-04 2011-11-03 James Marvel Buffer for a human joint and method of arthroscopically inserting
US8052749B2 (en) * 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US20120016468A1 (en) * 2010-05-19 2012-01-19 Direct Flow Medical, Inc. Low crossing profile delivery catheter for cardiovascular prosthetic implant
US8109995B2 (en) 2002-01-04 2012-02-07 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US8142495B2 (en) 2006-05-15 2012-03-27 Edwards Lifesciences Ag System and a method for altering the geometry of the heart
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US20120150290A1 (en) * 2010-11-12 2012-06-14 Shlomo Gabbay Beating heart buttress and implantation method to prevent prolapse of a heart valve
US20120158128A1 (en) * 2010-12-16 2012-06-21 Edwards Lifesciences Corporation Prosthetic heart valve delivery systems and packaging
US8211169B2 (en) 2005-05-27 2012-07-03 Medtronic, Inc. Gasket with collar for prosthetic heart valves and methods for using them
US20120179247A1 (en) * 2007-11-19 2012-07-12 The Cleveland Clinic Foundation Apparatus and method for treating a regurgitant heart valve
US8231670B2 (en) 2003-12-23 2012-07-31 Sadra Medical, Inc. Repositionable heart valve and method
US8246678B2 (en) 2003-12-23 2012-08-21 Sadra Medicl, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8252052B2 (en) 2003-12-23 2012-08-28 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8287584B2 (en) 2005-11-14 2012-10-16 Sadra Medical, Inc. Medical implant deployment tool
US8328868B2 (en) 2004-11-05 2012-12-11 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US20120316640A1 (en) * 2006-11-13 2012-12-13 Keraenen Olli Device And Method For Improving Function Of Heart Valve
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
US8361144B2 (en) 2010-03-01 2013-01-29 Colibri Heart Valve Llc Percutaneously deliverable heart valve and methods associated therewith
US20130053951A1 (en) * 2010-03-19 2013-02-28 Xavier Ruyra Baliarda Prosthetic band, in particular for repairing a mitral valve
US8414644B2 (en) 2009-04-15 2013-04-09 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US8529621B2 (en) 2001-05-17 2013-09-10 Edwards Lifesciences Corporation Methods of repairing an abnormal mitral valve
US8568473B2 (en) 2005-12-15 2013-10-29 Georgia Tech Research Corporation Systems and methods for enabling heart valve replacement
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
JP2013542764A (en) * 2010-09-30 2013-11-28 バイオステイブル サイエンス アンド エンジニアリング インコーポレイテッド Aortic valve device
US8603161B2 (en) 2003-10-08 2013-12-10 Medtronic, Inc. Attachment device and methods of using the same
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US8623076B2 (en) 2003-12-23 2014-01-07 Sadra Medical, Inc. Low profile heart valve and delivery system
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
US8652203B2 (en) 2010-09-23 2014-02-18 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US8668733B2 (en) 2004-06-16 2014-03-11 Sadra Medical, Inc. Everting heart valve
US8685083B2 (en) 2005-06-27 2014-04-01 Edwards Lifesciences Corporation Apparatus, system, and method for treatment of posterior leaflet prolapse
US8709076B1 (en) * 2013-03-01 2014-04-29 Cormatrix Cardiovascular, Inc. Two-piece prosthetic valve
US8728155B2 (en) 2011-03-21 2014-05-20 Cephea Valve Technologies, Inc. Disk-based valve apparatus and method for the treatment of valve dysfunction
US20140155990A1 (en) * 2012-05-30 2014-06-05 Neovasc Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US8821569B2 (en) 2006-04-29 2014-09-02 Medtronic, Inc. Multiple component prosthetic heart valve assemblies and methods for delivering them
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8845720B2 (en) 2010-09-27 2014-09-30 Edwards Lifesciences Corporation Prosthetic heart valve frame with flexible commissures
WO2014164364A1 (en) * 2013-03-13 2014-10-09 Aortic Innovations, Llc Dual frame stent and valve devices and implantation
US8858620B2 (en) 2003-12-23 2014-10-14 Sadra Medical Inc. Methods and apparatus for endovascularly replacing a heart valve
US8870948B1 (en) 2013-07-17 2014-10-28 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US20140330369A1 (en) * 2013-05-03 2014-11-06 Robert G Matheny Prosthetic Tissue Valves and Methods for Anchoring Same to Cardiovascular Structures
WO2014189509A1 (en) * 2013-05-22 2014-11-27 Nadav Yellin Transcatheter prosthetic valve for mitral or tricuspid valve replacement
US8900295B2 (en) 2011-09-26 2014-12-02 Edwards Lifesciences Corporation Prosthetic valve with ventricular tethers
US8906866B2 (en) 2010-06-23 2014-12-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8937040B2 (en) 2008-12-23 2015-01-20 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8940014B2 (en) 2011-11-15 2015-01-27 Boston Scientific Scimed, Inc. Bond between components of a medical device
US20150039081A1 (en) * 2013-07-31 2015-02-05 Medtronic Vascular Galway Mitral Valve Prosthesis for Transcatheter Valve Implantation
US8951243B2 (en) 2011-12-03 2015-02-10 Boston Scientific Scimed, Inc. Medical device handle
US20150045880A1 (en) * 2009-12-08 2015-02-12 Mitraltech Ltd. Implant for rotation-based anchoring
US8968394B2 (en) 2011-05-12 2015-03-03 Edwards Lifesciences Corporation Mitral heart valve holder and storage system
US20150073548A1 (en) * 2013-09-11 2015-03-12 Cormatrix Cardiovascular, Inc. Systems, Apparatus and Methods for Sealing Perivalvular Leaks
US8986374B2 (en) 2010-05-10 2015-03-24 Edwards Lifesciences Corporation Prosthetic heart valve
US8998976B2 (en) 2011-07-12 2015-04-07 Boston Scientific Scimed, Inc. Coupling system for medical devices
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US9011521B2 (en) 2003-12-23 2015-04-21 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9034033B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9044221B2 (en) 2010-12-29 2015-06-02 Neochord, Inc. Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
JP2015119993A (en) * 2009-11-05 2015-07-02 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Valve prosthesis
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US9078749B2 (en) 2007-09-13 2015-07-14 Georg Lutter Truncated cone heart valve stent
US9101472B2 (en) 2007-09-07 2015-08-11 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US20150223820A1 (en) * 2014-02-07 2015-08-13 St. Jude Medical, Cardiology Division, Inc. Mitral valve treatment device having left atrial appendage closure
US9119738B2 (en) 2010-06-28 2015-09-01 Colibri Heart Valve Llc Method and apparatus for the endoluminal delivery of intravascular devices
US20150245907A1 (en) * 2011-05-27 2015-09-03 Robert G. Matheny Extracellular Matrix Material Valve Conduit and Methods of Making Thereof
US9125740B2 (en) 2011-06-21 2015-09-08 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9125741B2 (en) 2010-09-10 2015-09-08 Edwards Lifesciences Corporation Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves
US9125742B2 (en) 2005-12-15 2015-09-08 Georgia Tech Research Foundation Papillary muscle position control devices, systems, and methods
US9131926B2 (en) 2011-11-10 2015-09-15 Boston Scientific Scimed, Inc. Direct connect flush system
US9149359B2 (en) 2001-08-28 2015-10-06 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US9155622B2 (en) 2013-08-14 2015-10-13 Sorin Group Italia S.R.L. Apparatus and method for chordal replacement
US9180008B2 (en) 2012-02-29 2015-11-10 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US9186249B2 (en) 2012-08-10 2015-11-17 Sorin Group Italia S.R.L. Valve prosthesis and kit
US20150351904A1 (en) * 2014-06-06 2015-12-10 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US9232996B2 (en) 2011-02-25 2016-01-12 University Of Connecticut Prosthetic heart valve
US9241790B2 (en) 2010-05-05 2016-01-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US20160045314A1 (en) * 2013-03-04 2016-02-18 Medical Research Infrastructure And Health Service Fund Of The Tel-Aviv Medical Center Cardiac valve commissure brace
US9277993B2 (en) 2011-12-20 2016-03-08 Boston Scientific Scimed, Inc. Medical device delivery systems
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9314334B2 (en) 2008-11-25 2016-04-19 Edwards Lifesciences Corporation Conformal expansion of prosthetic devices to anatomical shapes
US20160106539A1 (en) * 2013-05-29 2016-04-21 Mvalve Technologies Ltd. Cardiac valve support device fitted with valve leaflets
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US9326858B2 (en) 2010-08-24 2016-05-03 Edwards Lifesciences Corporation Flexible annuloplasty ring
US9364354B2 (en) 2000-03-27 2016-06-14 Neovasc Medical Ltd Methods for treating abnormal growths in the body using a flow reducing implant
US9370418B2 (en) 2010-09-10 2016-06-21 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US9387078B2 (en) 2011-08-05 2016-07-12 Mitraltech Ltd. Percutaneous mitral valve replacement and sealing
US9402721B2 (en) 2011-06-01 2016-08-02 Valcare, Inc. Percutaneous transcatheter repair of heart valves via trans-apical access
US9415225B2 (en) 2005-04-25 2016-08-16 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US9421098B2 (en) 2010-12-23 2016-08-23 Twelve, Inc. System for mitral valve repair and replacement
US20160242909A1 (en) * 2005-02-07 2016-08-25 Evalve, Inc. Methods, systems and devices for cardiac valve repair
US9433503B2 (en) 2010-08-04 2016-09-06 Valcare, Inc. Percutaneous transcatheter repair of heart valves
US9439757B2 (en) 2014-12-09 2016-09-13 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US9445897B2 (en) 2012-05-01 2016-09-20 Direct Flow Medical, Inc. Prosthetic implant delivery device with introducer catheter
US20160278916A1 (en) * 2008-04-08 2016-09-29 Medtronic, Inc. Multiple Orifice Implantable Heart Valve and Methods of Implantation
US9468527B2 (en) 2013-06-12 2016-10-18 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US9474607B2 (en) 2010-11-30 2016-10-25 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US9480560B2 (en) 2009-09-29 2016-11-01 Edwards Lifesciences Cardiaq Llc Method of securing an intralumenal frame assembly
US9480559B2 (en) 2011-08-11 2016-11-01 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US9486306B2 (en) 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
US9510945B2 (en) 2011-12-20 2016-12-06 Boston Scientific Scimed Inc. Medical device handle
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US9532868B2 (en) * 2007-09-28 2017-01-03 St. Jude Medical, Inc. Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9585752B2 (en) 2014-04-30 2017-03-07 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US9597181B2 (en) 2013-06-25 2017-03-21 Tendyne Holdings, Inc. Thrombus management and structural compliance features for prosthetic heart valves
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US20170156855A1 (en) * 2013-05-03 2017-06-08 Cormatrix Cardiovascular Inc Prosthetic Tissue Valves and Methods for Anchoring Same to Cardiovascular Structures
US9675454B2 (en) 2012-07-30 2017-06-13 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9687346B2 (en) 2013-03-14 2017-06-27 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US9717591B2 (en) 2009-12-04 2017-08-01 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9737400B2 (en) 2010-12-14 2017-08-22 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US9744059B2 (en) 2003-11-19 2017-08-29 Neovasc Medical Ltd. Vascular implant
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US9788941B2 (en) 2010-03-10 2017-10-17 Mitraltech Ltd. Axially-shortening prosthetic valve
USD800908S1 (en) 2016-08-10 2017-10-24 Mitraltech Ltd. Prosthetic valve element
US20170325938A1 (en) 2016-05-16 2017-11-16 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US9839519B2 (en) 2012-02-29 2017-12-12 Valcare, Inc. Percutaneous annuloplasty system with anterior-posterior adjustment
CN107530177A (en) * 2015-04-09 2018-01-02 弗里德曼德科技公司 For pre- anti-stroke 3D filters
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US9895225B2 (en) 2012-03-23 2018-02-20 Sorin Group Italia S.R.L. Collapsible valve prosthesis
US9895221B2 (en) 2012-07-28 2018-02-20 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US9901443B2 (en) 2011-10-19 2018-02-27 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
US9919137B2 (en) 2013-08-28 2018-03-20 Edwards Lifesciences Corporation Integrated balloon catheter inflation system
USD815744S1 (en) 2016-04-28 2018-04-17 Edwards Lifesciences Cardiaq Llc Valve frame for a delivery system
US9968454B2 (en) 2009-10-29 2018-05-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of artificial chordae
US9974651B2 (en) 2015-02-05 2018-05-22 Mitral Tech Ltd. Prosthetic valve with axially-sliding frames
US9986993B2 (en) 2014-02-11 2018-06-05 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
US10004599B2 (en) 2014-02-21 2018-06-26 Edwards Lifesciences Cardiaq Llc Prosthesis, delivery device and methods of use
US10022224B2 (en) 2012-08-17 2018-07-17 On-X Life Technologies, Inc. Biological chord repair system and methods
US10034747B2 (en) 2015-08-27 2018-07-31 Medtronic Vascular, Inc. Prosthetic valve system having a docking component and a prosthetic valve component
US10039531B2 (en) 2005-12-15 2018-08-07 Georgia Tech Research Corporation Systems and methods to control the dimension of a heart valve
US20180228590A1 (en) * 2015-09-09 2018-08-16 Frid Mind Technologies Bifurcated 3d filter assembly for prevention of stroke
WO2018148839A1 (en) * 2017-02-17 2018-08-23 Cardiovascular Diagnostics Inc. Transcatheter heart valve apparatus for calcific mitral stenosis
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
US10087503B2 (en) 2011-08-03 2018-10-02 The Curators Of The University Of Missouri Method for separation of chemically pure Os from metal mixtures
US10092400B2 (en) 2015-06-23 2018-10-09 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
US10111747B2 (en) 2013-05-20 2018-10-30 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10117741B2 (en) * 2013-10-23 2018-11-06 Caisson Interventional, LLC Methods and systems for heart valve therapy
US10117744B2 (en) 2015-08-26 2018-11-06 Edwards Lifesciences Cardiaq Llc Replacement heart valves and methods of delivery
US10130463B2 (en) 2007-08-23 2018-11-20 Dfm, Llc Translumenally implantable heart valve with formed in place support
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10143552B2 (en) 2015-05-14 2018-12-04 Cephea Valve Technologies, Inc. Replacement mitral valves
US10143550B2 (en) 2013-08-08 2018-12-04 Sorin Group Italia S.R.L. Heart valve prosthesis
US10166101B2 (en) 2001-05-17 2019-01-01 Edwards Lifesciences Corporation Methods for repairing mitral valves
US10166100B2 (en) 2013-03-15 2019-01-01 Valcare, Inc. Systems and methods for delivery of annuloplasty rings
US10172708B2 (en) 2012-01-25 2019-01-08 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
US10179044B2 (en) 2014-05-19 2019-01-15 Edwards Lifesciences Cardiaq Llc Replacement mitral valve
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
US10201418B2 (en) 2010-09-10 2019-02-12 Symetis, SA Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
US10201419B2 (en) 2014-02-05 2019-02-12 Tendyne Holdings, Inc. Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US10201417B2 (en) 2015-02-03 2019-02-12 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
USD841813S1 (en) 2017-08-03 2019-02-26 Cardiovalve Ltd. Prosthetic heart valve element
US10213298B2 (en) 2004-03-11 2019-02-26 Percutaneous Cardiovascular Solutions Pty Ltd Percutaneous heart valve prosthesis
US10226335B2 (en) 2015-06-22 2019-03-12 Edwards Lifesciences Cardiaq Llc Actively controllable heart valve implant and method of controlling same
US10245141B2 (en) 2014-05-14 2019-04-02 Sorin Group Italia S.R.L. Implant device and implantation kit
US10245136B2 (en) 2016-05-13 2019-04-02 Boston Scientific Scimed Inc. Containment vessel with implant sheathing guide
US10245143B2 (en) 2011-08-05 2019-04-02 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US10258465B2 (en) 2003-12-23 2019-04-16 Boston Scientific Scimed Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
USD846122S1 (en) 2016-12-16 2019-04-16 Edwards Lifesciences Corporation Heart valve sizer
US10265172B2 (en) 2016-04-29 2019-04-23 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US10278805B2 (en) 2000-08-18 2019-05-07 Atritech, Inc. Expandable implant devices for filtering blood flow from atrial appendages
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10299922B2 (en) 2005-12-22 2019-05-28 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US10314707B2 (en) 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US10327894B2 (en) 2015-09-18 2019-06-25 Tendyne Holdings, Inc. Methods for delivery of prosthetic mitral valves
US10335277B2 (en) 2015-07-02 2019-07-02 Boston Scientific Scimed Inc. Adjustable nosecone
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US10350066B2 (en) 2015-08-28 2019-07-16 Edwards Lifesciences Cardiaq Llc Steerable delivery system for replacement mitral valve and methods of use
US10350047B2 (en) 2015-09-02 2019-07-16 Edwards Lifesciences Corporation Method and system for packaging and preparing a prosthetic heart valve and associated delivery system
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
US10357351B2 (en) 2015-12-04 2019-07-23 Edwards Lifesciences Corporation Storage assembly for prosthetic valve
US10368990B2 (en) 2017-01-23 2019-08-06 Cephea Valve Technologies, Inc. Replacement mitral valves
US10376361B2 (en) 2011-08-05 2019-08-13 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US10376363B2 (en) 2015-04-30 2019-08-13 Edwards Lifesciences Cardiaq Llc Replacement mitral valve, delivery system for replacement mitral valve and methods of use
EP2688525B1 (en) 2011-03-23 2019-08-21 Daidalos Solutions B.V. Medical instrument, ring prosthesis, stent and stented valve
US10390952B2 (en) 2015-02-05 2019-08-27 Cardiovalve Ltd. Prosthetic valve with flexible tissue anchor portions
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10441416B2 (en) 2015-04-21 2019-10-15 Edwards Lifesciences Corporation Percutaneous mitral valve replacement device
US10449043B2 (en) 2015-01-16 2019-10-22 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US10456245B2 (en) 2016-05-16 2019-10-29 Edwards Lifesciences Corporation System and method for applying material to a stent
US10456246B2 (en) 2015-07-02 2019-10-29 Edwards Lifesciences Corporation Integrated hybrid heart valves
US10463494B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10470877B2 (en) 2016-05-03 2019-11-12 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
US10470881B2 (en) 2015-05-14 2019-11-12 Cephea Valve Technologies, Inc. Replacement mitral valves
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US10485660B2 (en) 2010-06-21 2019-11-26 Edwards Lifesciences Cardiaq Llc Replacement heart valve
US10492908B2 (en) 2014-07-30 2019-12-03 Cardiovalve Ltd. Anchoring of a prosthetic valve
US10517728B2 (en) 2014-03-10 2019-12-31 Tendyne Holdings, Inc. Devices and methods for positioning and monitoring tether load for prosthetic mitral valve
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10555809B2 (en) 2012-06-19 2020-02-11 Boston Scientific Scimed, Inc. Replacement heart valve
US10555718B2 (en) 2013-10-17 2020-02-11 Tendyne Holdings, Inc. Apparatus and methods for alignment and deployment of intracardiac devices
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US10575951B2 (en) 2015-08-26 2020-03-03 Edwards Lifesciences Cardiaq Llc Delivery device and methods of use for transapical delivery of replacement mitral valve
US10575948B2 (en) 2017-08-03 2020-03-03 Cardiovalve Ltd. Prosthetic heart valve
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
US10583000B2 (en) 2013-03-14 2020-03-10 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US10588620B2 (en) 2018-03-23 2020-03-17 Neochord, Inc. Device for suture attachment for minimally invasive heart valve repair
US10588745B2 (en) 2016-06-20 2020-03-17 Medtronic Vascular, Inc. Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis
US10610358B2 (en) 2015-12-28 2020-04-07 Tendyne Holdings, Inc. Atrial pocket closures for prosthetic heart valves
US10610354B2 (en) 2013-08-01 2020-04-07 Tendyne Holdings, Inc. Epicardial anchor devices and methods
US10610356B2 (en) 2015-02-05 2020-04-07 Tendyne Holdings, Inc. Expandable epicardial pads and devices and methods for delivery of same
US10631982B2 (en) 2013-01-24 2020-04-28 Cardiovale Ltd. Prosthetic valve and upstream support therefor
US10631968B2 (en) 2017-03-06 2020-04-28 Edwards Lifesciences Corporation Humidity-management packaging systems and methods
US10639143B2 (en) 2016-08-26 2020-05-05 Edwards Lifesciences Corporation Multi-portion replacement heart valve prosthesis
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US10646340B2 (en) 2016-08-19 2020-05-12 Edwards Lifesciences Corporation Steerable delivery system for replacement mitral valve
US10667905B2 (en) 2015-04-16 2020-06-02 Tendyne Holdings, Inc. Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves
US10695178B2 (en) 2011-06-01 2020-06-30 Neochord, Inc. Minimally invasive repair of heart valve leaflets
US10695170B2 (en) 2015-07-02 2020-06-30 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10702380B2 (en) 2011-10-19 2020-07-07 Twelve, Inc. Devices, systems and methods for heart valve replacement
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10758348B2 (en) 2016-11-02 2020-09-01 Edwards Lifesciences Corporation Supra and sub-annular mitral valve delivery system
US10765517B2 (en) 2015-10-01 2020-09-08 Neochord, Inc. Ringless web for repair of heart valves
US10779940B2 (en) 2015-09-03 2020-09-22 Boston Scientific Scimed, Inc. Medical device handle
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10786351B2 (en) 2015-01-07 2020-09-29 Tendyne Holdings, Inc. Prosthetic mitral valves and apparatus and methods for delivery of same
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10813757B2 (en) 2017-07-06 2020-10-27 Edwards Lifesciences Corporation Steerable rail delivery system
US10813751B2 (en) 2013-05-22 2020-10-27 Valcare, Inc. Transcatheter prosthetic valve for mitral or tricuspid valve replacement
US10820996B2 (en) 2015-08-21 2020-11-03 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10828154B2 (en) 2017-06-08 2020-11-10 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
US10849746B2 (en) 2015-05-14 2020-12-01 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10856975B2 (en) 2016-08-10 2020-12-08 Cardiovalve Ltd. Prosthetic valve with concentric frames
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
USD908874S1 (en) 2018-07-11 2021-01-26 Edwards Lifesciences Corporation Collapsible heart valve sizer
US10898325B2 (en) 2017-08-01 2021-01-26 Boston Scientific Scimed, Inc. Medical implant locking mechanism
US10939996B2 (en) 2017-08-16 2021-03-09 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US10966709B2 (en) 2018-09-07 2021-04-06 Neochord, Inc. Device for suture attachment for minimally invasive heart valve repair
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11026792B2 (en) 2018-09-17 2021-06-08 Cardiovalve Ltd. Leaflet-grouping system
US20210177587A1 (en) * 2013-11-19 2021-06-17 St. Jude Medical, Cardiology Division, Inc. Sealing Structures for Paravalvular Leak Protection
US11039921B2 (en) 2016-06-13 2021-06-22 Tendyne Holdings, Inc. Sequential delivery of two-part prosthetic mitral valve
US11051934B2 (en) 2018-02-28 2021-07-06 Edwards Lifesciences Corporation Prosthetic mitral valve with improved anchors and seal
US11058417B2 (en) 2013-06-28 2021-07-13 Valcare, Inc. Device, system, and method to secure an article to a tissue
US11065116B2 (en) 2016-07-12 2021-07-20 Tendyne Holdings, Inc. Apparatus and methods for trans-septal retrieval of prosthetic heart valves
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11065122B2 (en) 2017-10-19 2021-07-20 Cardiovalve Ltd. Techniques for use with prosthetic valve leaflets
US20210228349A1 (en) * 2018-04-04 2021-07-29 Vdyne, Inc. Devices and methods for anchoring transcatheter heart valve
US11090157B2 (en) 2016-06-30 2021-08-17 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
US11096782B2 (en) 2015-12-03 2021-08-24 Tendyne Holdings, Inc. Frame features for prosthetic mitral valves
US11103349B2 (en) 2016-08-15 2021-08-31 Valcare, Inc. Devices and methods for the treatment of heart valve insufficiencies
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
US11154399B2 (en) 2017-07-13 2021-10-26 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
US11173030B2 (en) 2018-05-09 2021-11-16 Neochord, Inc. Suture length adjustment for minimally invasive heart valve repair
US11179236B2 (en) 2009-12-08 2021-11-23 Colorado State University Research Foundation Device and system for transcatheter mitral valve replacement
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11191639B2 (en) 2017-08-28 2021-12-07 Tendyne Holdings, Inc. Prosthetic heart valves with tether coupling features
US11191641B2 (en) 2018-01-19 2021-12-07 Boston Scientific Scimed, Inc. Inductance mode deployment sensors for transcatheter valve system
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US11229517B2 (en) 2018-05-15 2022-01-25 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11241312B2 (en) 2018-12-10 2022-02-08 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US11246625B2 (en) 2018-01-19 2022-02-15 Boston Scientific Scimed, Inc. Medical device delivery system with feedback loop
US11253360B2 (en) 2018-05-09 2022-02-22 Neochord, Inc. Low profile tissue anchor for minimally invasive heart valve repair
US11259919B2 (en) 2008-01-24 2022-03-01 Medtronic, Inc. Stents for prosthetic heart valves
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US11285002B2 (en) 2003-12-23 2022-03-29 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a heart valve
US11284999B2 (en) 2008-01-24 2022-03-29 Medtronic, Inc. Stents for prosthetic heart valves
US11291546B2 (en) 2011-08-05 2022-04-05 Cardiovalve Ltd. Leaflet clip with collars
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US11304806B2 (en) 2017-09-19 2022-04-19 Cardiovalve Ltd. Prosthetic valve with atrial tissue anchors having variable flexibility and ventricular tissue anchors having constant flexibility
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11337805B2 (en) 2018-01-23 2022-05-24 Edwards Lifesciences Corporation Prosthetic valve holders, systems, and methods
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11357623B2 (en) * 2011-12-13 2022-06-14 Boston Scientific Scimed, Inc. Decalcifying heart valve
US11376126B2 (en) 2019-04-16 2022-07-05 Neochord, Inc. Transverse helical cardiac anchor for minimally invasive heart valve repair
US11382746B2 (en) 2017-12-13 2022-07-12 Cardiovalve Ltd. Prosthetic valve and delivery tool therefor
US11395726B2 (en) 2017-09-11 2022-07-26 Incubar Llc Conduit vascular implant sealing device for reducing endoleaks
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
US11439732B2 (en) 2018-02-26 2022-09-13 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
US11491033B2 (en) 2011-12-06 2022-11-08 Aortic Innovations, Llc Transcatheter valve repair having improved paravalvular seal
US11504232B2 (en) 2008-12-19 2022-11-22 Edwards Lifesciences Corporation Rapid implant prosthetic heart valve system
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11534300B2 (en) 2018-12-03 2022-12-27 Valcare, Inc. Stabilizing and adjusting tool for controlling a minimally invasive mitral / tricuspid valve repair system
US11554015B2 (en) 2018-07-30 2023-01-17 Edwards Lifesciences Corporation Minimally-invasive low strain annuloplasty ring
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11576779B2 (en) 2017-03-17 2023-02-14 Valcare, Inc. Mitral or tricuspid repair systems with multi-directional anchors
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11589989B2 (en) 2017-03-31 2023-02-28 Neochord, Inc. Minimally invasive heart valve repair in a beating heart
US11633277B2 (en) 2018-01-10 2023-04-25 Cardiovalve Ltd. Temperature-control during crimping of an implant
US11648110B2 (en) 2019-12-05 2023-05-16 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11654018B2 (en) 2013-05-24 2023-05-23 Valcare, Inc. Heart and peripheral vascular valve replacement in conjunction with a support ring
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US11678980B2 (en) 2020-08-19 2023-06-20 Tendyne Holdings, Inc. Fully-transseptal apical pad with pulley for tensioning
US11684474B2 (en) 2018-01-25 2023-06-27 Edwards Lifesciences Corporation Delivery system for aided replacement valve recapture and repositioning post-deployment
US11690709B2 (en) 2015-09-02 2023-07-04 Edwards Lifesciences Corporation Methods for securing a transcatheter valve to a bioprosthetic cardiac structure
US11707355B2 (en) 2020-05-28 2023-07-25 Medtronic, Inc. Modular heart valve prosthesis
US11712335B2 (en) 2019-05-04 2023-08-01 Vdyne, Inc. Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus
US11723783B2 (en) 2019-01-23 2023-08-15 Neovasc Medical Ltd. Covered flow modifying apparatus
US11771544B2 (en) 2011-05-05 2023-10-03 Symetis Sa Method and apparatus for compressing/loading stent-valves
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
US11793628B2 (en) 2019-07-15 2023-10-24 Valcare, Inc. Transcatheter bio-prosthesis member and support structure
US11931237B2 (en) 2021-11-08 2024-03-19 Edwards Lifesciences Corporation Humidity-management packaging systems and methods

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276078B2 (en) 2004-06-30 2007-10-02 Edwards Lifesciences Pvt Paravalvular leak detection, sealing, and prevention
US9427315B2 (en) 2012-04-19 2016-08-30 Caisson Interventional, LLC Valve replacement systems and methods
US9011515B2 (en) 2012-04-19 2015-04-21 Caisson Interventional, LLC Heart valve assembly systems and methods
DK2852354T3 (en) 2012-05-20 2020-08-24 Tel Hashomer Medical Res Infrastructure & Services Ltd ARTIFICIAL MITRAL CLAP
FR2997288B1 (en) 2012-10-25 2015-01-23 Cormove DEVICE FOR PLACING A SEAL AROUND AN IMPLANT IN A BLOOD CIRCULATION PASSAGE, AND TREATMENT NECESSARY THEREFOR
US8628571B1 (en) 2012-11-13 2014-01-14 Mitraltech Ltd. Percutaneously-deliverable mechanical valve
US20140200662A1 (en) * 2013-01-16 2014-07-17 Mvalve Technologies Ltd. Anchoring elements for intracardiac devices
FR3020265B1 (en) * 2014-04-24 2019-09-06 Cormove DEVICE FOR PLACING A SEAL AROUND AN IMPLANT IN A BLOOD CIRCULATION PASSAGE, AND TREATMENT NECESSARY THEREFOR
US9974647B2 (en) 2014-06-12 2018-05-22 Caisson Interventional, LLC Two stage anchor and mitral valve assembly
US9750607B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9750605B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
DE102015206097A1 (en) * 2015-04-02 2016-10-06 Hans-Hinrich Sievers Heart valve prosthesis
GB2539444A (en) 2015-06-16 2016-12-21 Ucl Business Plc Prosthetic heart valve
US10456243B2 (en) 2015-10-09 2019-10-29 Medtronic Vascular, Inc. Heart valves prostheses and methods for percutaneous heart valve replacement
AU2016380345B2 (en) 2015-12-30 2021-10-28 Caisson Interventional, LLC Systems and methods for heart valve therapy
CN108882981B (en) 2016-01-29 2021-08-10 内奥瓦斯克迪亚拉公司 Prosthetic valve for preventing outflow obstruction
US10321992B2 (en) 2016-02-01 2019-06-18 Medtronic, Inc. Heart valve prostheses having multiple support arms and methods for percutaneous heart valve replacement
WO2018090148A1 (en) 2016-11-21 2018-05-24 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
JP6159041B1 (en) * 2017-02-17 2017-07-05 実 田端 Artificial valve
US20190358034A1 (en) * 2017-02-17 2019-11-28 Mitrapex, Inc. Artificial heart valve
EP3639792B1 (en) 2017-05-31 2021-10-27 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US11666444B2 (en) * 2017-08-03 2023-06-06 The Regents Of The University Of California Atrial cage for placement, securing and anchoring of atrioventricular valves
WO2019036810A1 (en) 2017-08-25 2019-02-28 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US20190365538A1 (en) * 2018-06-04 2019-12-05 4C Medical Technologies, Inc. Devices, systems and methods for preventing prolapse of native cardiac valve leaflets
US11857441B2 (en) 2018-09-04 2024-01-02 4C Medical Technologies, Inc. Stent loading device
US11737872B2 (en) 2018-11-08 2023-08-29 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US20200261219A1 (en) * 2019-02-14 2020-08-20 4C Medical Technologies, Inc. Hydrophilic skirt for paravalvular leak mitigation and fit and apposition optimization for prosthetic heart valve implants
CA3135753C (en) 2019-04-01 2023-10-24 Neovasc Tiara Inc. Controllably deployable prosthetic valve
CA3136334A1 (en) 2019-04-10 2020-10-15 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
WO2020236931A1 (en) 2019-05-20 2020-11-26 Neovasc Tiara Inc. Introducer with hemostasis mechanism
CN114144144A (en) 2019-06-20 2022-03-04 内奥瓦斯克迪亚拉公司 Low-profile prosthetic mitral valve
CN114667117A (en) 2019-09-09 2022-06-24 施菲姆德控股有限责任公司 Adjustable flow splitters and associated systems and methods
AU2020398239A1 (en) 2019-12-05 2022-06-02 Shifamed Holdings, Llc Implantable shunt systems and methods
WO2021150761A1 (en) * 2020-01-21 2021-07-29 Shifamed Holdings, Llc Interatrial shunts with anchoring mechanisms and associated systems and methods
CN113476181B (en) * 2021-08-19 2022-04-26 苏州茵络医疗器械有限公司 Mitral valve repair support

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156621A (en) * 1988-03-22 1992-10-20 Navia Jose A Stentless bioprosthetic cardiac valve
US5415667A (en) * 1990-06-07 1995-05-16 Frater; Robert W. M. Mitral heart valve replacements
US5533519A (en) * 1993-06-24 1996-07-09 Radke; John C. Method and apparatus for diagnosing joints
WO2000044311A2 (en) * 1999-05-25 2000-08-03 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US20020133183A1 (en) * 2000-09-29 2002-09-19 Lentz David Christian Coated medical devices
US20030023303A1 (en) * 1999-11-19 2003-01-30 Palmaz Julio C. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US6534004B2 (en) * 1998-05-14 2003-03-18 The Cleveland Clinic Foundation Processing of implantable animal tissues for dry storage
US6547827B2 (en) * 1998-09-21 2003-04-15 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US6561970B1 (en) * 1994-07-29 2003-05-13 Edwards Lifesciences Corporation Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US6641611B2 (en) * 2001-11-26 2003-11-04 Swaminathan Jayaraman Therapeutic coating for an intravascular implant
US6878168B2 (en) * 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US20050113932A1 (en) * 2001-10-05 2005-05-26 Nebojsa Kovacevic Prosthetic shock absorber
US20050137688A1 (en) * 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Repositionable heart valve and method
US20050137691A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US20050216079A1 (en) * 2000-09-20 2005-09-29 Ample Medical, Inc. Heart valve annulus device and method of using same
US20080281411A1 (en) * 2004-03-26 2008-11-13 Eric Berreklouw Assembly Comprising A Ring For Attachment In A Passage Surrounded By Body Tissue As Well As An Applicator For Fitting The Ring In The Passage

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0850607A1 (en) * 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
US8579966B2 (en) * 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
JP4458845B2 (en) * 2001-10-01 2010-04-28 アンプル メディカル,インコーポレイテッド Medical device
US8512403B2 (en) * 2003-05-20 2013-08-20 The Cleveland Clinic Foundation Annuloplasty ring with wing members for repair of a cardiac valve

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156621A (en) * 1988-03-22 1992-10-20 Navia Jose A Stentless bioprosthetic cardiac valve
US5415667A (en) * 1990-06-07 1995-05-16 Frater; Robert W. M. Mitral heart valve replacements
US5533519A (en) * 1993-06-24 1996-07-09 Radke; John C. Method and apparatus for diagnosing joints
US6561970B1 (en) * 1994-07-29 2003-05-13 Edwards Lifesciences Corporation Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US6534004B2 (en) * 1998-05-14 2003-03-18 The Cleveland Clinic Foundation Processing of implantable animal tissues for dry storage
US6547827B2 (en) * 1998-09-21 2003-04-15 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
WO2000044311A2 (en) * 1999-05-25 2000-08-03 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
US20030023303A1 (en) * 1999-11-19 2003-01-30 Palmaz Julio C. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US20050216079A1 (en) * 2000-09-20 2005-09-29 Ample Medical, Inc. Heart valve annulus device and method of using same
US20020133183A1 (en) * 2000-09-29 2002-09-19 Lentz David Christian Coated medical devices
US20050113932A1 (en) * 2001-10-05 2005-05-26 Nebojsa Kovacevic Prosthetic shock absorber
US6641611B2 (en) * 2001-11-26 2003-11-04 Swaminathan Jayaraman Therapeutic coating for an intravascular implant
US6878168B2 (en) * 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US20050137688A1 (en) * 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Repositionable heart valve and method
US20050137691A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US20080281411A1 (en) * 2004-03-26 2008-11-13 Eric Berreklouw Assembly Comprising A Ring For Attachment In A Passage Surrounded By Body Tissue As Well As An Applicator For Fitting The Ring In The Passage

Cited By (857)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9364354B2 (en) 2000-03-27 2016-06-14 Neovasc Medical Ltd Methods for treating abnormal growths in the body using a flow reducing implant
US11497503B2 (en) 2000-03-27 2022-11-15 Neovasc Medical Ltd. Methods for treating abnormal growths in the body using a flow reducing implant
US10542994B2 (en) 2000-03-27 2020-01-28 Neovasc Medical Ltd. Methods for treating abnormal growths in the body using a flow reducing implant
US10278805B2 (en) 2000-08-18 2019-05-07 Atritech, Inc. Expandable implant devices for filtering blood flow from atrial appendages
US20050216079A1 (en) * 2000-09-20 2005-09-29 Ample Medical, Inc. Heart valve annulus device and method of using same
US7887583B2 (en) * 2000-09-20 2011-02-15 Mvrx, Inc. Heart valve annulus device and method of using same
US20110137411A1 (en) * 2000-09-20 2011-06-09 Mvrx, Inc. Heart valve annulus device and method uf using same
US9770328B2 (en) 2000-09-20 2017-09-26 Mvrx, Inc. Heart valve annulus device and method of using same
US8529621B2 (en) 2001-05-17 2013-09-10 Edwards Lifesciences Corporation Methods of repairing an abnormal mitral valve
US10166101B2 (en) 2001-05-17 2019-01-01 Edwards Lifesciences Corporation Methods for repairing mitral valves
US9149359B2 (en) 2001-08-28 2015-10-06 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US10188518B2 (en) 2001-08-28 2019-01-29 Edwards Lifesciences Corporation Annuloplasty ring with variable cross-section
US9414922B2 (en) 2001-08-28 2016-08-16 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US7972377B2 (en) 2001-12-27 2011-07-05 Medtronic, Inc. Bioprosthetic heart valve
US9610158B2 (en) 2002-01-04 2017-04-04 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US9554898B2 (en) 2002-01-04 2017-01-31 Colibri Heart Valve Llc Percutaneous prosthetic heart valve
US8900294B2 (en) 2002-01-04 2014-12-02 Colibri Heart Valve Llc Method of controlled release of a percutaneous replacement heart valve
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US8790398B2 (en) 2002-01-04 2014-07-29 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US9125739B2 (en) 2002-01-04 2015-09-08 Colibri Heart Valve Llc Percutaneous replacement heart valve and a delivery and implantation system
US9186248B2 (en) 2002-01-04 2015-11-17 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US8109995B2 (en) 2002-01-04 2012-02-07 Colibri Heart Valve Llc Percutaneously implantable replacement heart valve device and method of making same
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US8349003B2 (en) 2002-07-16 2013-01-08 Medtronic, Inc. Suture locking assembly and method of use
US7981153B2 (en) 2002-12-20 2011-07-19 Medtronic, Inc. Biologically implantable prosthesis methods of using
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US8623080B2 (en) 2002-12-20 2014-01-07 Medtronic, Inc. Biologically implantable prosthesis and methods of using the same
US8025695B2 (en) 2002-12-20 2011-09-27 Medtronic, Inc. Biologically implantable heart valve system
US8460373B2 (en) 2002-12-20 2013-06-11 Medtronic, Inc. Method for implanting a heart valve within an annulus of a patient
US9333078B2 (en) 2002-12-20 2016-05-10 Medtronic, Inc. Heart valve assemblies
US10595991B2 (en) 2002-12-20 2020-03-24 Medtronic, Inc. Heart valve assemblies
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US8747463B2 (en) 2003-08-22 2014-06-10 Medtronic, Inc. Methods of using a prosthesis fixturing device
US20100100176A1 (en) * 2003-10-06 2010-04-22 Ats Medical, Inc. Anchoring structure with concave landing zone
US9579194B2 (en) * 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US8603161B2 (en) 2003-10-08 2013-12-10 Medtronic, Inc. Attachment device and methods of using the same
US11564818B2 (en) 2003-11-19 2023-01-31 Neovase Medical Ltd. Vascular implant
US9744059B2 (en) 2003-11-19 2017-08-29 Neovasc Medical Ltd. Vascular implant
US8252052B2 (en) 2003-12-23 2012-08-28 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9956075B2 (en) 2003-12-23 2018-05-01 Boston Scientific Scimed Inc. Methods and apparatus for endovascularly replacing a heart valve
US8052749B2 (en) * 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US9358110B2 (en) 2003-12-23 2016-06-07 Boston Scientific Scimed, Inc. Medical devices and delivery systems for delivering medical devices
US9358106B2 (en) 2003-12-23 2016-06-07 Boston Scientific Scimed Inc. Methods and apparatus for performing valvuloplasty
US10925724B2 (en) 2003-12-23 2021-02-23 Boston Scientific Scimed, Inc. Replacement valve and anchor
US20120029627A1 (en) * 2003-12-23 2012-02-02 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
US7988724B2 (en) 2003-12-23 2011-08-02 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US9387076B2 (en) 2003-12-23 2016-07-12 Boston Scientific Scimed Inc. Medical devices and delivery systems for delivering medical devices
US9320599B2 (en) * 2003-12-23 2016-04-26 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a heart valve
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US8840662B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve and method
US10206774B2 (en) 2003-12-23 2019-02-19 Boston Scientific Scimed Inc. Low profile heart valve and delivery system
US9308085B2 (en) 2003-12-23 2016-04-12 Boston Scientific Scimed, Inc. Repositionable heart valve and method
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8231670B2 (en) 2003-12-23 2012-07-31 Sadra Medical, Inc. Repositionable heart valve and method
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8246678B2 (en) 2003-12-23 2012-08-21 Sadra Medicl, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9393113B2 (en) 2003-12-23 2016-07-19 Boston Scientific Scimed Inc. Retrievable heart valve anchor and method
US9277991B2 (en) 2003-12-23 2016-03-08 Boston Scientific Scimed, Inc. Low profile heart valve and delivery system
US8828078B2 (en) 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8858620B2 (en) 2003-12-23 2014-10-14 Sadra Medical Inc. Methods and apparatus for endovascularly replacing a heart valve
US20140243967A1 (en) * 2003-12-23 2014-08-28 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
US10258465B2 (en) 2003-12-23 2019-04-16 Boston Scientific Scimed Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US11285002B2 (en) 2003-12-23 2022-03-29 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a heart valve
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US20060173524A1 (en) * 2003-12-23 2006-08-03 Amr Salahieh Medical Implant Delivery And Deployment Tool
US7824443B2 (en) * 2003-12-23 2010-11-02 Sadra Medical, Inc. Medical implant delivery and deployment tool
US10716663B2 (en) 2003-12-23 2020-07-21 Boston Scientific Scimed, Inc. Methods and apparatus for performing valvuloplasty
US10314695B2 (en) * 2003-12-23 2019-06-11 Boston Scientific Scimed Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8894703B2 (en) 2003-12-23 2014-11-25 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US10335273B2 (en) 2003-12-23 2019-07-02 Boston Scientific Scimed Inc. Leaflet engagement elements and methods for use thereof
US10357359B2 (en) 2003-12-23 2019-07-23 Boston Scientific Scimed Inc Methods and apparatus for endovascularly replacing a patient's heart valve
US9585749B2 (en) 2003-12-23 2017-03-07 Boston Scientific Scimed, Inc. Replacement heart valve assembly
US9585750B2 (en) 2003-12-23 2017-03-07 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US11696825B2 (en) 2003-12-23 2023-07-11 Boston Scientific Scimed, Inc. Replacement valve and anchor
US9532872B2 (en) 2003-12-23 2017-01-03 Boston Scientific Scimed, Inc. Systems and methods for delivering a medical implant
US10413409B2 (en) 2003-12-23 2019-09-17 Boston Scientific Scimed, Inc. Systems and methods for delivering a medical implant
US10772724B2 (en) 2003-12-23 2020-09-15 Boston Scientific Scimed, Inc. Medical devices and delivery systems for delivering medical devices
US9872768B2 (en) 2003-12-23 2018-01-23 Boston Scientific Scimed, Inc. Medical devices and delivery systems for delivering medical devices
US10413412B2 (en) 2003-12-23 2019-09-17 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a heart valve
US10426608B2 (en) 2003-12-23 2019-10-01 Boston Scientific Scimed, Inc. Repositionable heart valve
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US9011521B2 (en) 2003-12-23 2015-04-21 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8951299B2 (en) 2003-12-23 2015-02-10 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US9861476B2 (en) 2003-12-23 2018-01-09 Boston Scientific Scimed Inc. Leaflet engagement elements and methods for use thereof
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US20150073540A1 (en) * 2003-12-23 2015-03-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8623076B2 (en) 2003-12-23 2014-01-07 Sadra Medical, Inc. Low profile heart valve and delivery system
US8623078B2 (en) 2003-12-23 2014-01-07 Sadra Medical, Inc. Replacement valve and anchor
US11185408B2 (en) 2003-12-23 2021-11-30 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US10478289B2 (en) 2003-12-23 2019-11-19 Boston Scientific Scimed, Inc. Replacement valve and anchor
US10993806B2 (en) 2004-03-11 2021-05-04 Percutaneous Cardiovascular Solutions Pty Ltd Percutaneous heart valve prosthesis
US11213390B2 (en) 2004-03-11 2022-01-04 Percutaneous Cardiovascular Solutions Pty Ltd Method of implanting a heart valve prosthesis
US10213298B2 (en) 2004-03-11 2019-02-26 Percutaneous Cardiovascular Solutions Pty Ltd Percutaneous heart valve prosthesis
US11622856B2 (en) 2004-03-11 2023-04-11 Percutaneous Cardiovascular Solutions Pty Ltd Percutaneous heart valve prosthesis
US11744705B2 (en) 2004-03-11 2023-09-05 Percutaneous Cardiovascular Solutions Pty Ltd Method of implanting a heart valve prosthesis
US9744035B2 (en) 2004-06-16 2017-08-29 Boston Scientific Scimed, Inc. Everting heart valve
US8668733B2 (en) 2004-06-16 2014-03-11 Sadra Medical, Inc. Everting heart valve
US11484405B2 (en) 2004-06-16 2022-11-01 Boston Scientific Scimed, Inc. Everting heart valve
US8992608B2 (en) 2004-06-16 2015-03-31 Sadra Medical, Inc. Everting heart valve
US20080207874A1 (en) * 2004-07-01 2008-08-28 Biosource Pharm, Inc. Peptide Antibiotics and Methods For Making Same
US8889826B2 (en) 2004-07-01 2014-11-18 Biosource Pharm, Inc. Peptide antibiotics and methods for making same
US10531952B2 (en) 2004-11-05 2020-01-14 Boston Scientific Scimed, Inc. Medical devices and delivery systems for delivering medical devices
US8328868B2 (en) 2004-11-05 2012-12-11 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US8617236B2 (en) 2004-11-05 2013-12-31 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US20160242909A1 (en) * 2005-02-07 2016-08-25 Evalve, Inc. Methods, systems and devices for cardiac valve repair
US10667911B2 (en) 2005-02-07 2020-06-02 Evalve, Inc. Methods, systems and devices for cardiac valve repair
US8500802B2 (en) 2005-04-08 2013-08-06 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US7951197B2 (en) 2005-04-08 2011-05-31 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US10549101B2 (en) 2005-04-25 2020-02-04 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US9649495B2 (en) 2005-04-25 2017-05-16 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US9415225B2 (en) 2005-04-25 2016-08-16 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US8911493B2 (en) 2005-05-24 2014-12-16 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valves
US10456251B2 (en) 2005-05-24 2019-10-29 Edwards Lifesciences Corporation Surgical methods of replacing prosthetic heart valves
US7708775B2 (en) 2005-05-24 2010-05-04 Edwards Lifesciences Corporation Methods for rapid deployment of prosthetic heart valves
US11284998B2 (en) 2005-05-24 2022-03-29 Edwards Lifesciences Corporation Surgical methods of replacing prosthetic heart valves
US9554903B2 (en) 2005-05-24 2017-01-31 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US10130468B2 (en) 2005-05-24 2018-11-20 Edwards Lifesciences Corporation Replacement prosthetic heart valves
US8500798B2 (en) 2005-05-24 2013-08-06 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US8211169B2 (en) 2005-05-27 2012-07-03 Medtronic, Inc. Gasket with collar for prosthetic heart valves and methods for using them
US20060287716A1 (en) * 2005-06-08 2006-12-21 The Cleveland Clinic Foundation Artificial chordae
US8685083B2 (en) 2005-06-27 2014-04-01 Edwards Lifesciences Corporation Apparatus, system, and method for treatment of posterior leaflet prolapse
US9393094B2 (en) 2005-09-13 2016-07-19 Boston Scientific Scimed, Inc. Two-part package for medical implant
US7712606B2 (en) 2005-09-13 2010-05-11 Sadra Medical, Inc. Two-part package for medical implant
US10370150B2 (en) 2005-09-13 2019-08-06 Boston Scientific Scimed Inc. Two-part package for medical implant
US8136659B2 (en) 2005-09-13 2012-03-20 Sadra Medical, Inc. Two-part package for medical implant
US20070061008A1 (en) * 2005-09-13 2007-03-15 Amr Salahieh Two-Part Package For Medical Implant
US9486336B2 (en) 2005-11-10 2016-11-08 Edwards Lifesciences Cardiaq Llc Prosthesis having a plurality of distal and proximal prongs
US10456277B2 (en) 2005-11-10 2019-10-29 Edwards Lifesciences Cardiaq Llc Percutaneous heart valve
US20090216314A1 (en) * 2005-11-10 2009-08-27 Arshad Quadri Balloon-Expandable, Self-Expanding, Vascular Prosthesis Connecting Stent
US9433514B2 (en) 2005-11-10 2016-09-06 Edwards Lifesciences Cardiaq Llc Method of securing a prosthesis
US8092520B2 (en) 2005-11-10 2012-01-10 CardiAQ Technologies, Inc. Vascular prosthesis connecting stent
US9974669B2 (en) 2005-11-10 2018-05-22 Edwards Lifesciences Cardiaq Llc Percutaneous heart valve
US8287584B2 (en) 2005-11-14 2012-10-16 Sadra Medical, Inc. Medical implant deployment tool
US8568473B2 (en) 2005-12-15 2013-10-29 Georgia Tech Research Corporation Systems and methods for enabling heart valve replacement
US10010419B2 (en) 2005-12-15 2018-07-03 Georgia Tech Research Corporation Papillary muscle position control devices, systems, and methods
US10039531B2 (en) 2005-12-15 2018-08-07 Georgia Tech Research Corporation Systems and methods to control the dimension of a heart valve
US9125742B2 (en) 2005-12-15 2015-09-08 Georgia Tech Research Foundation Papillary muscle position control devices, systems, and methods
US10314701B2 (en) 2005-12-22 2019-06-11 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US10299922B2 (en) 2005-12-22 2019-05-28 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
US8821569B2 (en) 2006-04-29 2014-09-02 Medtronic, Inc. Multiple component prosthetic heart valve assemblies and methods for delivering them
US8142495B2 (en) 2006-05-15 2012-03-27 Edwards Lifesciences Ag System and a method for altering the geometry of the heart
US8591576B2 (en) 2006-05-15 2013-11-26 Edwards Lifesciences Ag Method for altering the geometry of the heart
US20090306768A1 (en) * 2006-07-28 2009-12-10 Cardiaq Valve Technologies, Inc. Percutaneous valve prosthesis and system and method for implanting same
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US20100137979A1 (en) * 2006-09-19 2010-06-03 Yosi Tuval Sinus-engaging Valve Fixation Member
US9642704B2 (en) * 2006-09-19 2017-05-09 Medtronic Ventor Technologies Ltd. Catheter for implanting a valve prosthesis
US8747460B2 (en) 2006-09-19 2014-06-10 Medtronic Ventor Technologies Ltd. Methods for implanting a valve prothesis
US11304802B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US11304801B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US8771346B2 (en) 2006-09-19 2014-07-08 Medtronic Ventor Technologies Ltd. Valve prosthetic fixation techniques using sandwiching
US8771345B2 (en) 2006-09-19 2014-07-08 Medtronic Ventor Technologies Ltd. Valve prosthesis fixation techniques using sandwiching
US9138312B2 (en) 2006-09-19 2015-09-22 Medtronic Ventor Technologies Ltd. Valve prostheses
US9056009B2 (en) * 2006-11-13 2015-06-16 Medtentia International Ltd. Oy Device and method for improving function of heart valve
US20120316640A1 (en) * 2006-11-13 2012-12-13 Keraenen Olli Device And Method For Improving Function Of Heart Valve
US11547560B2 (en) * 2007-01-19 2023-01-10 The Cleveland Clinic Foundation Implantable cardiovascular valve
US8105375B2 (en) 2007-01-19 2012-01-31 The Cleveland Clinic Foundation Method for implanting a cardiovascular valve
US20080177381A1 (en) * 2007-01-19 2008-07-24 The Cleveland Clinic Foundation Method for implanting a cardiovascular valve
US8764821B2 (en) 2007-02-09 2014-07-01 Edwards Lifesciences Corporation Degenerative vavlular disease specific annuloplasty ring sets
US7959673B2 (en) 2007-02-09 2011-06-14 Edwards Lifesciences Corporation Degenerative valvular disease specific annuloplasty rings
US9011529B2 (en) 2007-02-09 2015-04-21 Edwards Lifesciences Corporation Mitral annuloplasty rings with sewing cuff
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US10130463B2 (en) 2007-08-23 2018-11-20 Dfm, Llc Translumenally implantable heart valve with formed in place support
US10842629B2 (en) 2007-09-07 2020-11-24 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US9101472B2 (en) 2007-09-07 2015-08-11 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US11576784B2 (en) 2007-09-07 2023-02-14 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US9730792B2 (en) 2007-09-13 2017-08-15 Georg Lutter Truncated cone heart valve stent
US9078749B2 (en) 2007-09-13 2015-07-14 Georg Lutter Truncated cone heart valve stent
US11213387B2 (en) 2007-09-13 2022-01-04 Georg Lutter Truncated cone heart valve stent
US9254192B2 (en) 2007-09-13 2016-02-09 Georg Lutter Truncated cone heart valve stent
US10456248B2 (en) 2007-09-13 2019-10-29 Georg Lutter Truncated cone heart valve stent
US11660187B2 (en) 2007-09-28 2023-05-30 St. Jude Medical, Llc Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US20090088837A1 (en) * 2007-09-28 2009-04-02 The Cleveland Clinic Foundation Prosthetic chordae assembly and method of use
US11382740B2 (en) 2007-09-28 2022-07-12 St. Jude Medical, Llc Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US11534294B2 (en) 2007-09-28 2022-12-27 St. Jude Medical, Llc Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US10426604B2 (en) 2007-09-28 2019-10-01 St. Jude Medical, Llc Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US9820851B2 (en) 2007-09-28 2017-11-21 St. Jude Medical, Llc Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US9532868B2 (en) * 2007-09-28 2017-01-03 St. Jude Medical, Inc. Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
US20090105751A1 (en) * 2007-10-18 2009-04-23 John Zentgraf Minimally invasive repair of a valve leaflet in a beating heart
US8758393B2 (en) 2007-10-18 2014-06-24 Neochord, Inc. Minimally invasive repair of a valve leaflet in a beating heart
US11419602B2 (en) 2007-10-18 2022-08-23 Neochord, Inc. Minimally invasive repair of a valve leaflet in a beating heart
US9192374B2 (en) 2007-10-18 2015-11-24 Neochord, Inc. Minimally invasive repair of a valve leaflet in a beating heart
US10507018B2 (en) 2007-10-18 2019-12-17 Neochord, Inc. Minimally invasive repair of a valve leaflet in a beating heart
US20120179247A1 (en) * 2007-11-19 2012-07-12 The Cleveland Clinic Foundation Apparatus and method for treating a regurgitant heart valve
US8784483B2 (en) * 2007-11-19 2014-07-22 The Cleveland Clinic Foundation Apparatus and method for treating a regurgitant heart valve
US11259919B2 (en) 2008-01-24 2022-03-01 Medtronic, Inc. Stents for prosthetic heart valves
US11607311B2 (en) 2008-01-24 2023-03-21 Medtronic, Inc. Stents for prosthetic heart valves
US11284999B2 (en) 2008-01-24 2022-03-29 Medtronic, Inc. Stents for prosthetic heart valves
US11786367B2 (en) 2008-01-24 2023-10-17 Medtronic, Inc. Stents for prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US20160278916A1 (en) * 2008-04-08 2016-09-29 Medtronic, Inc. Multiple Orifice Implantable Heart Valve and Methods of Implantation
US10245142B2 (en) * 2008-04-08 2019-04-02 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US20100036479A1 (en) * 2008-04-23 2010-02-11 Medtronic, Inc. Stented Heart Valve Devices
US8323336B2 (en) * 2008-04-23 2012-12-04 Medtronic, Inc. Prosthetic heart valve devices and methods of valve replacement
US9827090B2 (en) 2008-04-23 2017-11-28 Medtronic, Inc. Prosthetic heart valve devices and methods of valve replacement
CN102083391A (en) * 2008-04-23 2011-06-01 麦德托尼克公司 Stented heart valve devices
AU2009240565B2 (en) * 2008-04-23 2013-08-22 Medtronic, Inc. Stented heart valve devices
US20090281618A1 (en) * 2008-04-23 2009-11-12 Medtronic, Inc. Prosthetic Heart Valve Devices and Methods of Valve Replacement
US10548723B2 (en) 2008-04-23 2020-02-04 Medtronic, Inc. Prosthetic heart valve devices and methods of valve replacement
US9173737B2 (en) * 2008-04-23 2015-11-03 Medtronic, Inc. Stented heart valve devices
US10617520B2 (en) 2008-05-01 2020-04-14 Edwards Lifesciences Corporation Method of replacing mitral valve
US11717401B2 (en) 2008-05-01 2023-08-08 Edwards Lifesciences Corporation Prosthetic heart valve assembly
US10226334B2 (en) * 2008-05-01 2019-03-12 Edwards Lifesciences Corporation Method for replacing mitral valve
US20130053950A1 (en) * 2008-05-01 2013-02-28 Edwards Lifesciences Corporation Device and method for replacing mitral valve
EP3050541B1 (en) 2008-05-01 2019-08-14 Edwards Lifesciences Corporation Prosthetic mitral valve assembly
US10952846B2 (en) 2008-05-01 2021-03-23 Edwards Lifesciences Corporation Method of replacing mitral valve
US20090276040A1 (en) * 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
EP3132773B1 (en) 2008-05-01 2017-11-22 Edwards Lifesciences Corporation Device for replacing mitral valve
US20150127096A1 (en) * 2008-05-01 2015-05-07 Edwards Lifesciences Corporation Method for replacing mitral valve
US20110270393A1 (en) * 2008-06-04 2011-11-03 James Marvel Buffer for a human joint and method of arthroscopically inserting
US8764829B2 (en) * 2008-06-04 2014-07-01 James Marvel Buffer for a human joint and method of arthroscopically inserting
US8236049B2 (en) * 2008-06-20 2012-08-07 Edwards Lifesciences Corporation Multipiece prosthetic mitral valve and method
US20100256751A1 (en) * 2008-06-20 2010-10-07 Edwards Lifesciences Corporation Retaining Mechanisms for Prosthetic Valves
US10646334B2 (en) 2008-09-29 2020-05-12 Edwards Lifesciences Cardiaq Llc Heart valve
US20100082094A1 (en) * 2008-09-29 2010-04-01 Arshad Quadri Heart valve
US9456896B2 (en) 2008-09-29 2016-10-04 Edwards Lifesciences Cardiaq Llc Body cavity prosthesis
US8894702B2 (en) 2008-09-29 2014-11-25 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US8403983B2 (en) 2008-09-29 2013-03-26 Cardiaq Valve Technologies, Inc. Heart valve
US11589983B2 (en) 2008-09-29 2023-02-28 Edwards Lifesciences Cardiaq Llc Heart valve
US10149756B2 (en) 2008-09-29 2018-12-11 Edwards Lifesciences Cardiaq Llc Heart valve
US9339377B2 (en) 2008-09-29 2016-05-17 Edwards Lifesciences Cardiaq Llc Body cavity prosthesis
US11819404B2 (en) 2008-09-29 2023-11-21 Edwards Lifesciences Cardiaq Llc Heart valve
US8337541B2 (en) 2008-10-01 2012-12-25 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US20100082089A1 (en) * 2008-10-01 2010-04-01 Arshad Quadri Delivery system for vascular implant
US8911455B2 (en) 2008-10-01 2014-12-16 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US9597183B2 (en) 2008-10-01 2017-03-21 Edwards Lifesciences Cardiaq Llc Delivery system for vascular implant
US10667906B2 (en) 2008-11-25 2020-06-02 Edwards Lifesciences Corporation Methods of conformal expansion of prosthetic heart valves
US9314334B2 (en) 2008-11-25 2016-04-19 Edwards Lifesciences Corporation Conformal expansion of prosthetic devices to anatomical shapes
US11504232B2 (en) 2008-12-19 2022-11-22 Edwards Lifesciences Corporation Rapid implant prosthetic heart valve system
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US8937040B2 (en) 2008-12-23 2015-01-20 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US20110268774A1 (en) * 2008-12-30 2011-11-03 Andrey Stepanovich Bryukhovetskiy preparation of stem cells with reprogrammed cell signalling, a method of producing the preparation and a method of use thereof
US9750604B2 (en) 2009-03-17 2017-09-05 Mitrassist Medical Ltd. Heart valve prosthesis with collapsible valve and method of delivery thereof
US20100280606A1 (en) * 2009-03-17 2010-11-04 Biomedxl Heart valve prosthesis with collapsible valve and method of delivery thereof
US9078751B2 (en) * 2009-03-17 2015-07-14 Mitrassist Medical Ltd. Heart valve prosthesis with collapsible valve and method of delivery thereof
US20100249919A1 (en) * 2009-03-31 2010-09-30 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US8439969B2 (en) 2009-03-31 2013-05-14 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US11389296B2 (en) 2009-03-31 2022-07-19 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US10368987B2 (en) 2009-03-31 2019-08-06 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US9480562B2 (en) 2009-03-31 2016-11-01 The Cleveland Clinic Foundation Pre-sized prosthetic chordae implantation system
US9585747B2 (en) 2009-04-15 2017-03-07 Edwards Lifesciences Cardiaq Llc Vascular implant
US9339380B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant
US9333074B2 (en) 2009-04-15 2016-05-10 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US8795356B2 (en) 2009-04-15 2014-08-05 Cardiaq Valve Technologies, Inc. Vascular implant
US9333073B2 (en) 2009-04-15 2016-05-10 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery method
US10441412B2 (en) 2009-04-15 2019-10-15 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US8414644B2 (en) 2009-04-15 2013-04-09 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US11376119B2 (en) 2009-04-15 2022-07-05 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9339379B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9339378B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US10555810B2 (en) 2009-06-26 2020-02-11 Edwards Lifesciences Corporation Prosthetic heart valve deployment systems
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
US8696742B2 (en) 2009-06-26 2014-04-15 Edwards Lifesciences Corporation Unitary quick-connect prosthetic heart valve deployment methods
US9005277B2 (en) 2009-06-26 2015-04-14 Edwards Lifesciences Corporation Unitary quick-connect prosthetic heart valve deployment system
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US9949827B2 (en) 2009-09-29 2018-04-24 Edwards Lifesciences Cardiaq Llc Replacement heart valves, delivery devices and methods
US9480560B2 (en) 2009-09-29 2016-11-01 Edwards Lifesciences Cardiaq Llc Method of securing an intralumenal frame assembly
US10166097B2 (en) 2009-09-29 2019-01-01 Edwards Lifesciences Cardiaq Llc Replacement heart valve and method
US9023100B2 (en) 2009-09-29 2015-05-05 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US10524901B2 (en) 2009-09-29 2020-01-07 Edwards Lifesciences Cardiaq Llc Replacement heart valve
US9968454B2 (en) 2009-10-29 2018-05-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of artificial chordae
US9289291B2 (en) 2009-11-05 2016-03-22 The Trustees Of The University Of Pennsylvania Valve prosthesis
US20170143485A1 (en) * 2009-11-05 2017-05-25 The Trustees Of The University Of Pennsylvania Valve prosthesis
JP2017060777A (en) * 2009-11-05 2017-03-30 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Valve prosthesis
US11864993B2 (en) * 2009-11-05 2024-01-09 The Trustees Of The University Of Pennsylvania Valve prosthesis
JP2015119993A (en) * 2009-11-05 2015-07-02 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Valve prosthesis
US11628060B2 (en) 2009-11-05 2023-04-18 The Trustees Of The University Of Pennsylvania Valve prosthesis
US9717591B2 (en) 2009-12-04 2017-08-01 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US11911264B2 (en) 2009-12-04 2024-02-27 Edwards Lifesciences Corporation Valve repair and replacement devices
US11583396B2 (en) 2009-12-04 2023-02-21 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US10507102B2 (en) 2009-12-04 2019-12-17 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US10758342B2 (en) 2009-12-04 2020-09-01 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US10111748B2 (en) 2009-12-04 2018-10-30 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US20150045880A1 (en) * 2009-12-08 2015-02-12 Mitraltech Ltd. Implant for rotation-based anchoring
US10660751B2 (en) 2009-12-08 2020-05-26 Cardiovalve Ltd. Prosthetic heart valve with upper skirt
US11179236B2 (en) 2009-12-08 2021-11-23 Colorado State University Research Foundation Device and system for transcatheter mitral valve replacement
US11351026B2 (en) 2009-12-08 2022-06-07 Cardiovalve Ltd. Rotation-based anchoring of an implant
US11839541B2 (en) 2009-12-08 2023-12-12 Cardiovalve Ltd. Prosthetic heart valve with upper skirt
US11141268B2 (en) * 2009-12-08 2021-10-12 Cardiovalve Ltd. Prosthetic heart valve with upper and lower skirts
US10548726B2 (en) 2009-12-08 2020-02-04 Cardiovalve Ltd. Rotation-based anchoring of an implant
US10835378B2 (en) 2009-12-18 2020-11-17 Edwards Lifesciences Corporation Prosthetic heart valve packaging and deployment systems
US8869982B2 (en) 2009-12-18 2014-10-28 Edwards Lifesciences Corporation Prosthetic heart valve packaging and deployment system
US11311378B2 (en) 2009-12-18 2022-04-26 Edwards Lifesciences Corporation Prosthetic heart valve packaging and deployment systems
US20110147251A1 (en) * 2009-12-18 2011-06-23 Edwards Lifesciences Corporation Prosthetic heart valve packaging and deployment system
US8839957B2 (en) 2010-02-15 2014-09-23 Michael C. Murad Prosthetic heart valve packaging system
US20110198244A1 (en) * 2010-02-15 2011-08-18 Edwards Lifesciences Corporation Prosthetic heart valve packaging system
US8361144B2 (en) 2010-03-01 2013-01-29 Colibri Heart Valve Llc Percutaneously deliverable heart valve and methods associated therewith
US10561486B2 (en) 2010-03-05 2020-02-18 Edwards Lifesciences Corporation Dry prosthetic heart valve packaging system
US9539080B2 (en) 2010-03-05 2017-01-10 Edwards Lifesciences Corporation Dry prosthetic heart valve packaging system
US8679404B2 (en) 2010-03-05 2014-03-25 Edwards Lifesciences Corporation Dry prosthetic heart valve packaging system
US9937030B2 (en) 2010-03-05 2018-04-10 Edwards Lifesciences Corporation Dry prosthetic heart valve packaging system
US11911256B2 (en) 2010-03-05 2024-02-27 Edwards Lifesciences Corporation Dry prosthetic heart valve packaging system
US20110214398A1 (en) * 2010-03-05 2011-09-08 Edwards Lifesciences Corporation Dry Prosthetic Heart Valve Packaging System
US9788941B2 (en) 2010-03-10 2017-10-17 Mitraltech Ltd. Axially-shortening prosthetic valve
US11109964B2 (en) 2010-03-10 2021-09-07 Cardiovalve Ltd. Axially-shortening prosthetic valve
US8992606B2 (en) * 2010-03-19 2015-03-31 Xavier Ruyra Baliarda Prosthetic device for repairing a mitral valve
US20130053951A1 (en) * 2010-03-19 2013-02-28 Xavier Ruyra Baliarda Prosthetic band, in particular for repairing a mitral valve
US11419720B2 (en) 2010-05-05 2022-08-23 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US11432924B2 (en) 2010-05-05 2022-09-06 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
JP2021037423A (en) * 2010-05-05 2021-03-11 ニオバスク ティアラ インコーポレイテッド Transcatheter mitral valve prosthesis
JP7204724B2 (en) 2010-05-05 2023-01-16 ニオバスク ティアラ インコーポレイテッド transcatheter mitral valve prosthesis
US9770329B2 (en) 2010-05-05 2017-09-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9241790B2 (en) 2010-05-05 2016-01-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US10449042B2 (en) 2010-05-05 2019-10-22 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9248014B2 (en) 2010-05-05 2016-02-02 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US8986374B2 (en) 2010-05-10 2015-03-24 Edwards Lifesciences Corporation Prosthetic heart valve
US10702383B2 (en) 2010-05-10 2020-07-07 Edwards Lifesciences Corporation Methods of delivering and implanting resilient prosthetic surgical heart valves
US11571299B2 (en) 2010-05-10 2023-02-07 Edwards Lifesciences Corporation Methods for manufacturing resilient prosthetic surgical heart valves
US9603708B2 (en) * 2010-05-19 2017-03-28 Dfm, Llc Low crossing profile delivery catheter for cardiovascular prosthetic implant
US20120016468A1 (en) * 2010-05-19 2012-01-19 Direct Flow Medical, Inc. Low crossing profile delivery catheter for cardiovascular prosthetic implant
US10478299B2 (en) 2010-05-19 2019-11-19 Dfm, Llc Low crossing profile delivery catheter for cardiovascular prosthetic implant
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US10485660B2 (en) 2010-06-21 2019-11-26 Edwards Lifesciences Cardiaq Llc Replacement heart valve
US10639146B2 (en) 2010-06-21 2020-05-05 Edwards Lifesciences Cardiaq Llc Replacement heart valve
US11452597B2 (en) 2010-06-21 2022-09-27 Edwards Lifesciences Cardiaq Llc Replacement heart valve
US8906866B2 (en) 2010-06-23 2014-12-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US9119738B2 (en) 2010-06-28 2015-09-01 Colibri Heart Valve Llc Method and apparatus for the endoluminal delivery of intravascular devices
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US10531872B2 (en) 2010-07-21 2020-01-14 Cardiovalve Ltd. Valve prosthesis configured for deployment in annular spacer
US10925595B2 (en) 2010-07-21 2021-02-23 Cardiovalve Ltd. Valve prosthesis configured for deployment in annular spacer
US10512456B2 (en) 2010-07-21 2019-12-24 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11426155B2 (en) 2010-07-21 2022-08-30 Cardiovalve Ltd. Helical anchor implantation
US9433503B2 (en) 2010-08-04 2016-09-06 Valcare, Inc. Percutaneous transcatheter repair of heart valves
US10940003B2 (en) 2010-08-24 2021-03-09 Edwards Lifesciences Corporation Methods of delivering a flexible annuloplasty ring
US10182912B2 (en) 2010-08-24 2019-01-22 Edwards Lifesciences Corporation Methods of delivering a flexible annuloplasty ring
US9326858B2 (en) 2010-08-24 2016-05-03 Edwards Lifesciences Corporation Flexible annuloplasty ring
US10548728B2 (en) 2010-09-10 2020-02-04 Edwards Lifesciences Corporation Safety systems for expansion of prosthetic heart valves
US9370418B2 (en) 2010-09-10 2016-06-21 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US10039641B2 (en) 2010-09-10 2018-08-07 Edwards Lifesciences Corporation Methods of rapidly deployable surgical heart valves
US11471279B2 (en) 2010-09-10 2022-10-18 Edwards Lifesciences Corporation Systems for rapidly deployable surgical heart valves
US9504563B2 (en) 2010-09-10 2016-11-29 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
US10201418B2 (en) 2010-09-10 2019-02-12 Symetis, SA Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
US10722358B2 (en) 2010-09-10 2020-07-28 Edwards Lifesciences Corporation Systems for rapidly deployable surgical heart valves
US9968450B2 (en) 2010-09-10 2018-05-15 Edwards Lifesciences Corporation Methods for ensuring safe and rapid deployment of prosthetic heart valves
US11197757B2 (en) 2010-09-10 2021-12-14 Edwards Lifesciences Corporation Methods of safely expanding prosthetic heart valves
US9125741B2 (en) 2010-09-10 2015-09-08 Edwards Lifesciences Corporation Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves
US11775613B2 (en) 2010-09-10 2023-10-03 Edwards Lifesciences Corporation Methods of safely expanding prosthetic heart valves
US10869760B2 (en) 2010-09-10 2020-12-22 Symetis Sa Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
US10610362B2 (en) 2010-09-23 2020-04-07 Edwards Lifesciences Cardiaq Llc Replacement heart valves, delivery devices and methods
US8652203B2 (en) 2010-09-23 2014-02-18 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US10881510B2 (en) 2010-09-23 2021-01-05 Edwards Lifesciences Cardiaq Llc Replacement heart valves, delivery devices and methods
US10736741B2 (en) 2010-09-27 2020-08-11 Edwards Lifesciences Corporation Methods of delivery of heart valves
US9861479B2 (en) 2010-09-27 2018-01-09 Edwards Lifesciences Corporation Methods of delivery of flexible heart valves
US11207178B2 (en) 2010-09-27 2021-12-28 Edwards Lifesciences Corporation Collapsible-expandable heart valves
US8845720B2 (en) 2010-09-27 2014-09-30 Edwards Lifesciences Corporation Prosthetic heart valve frame with flexible commissures
JP2013542764A (en) * 2010-09-30 2013-11-28 バイオステイブル サイエンス アンド エンジニアリング インコーポレイテッド Aortic valve device
US9005279B2 (en) * 2010-11-12 2015-04-14 Shlomo Gabbay Beating heart buttress and implantation method to prevent prolapse of a heart valve
US20120150290A1 (en) * 2010-11-12 2012-06-14 Shlomo Gabbay Beating heart buttress and implantation method to prevent prolapse of a heart valve
US10543089B2 (en) 2010-11-30 2020-01-28 Edwards Lifesciences Corporation Annuloplasty ring with reduced dehiscence
US11872132B2 (en) 2010-11-30 2024-01-16 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US9474607B2 (en) 2010-11-30 2016-10-25 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US9737400B2 (en) 2010-12-14 2017-08-22 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US10973632B2 (en) 2010-12-14 2021-04-13 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
US20120158128A1 (en) * 2010-12-16 2012-06-21 Edwards Lifesciences Corporation Prosthetic heart valve delivery systems and packaging
CN103370035A (en) * 2010-12-16 2013-10-23 爱德华兹生命科学公司 Prosthetic heart valve delivery systems and packaging
US9498317B2 (en) * 2010-12-16 2016-11-22 Edwards Lifesciences Corporation Prosthetic heart valve delivery systems and packaging
US11027870B2 (en) 2010-12-16 2021-06-08 Edwards Lifesciences Corporation Prosthetic heart valve delivery systems and packaging
US10517725B2 (en) 2010-12-23 2019-12-31 Twelve, Inc. System for mitral valve repair and replacement
US9421098B2 (en) 2010-12-23 2016-08-23 Twelve, Inc. System for mitral valve repair and replacement
US11571303B2 (en) 2010-12-23 2023-02-07 Twelve, Inc. System for mitral valve repair and replacement
US9770331B2 (en) 2010-12-23 2017-09-26 Twelve, Inc. System for mitral valve repair and replacement
US9044221B2 (en) 2010-12-29 2015-06-02 Neochord, Inc. Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
US10130474B2 (en) 2010-12-29 2018-11-20 Neochord, Inc. Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
US10080659B1 (en) * 2010-12-29 2018-09-25 Neochord, Inc. Devices and methods for minimally invasive repair of heart valves
US10779938B2 (en) 2011-02-23 2020-09-22 Edwards Lifesciences Cardiaq Llc Replacement heart valve and method
US11903825B2 (en) 2011-02-23 2024-02-20 Edwards Lifesciences Cardiaq Llc Replacement heart valve and method
US9232996B2 (en) 2011-02-25 2016-01-12 University Of Connecticut Prosthetic heart valve
US10456255B2 (en) 2011-03-21 2019-10-29 Cephea Valve Technologies, Inc. Disk-based valve apparatus and method for the treatment of valve dysfunction
US8728155B2 (en) 2011-03-21 2014-05-20 Cephea Valve Technologies, Inc. Disk-based valve apparatus and method for the treatment of valve dysfunction
US11660219B2 (en) 2011-03-23 2023-05-30 Daidalos Solutions B.V. Medical instrument, ring prosthesis, stent and stented valve
EP2688525B1 (en) 2011-03-23 2019-08-21 Daidalos Solutions B.V. Medical instrument, ring prosthesis, stent and stented valve
US9713529B2 (en) 2011-04-28 2017-07-25 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US11771544B2 (en) 2011-05-05 2023-10-03 Symetis Sa Method and apparatus for compressing/loading stent-valves
US9861478B2 (en) 2011-05-12 2018-01-09 Edwards Lifesciences Corporation Methods of deploying a mitral heart valve
US11678981B2 (en) 2011-05-12 2023-06-20 Edwards Lifesciences Corporation Mitral heart valve storage and handling system
US8968394B2 (en) 2011-05-12 2015-03-03 Edwards Lifesciences Corporation Mitral heart valve holder and storage system
US10772725B2 (en) 2011-05-12 2020-09-15 Edwards Lifesciences Corporation Mitral heart valve storage and handling system
US9241789B2 (en) * 2011-05-27 2016-01-26 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
US20150245907A1 (en) * 2011-05-27 2015-09-03 Robert G. Matheny Extracellular Matrix Material Valve Conduit and Methods of Making Thereof
US20160331534A1 (en) * 2011-06-01 2016-11-17 Valcare, Inc. Percutaneous transcatheter repair of heart valves via trans-apical access
US10695178B2 (en) 2011-06-01 2020-06-30 Neochord, Inc. Minimally invasive repair of heart valve leaflets
US9402721B2 (en) 2011-06-01 2016-08-02 Valcare, Inc. Percutaneous transcatheter repair of heart valves via trans-apical access
US10779945B2 (en) * 2011-06-01 2020-09-22 Valcare, Inc. Percutaneous transcatheter repair of heart valves via trans-apical access
US10034750B2 (en) 2011-06-21 2018-07-31 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11712334B2 (en) 2011-06-21 2023-08-01 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10028827B2 (en) 2011-06-21 2018-07-24 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9572662B2 (en) 2011-06-21 2017-02-21 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9585751B2 (en) 2011-06-21 2017-03-07 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10751173B2 (en) 2011-06-21 2020-08-25 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9125740B2 (en) 2011-06-21 2015-09-08 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11523900B2 (en) 2011-06-21 2022-12-13 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9579196B2 (en) 2011-06-21 2017-02-28 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US8998976B2 (en) 2011-07-12 2015-04-07 Boston Scientific Scimed, Inc. Coupling system for medical devices
US10087503B2 (en) 2011-08-03 2018-10-02 The Curators Of The University Of Missouri Method for separation of chemically pure Os from metal mixtures
US11517436B2 (en) 2011-08-05 2022-12-06 Cardiovalve Ltd. Implant for heart valve
US11291546B2 (en) 2011-08-05 2022-04-05 Cardiovalve Ltd. Leaflet clip with collars
US10702385B2 (en) 2011-08-05 2020-07-07 Cardiovalve Ltd. Implant for heart valve
US10226341B2 (en) 2011-08-05 2019-03-12 Cardiovalve Ltd. Implant for heart valve
US11690712B2 (en) 2011-08-05 2023-07-04 Cardiovalve Ltd. Clip-secured implant for heart valve
US11344410B2 (en) 2011-08-05 2022-05-31 Cardiovalve Ltd. Implant for heart valve
US11369469B2 (en) 2011-08-05 2022-06-28 Cardiovalve Ltd. Method for use at a heart valve
US9387078B2 (en) 2011-08-05 2016-07-12 Mitraltech Ltd. Percutaneous mitral valve replacement and sealing
US11517429B2 (en) 2011-08-05 2022-12-06 Cardiovalve Ltd. Apparatus for use at a heart valve
US10695173B2 (en) 2011-08-05 2020-06-30 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11291545B2 (en) 2011-08-05 2022-04-05 Cardiovalve Ltd. Implant for heart valve
US11291547B2 (en) 2011-08-05 2022-04-05 Cardiovalve Ltd. Leaflet clip with collars
US10245143B2 (en) 2011-08-05 2019-04-02 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11864995B2 (en) 2011-08-05 2024-01-09 Cardiovalve Ltd. Implant for heart valve
US10376361B2 (en) 2011-08-05 2019-08-13 Cardiovalve Ltd. Techniques for percutaneous mitral valve replacement and sealing
US11484404B2 (en) 2011-08-11 2022-11-01 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US20180147055A1 (en) * 2011-08-11 2018-05-31 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US11123181B2 (en) 2011-08-11 2021-09-21 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US11123180B2 (en) * 2011-08-11 2021-09-21 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US11135055B2 (en) 2011-08-11 2021-10-05 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US11311374B2 (en) 2011-08-11 2022-04-26 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US10639145B2 (en) * 2011-08-11 2020-05-05 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US11364116B2 (en) * 2011-08-11 2022-06-21 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US11382737B2 (en) 2011-08-11 2022-07-12 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US9833315B2 (en) 2011-08-11 2017-12-05 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US9480559B2 (en) 2011-08-11 2016-11-01 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US10617519B2 (en) 2011-08-11 2020-04-14 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US8900295B2 (en) 2011-09-26 2014-12-02 Edwards Lifesciences Corporation Prosthetic valve with ventricular tethers
USRE47490E1 (en) 2011-09-26 2019-07-09 Edwards Lifesciences Corporation Prosthetic valve with ventricular tethers
US10016271B2 (en) 2011-10-19 2018-07-10 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10052204B2 (en) 2011-10-19 2018-08-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11617648B2 (en) 2011-10-19 2023-04-04 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10702380B2 (en) 2011-10-19 2020-07-07 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9901443B2 (en) 2011-10-19 2018-02-27 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9034033B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9295552B2 (en) 2011-10-19 2016-03-29 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11628063B2 (en) 2011-10-19 2023-04-18 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10299917B2 (en) 2011-10-19 2019-05-28 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10299927B2 (en) 2011-10-19 2019-05-28 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9034032B2 (en) 2011-10-19 2015-05-19 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US10335278B2 (en) 2011-10-19 2019-07-02 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11826249B2 (en) 2011-10-19 2023-11-28 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11497603B2 (en) 2011-10-19 2022-11-15 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US10945835B2 (en) 2011-10-19 2021-03-16 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11197758B2 (en) 2011-10-19 2021-12-14 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9555219B2 (en) 2011-11-10 2017-01-31 Boston Scientific Scimed, Inc. Direct connect flush system
US9131926B2 (en) 2011-11-10 2015-09-15 Boston Scientific Scimed, Inc. Direct connect flush system
US10478300B2 (en) 2011-11-15 2019-11-19 Boston Scientific Scimed, Inc. Bond between components of a medical device
US9642705B2 (en) 2011-11-15 2017-05-09 Boston Scientific Scimed Inc. Bond between components of a medical device
US8940014B2 (en) 2011-11-15 2015-01-27 Boston Scientific Scimed, Inc. Bond between components of a medical device
US11413139B2 (en) 2011-11-23 2022-08-16 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US10537422B2 (en) 2011-11-23 2020-01-21 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US8951243B2 (en) 2011-12-03 2015-02-10 Boston Scientific Scimed, Inc. Medical device handle
US9370421B2 (en) 2011-12-03 2016-06-21 Boston Scientific Scimed, Inc. Medical device handle
US11523918B2 (en) 2011-12-06 2022-12-13 Aortic Innovations, Llc Transcatheter valve repair having improved paravalvular seal
US11491033B2 (en) 2011-12-06 2022-11-08 Aortic Innovations, Llc Transcatheter valve repair having improved paravalvular seal
US11497634B2 (en) 2011-12-06 2022-11-15 Aortic Innovations, Llc Transcatheter valve repair having improved paravalvular seal
US11833068B2 (en) 2011-12-06 2023-12-05 Aortic Innovations, Llc Transcatheter valve having improved paravalvular seal
US11839559B2 (en) 2011-12-06 2023-12-12 Aortic Innovations, Llc Transcatheter heart valve having paravalvular leakage seal
US11357623B2 (en) * 2011-12-13 2022-06-14 Boston Scientific Scimed, Inc. Decalcifying heart valve
US10952844B2 (en) 2011-12-16 2021-03-23 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US9510945B2 (en) 2011-12-20 2016-12-06 Boston Scientific Scimed Inc. Medical device handle
US9277993B2 (en) 2011-12-20 2016-03-08 Boston Scientific Scimed, Inc. Medical device delivery systems
US11452602B2 (en) 2011-12-21 2022-09-27 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a native heart valve annulus
US10849752B2 (en) 2011-12-21 2020-12-01 Edwards Lifesciences Corporation Methods for anchoring a device at a native heart valve annulus
US10238489B2 (en) 2011-12-21 2019-03-26 Edwards Lifesciences Corporation Anchoring device and method for replacing or repairing a heart valve
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US10172708B2 (en) 2012-01-25 2019-01-08 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
US11497602B2 (en) 2012-02-14 2022-11-15 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US10363133B2 (en) 2012-02-14 2019-07-30 Neovac Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9180008B2 (en) 2012-02-29 2015-11-10 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US11298230B2 (en) 2012-02-29 2022-04-12 Valcare, Inc. Percutaneous annuloplasty system with anterior-posterior adjustment
US9814576B2 (en) 2012-02-29 2017-11-14 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US10722363B2 (en) 2012-02-29 2020-07-28 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US9839519B2 (en) 2012-02-29 2017-12-12 Valcare, Inc. Percutaneous annuloplasty system with anterior-posterior adjustment
US11571307B2 (en) 2012-02-29 2023-02-07 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US10258468B2 (en) 2012-03-01 2019-04-16 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US11129714B2 (en) 2012-03-01 2021-09-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9895225B2 (en) 2012-03-23 2018-02-20 Sorin Group Italia S.R.L. Collapsible valve prosthesis
US9445897B2 (en) 2012-05-01 2016-09-20 Direct Flow Medical, Inc. Prosthetic implant delivery device with introducer catheter
US20140155990A1 (en) * 2012-05-30 2014-06-05 Neovasc Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10016275B2 (en) 2012-05-30 2018-07-10 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9345573B2 (en) * 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US11617650B2 (en) 2012-05-30 2023-04-04 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10940001B2 (en) 2012-05-30 2021-03-09 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10314705B2 (en) 2012-05-30 2019-06-11 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US11389294B2 (en) 2012-05-30 2022-07-19 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US11382739B2 (en) 2012-06-19 2022-07-12 Boston Scientific Scimed, Inc. Replacement heart valve
US10555809B2 (en) 2012-06-19 2020-02-11 Boston Scientific Scimed, Inc. Replacement heart valve
US9895221B2 (en) 2012-07-28 2018-02-20 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US11759318B2 (en) 2012-07-28 2023-09-19 Tendyne Holdings, Inc. Multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US11090155B2 (en) 2012-07-30 2021-08-17 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US9675454B2 (en) 2012-07-30 2017-06-13 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US10219900B2 (en) 2012-07-30 2019-03-05 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US9186249B2 (en) 2012-08-10 2015-11-17 Sorin Group Italia S.R.L. Valve prosthesis and kit
US10987219B2 (en) 2012-08-17 2021-04-27 On-X Life Technologies, Inc Biological chord repair system and methods
US10022224B2 (en) 2012-08-17 2018-07-17 On-X Life Technologies, Inc. Biological chord repair system and methods
US10631982B2 (en) 2013-01-24 2020-04-28 Cardiovale Ltd. Prosthetic valve and upstream support therefor
US11135059B2 (en) 2013-01-24 2021-10-05 Cardiovalve Ltd. Prosthetic valve and upstream support therefor
US11844691B2 (en) 2013-01-24 2023-12-19 Cardiovalve Ltd. Partially-covered prosthetic valves
US8709076B1 (en) * 2013-03-01 2014-04-29 Cormatrix Cardiovascular, Inc. Two-piece prosthetic valve
US11065118B2 (en) * 2013-03-04 2021-07-20 The Medical Research, Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center Cardiac valve commissure brace
US20160045314A1 (en) * 2013-03-04 2016-02-18 Medical Research Infrastructure And Health Service Fund Of The Tel-Aviv Medical Center Cardiac valve commissure brace
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
WO2014164364A1 (en) * 2013-03-13 2014-10-09 Aortic Innovations, Llc Dual frame stent and valve devices and implantation
US20160030169A1 (en) * 2013-03-13 2016-02-04 Aortic Innovations, Llc Dual frame stent and valve devices and implantation
US9687346B2 (en) 2013-03-14 2017-06-27 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US11324591B2 (en) 2013-03-14 2022-05-10 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US10716664B2 (en) 2013-03-14 2020-07-21 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US11045319B2 (en) 2013-03-14 2021-06-29 Edwards Lifesciences Corporation Methods of forming heat set annuloplasty rings
US10265171B2 (en) 2013-03-14 2019-04-23 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US10583000B2 (en) 2013-03-14 2020-03-10 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US11382749B2 (en) 2013-03-15 2022-07-12 Valcare, Inc. Systems and methods for delivery of annuloplasty rings
US10166100B2 (en) 2013-03-15 2019-01-01 Valcare, Inc. Systems and methods for delivery of annuloplasty rings
US9486306B2 (en) 2013-04-02 2016-11-08 Tendyne Holdings, Inc. Inflatable annular sealing device for prosthetic mitral valve
US11311379B2 (en) 2013-04-02 2022-04-26 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10463494B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US11389291B2 (en) 2013-04-04 2022-07-19 Neovase Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US11364119B2 (en) 2013-04-04 2022-06-21 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US10383728B2 (en) 2013-04-04 2019-08-20 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US20170156855A1 (en) * 2013-05-03 2017-06-08 Cormatrix Cardiovascular Inc Prosthetic Tissue Valves and Methods for Anchoring Same to Cardiovascular Structures
US9907649B2 (en) * 2013-05-03 2018-03-06 Cormatrix Cardiovascular, Inc. Prosthetic tissue valves and methods for anchoring same to cardiovascular structures
US20140330369A1 (en) * 2013-05-03 2014-11-06 Robert G Matheny Prosthetic Tissue Valves and Methods for Anchoring Same to Cardiovascular Structures
US9308084B2 (en) * 2013-05-03 2016-04-12 Cormatrix Cardiovascular, Inc Prosthetic tissue valves and methods for anchoring same to cardiovascular structures
US10111747B2 (en) 2013-05-20 2018-10-30 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US11234821B2 (en) 2013-05-20 2022-02-01 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US11617647B2 (en) 2013-05-22 2023-04-04 Valcare, Inc. Transcatheter prosthetic valve for mitral or tricuspid valve replacement
US10813751B2 (en) 2013-05-22 2020-10-27 Valcare, Inc. Transcatheter prosthetic valve for mitral or tricuspid valve replacement
WO2014189509A1 (en) * 2013-05-22 2014-11-27 Nadav Yellin Transcatheter prosthetic valve for mitral or tricuspid valve replacement
US11654017B2 (en) 2013-05-24 2023-05-23 Valcare, Inc. Heart and peripheral vascular valve replacement in conjunction with a support ring
US11654018B2 (en) 2013-05-24 2023-05-23 Valcare, Inc. Heart and peripheral vascular valve replacement in conjunction with a support ring
US20160106539A1 (en) * 2013-05-29 2016-04-21 Mvalve Technologies Ltd. Cardiac valve support device fitted with valve leaflets
US11617645B2 (en) 2013-05-30 2023-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
US10405976B2 (en) 2013-05-30 2019-09-10 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
US9968451B2 (en) 2013-06-12 2018-05-15 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US10314706B2 (en) 2013-06-12 2019-06-11 Edwards Lifesciences Corporation Methods of implanting a cardiac implant with integrated suture fasteners
US11464633B2 (en) 2013-06-12 2022-10-11 Edwards Lifesciences Corporation Heart valve implants with side slits
US9468527B2 (en) 2013-06-12 2016-10-18 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US10595996B2 (en) 2013-06-25 2020-03-24 Tendyne Holdings, Inc. Thrombus management and structural compliance features for prosthetic heart valves
US9597181B2 (en) 2013-06-25 2017-03-21 Tendyne Holdings, Inc. Thrombus management and structural compliance features for prosthetic heart valves
US11471281B2 (en) 2013-06-25 2022-10-18 Tendyne Holdings, Inc. Thrombus management and structural compliance features for prosthetic heart valves
US11224422B2 (en) 2013-06-28 2022-01-18 Valcare, Inc. Device, system, and method to secure an article to a tissue
US11058417B2 (en) 2013-06-28 2021-07-13 Valcare, Inc. Device, system, and method to secure an article to a tissue
US11806009B2 (en) 2013-06-28 2023-11-07 Valcare, Inc. Device, system, and method to secure an article to a tissue
US11191536B2 (en) 2013-06-28 2021-12-07 Valcare, Inc. Device, system, and method to secure an article to a tissue
US9554899B2 (en) 2013-07-17 2017-01-31 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US10624742B2 (en) 2013-07-17 2020-04-21 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US9561103B2 (en) 2013-07-17 2017-02-07 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US11510780B2 (en) 2013-07-17 2022-11-29 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US10149761B2 (en) 2013-07-17 2018-12-11 Cephea Valve Technlologies, Inc. System and method for cardiac valve repair and replacement
US8870948B1 (en) 2013-07-17 2014-10-28 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US10154906B2 (en) 2013-07-17 2018-12-18 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
US9895219B2 (en) * 2013-07-31 2018-02-20 Medtronic Vascular Galway Mitral valve prosthesis for transcatheter valve implantation
US20150039081A1 (en) * 2013-07-31 2015-02-05 Medtronic Vascular Galway Mitral Valve Prosthesis for Transcatheter Valve Implantation
US10813750B2 (en) 2013-07-31 2020-10-27 Medtronic Vascular Galway Mitral valve prosthesis for transcatheter valve implantation
US11376120B2 (en) 2013-07-31 2022-07-05 Medtronic Vascular Galway Mitral valve prosthesis for transcatheter valve implantation
US10610354B2 (en) 2013-08-01 2020-04-07 Tendyne Holdings, Inc. Epicardial anchor devices and methods
US11612480B2 (en) 2013-08-01 2023-03-28 Tendyne Holdings, Inc. Epicardial anchor devices and methods
US10143550B2 (en) 2013-08-08 2018-12-04 Sorin Group Italia S.R.L. Heart valve prosthesis
US9700413B2 (en) 2013-08-14 2017-07-11 Sorin Group Italia, S.r.l. Apparatus and method for chordal replacement
US9155622B2 (en) 2013-08-14 2015-10-13 Sorin Group Italia S.R.L. Apparatus and method for chordal replacement
US10702680B2 (en) 2013-08-28 2020-07-07 Edwards Lifesciences Corporation Method of operating an integrated balloon catheter inflation system
US9919137B2 (en) 2013-08-28 2018-03-20 Edwards Lifesciences Corporation Integrated balloon catheter inflation system
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US20150073548A1 (en) * 2013-09-11 2015-03-12 Cormatrix Cardiovascular, Inc. Systems, Apparatus and Methods for Sealing Perivalvular Leaks
US9737399B2 (en) * 2013-09-11 2017-08-22 Cormatrix Cardiovascular, Inc. Systems, apparatus and methods for sealing perivalvular leaks
US11246562B2 (en) 2013-10-17 2022-02-15 Tendyne Holdings, Inc. Apparatus and methods for alignment and deployment of intracardiac devices
US10555718B2 (en) 2013-10-17 2020-02-11 Tendyne Holdings, Inc. Apparatus and methods for alignment and deployment of intracardiac devices
US10736736B2 (en) 2013-10-23 2020-08-11 Caisson Interventional, LLC Methods and systems for heart valve therapy
US11833035B2 (en) 2013-10-23 2023-12-05 Caisson Interventional Llc Methods and systems for heart valve therapy
US10117741B2 (en) * 2013-10-23 2018-11-06 Caisson Interventional, LLC Methods and systems for heart valve therapy
US10363135B2 (en) 2013-10-29 2019-07-30 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US11096783B2 (en) 2013-10-29 2021-08-24 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
US20210177587A1 (en) * 2013-11-19 2021-06-17 St. Jude Medical, Cardiology Division, Inc. Sealing Structures for Paravalvular Leak Protection
US11813162B2 (en) * 2013-11-19 2023-11-14 St. Jude Medical, Cardiology Division, Inc. Sealing structures for paravalvular leak protection
US11589985B2 (en) 2014-02-05 2023-02-28 Tendyne Holdings, Inc. Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US11464628B2 (en) 2014-02-05 2022-10-11 Tendyne Holdings, Inc. Expandable epicardial pads and devices and methods for delivery of same
US10201419B2 (en) 2014-02-05 2019-02-12 Tendyne Holdings, Inc. Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US20150223820A1 (en) * 2014-02-07 2015-08-13 St. Jude Medical, Cardiology Division, Inc. Mitral valve treatment device having left atrial appendage closure
US10292711B2 (en) * 2014-02-07 2019-05-21 St. Jude Medical, Cardiology Division, Inc. Mitral valve treatment device having left atrial appendage closure
US11045183B2 (en) 2014-02-11 2021-06-29 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
US9986993B2 (en) 2014-02-11 2018-06-05 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
US10952849B2 (en) 2014-02-21 2021-03-23 Edwards Lifesciences Cardiaq Llc Prosthesis, delivery device and methods of use
US10004599B2 (en) 2014-02-21 2018-06-26 Edwards Lifesciences Cardiaq Llc Prosthesis, delivery device and methods of use
US11633279B2 (en) 2014-02-21 2023-04-25 Edwards Lifesciences Cardiaq Llc Prosthesis, delivery device and methods of use
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US11382753B2 (en) 2014-03-10 2022-07-12 Tendyne Holdings, Inc. Devices and methods for positioning and monitoring tether load for prosthetic mitral valve
US10517728B2 (en) 2014-03-10 2019-12-31 Tendyne Holdings, Inc. Devices and methods for positioning and monitoring tether load for prosthetic mitral valve
US9585752B2 (en) 2014-04-30 2017-03-07 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US10307249B2 (en) 2014-04-30 2019-06-04 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US11376122B2 (en) 2014-04-30 2022-07-05 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
USRE49792E1 (en) 2014-05-14 2024-01-09 Corcym S.R.L. Implant device and implantation kit
US10245141B2 (en) 2014-05-14 2019-04-02 Sorin Group Italia S.R.L. Implant device and implantation kit
US10179044B2 (en) 2014-05-19 2019-01-15 Edwards Lifesciences Cardiaq Llc Replacement mitral valve
US11045313B2 (en) 2014-05-19 2021-06-29 Edwards Lifesciences Cardiaq Llc Replacement mitral valve
US9532870B2 (en) * 2014-06-06 2017-01-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US11684471B2 (en) 2014-06-06 2023-06-27 Edwards Lifesciences Corporation Prosthetic valve for replacing a native mitral or tricuspid valve
US10010414B2 (en) 2014-06-06 2018-07-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US10687939B2 (en) 2014-06-06 2020-06-23 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US20150351904A1 (en) * 2014-06-06 2015-12-10 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US11701225B2 (en) 2014-07-30 2023-07-18 Cardiovalve Ltd. Delivery of a prosthetic valve
US11872130B2 (en) 2014-07-30 2024-01-16 Cardiovalve Ltd. Prosthetic heart valve implant
US10492908B2 (en) 2014-07-30 2019-12-03 Cardiovalve Ltd. Anchoring of a prosthetic valve
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
US10548721B2 (en) 2014-12-09 2020-02-04 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US11147665B2 (en) 2014-12-09 2021-10-19 Cepha Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US10869755B2 (en) 2014-12-09 2020-12-22 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US10433953B2 (en) 2014-12-09 2019-10-08 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US9439757B2 (en) 2014-12-09 2016-09-13 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US9492273B2 (en) 2014-12-09 2016-11-15 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US10786351B2 (en) 2015-01-07 2020-09-29 Tendyne Holdings, Inc. Prosthetic mitral valves and apparatus and methods for delivery of same
US10449043B2 (en) 2015-01-16 2019-10-22 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US10201417B2 (en) 2015-02-03 2019-02-12 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US11793635B2 (en) 2015-02-05 2023-10-24 Cardiovalve Ltd. Prosthetic valve with angularly offset frames
US11793638B2 (en) 2015-02-05 2023-10-24 Cardiovalve Ltd. Prosthetic valve with pivoting tissue anchor portions
US10918481B2 (en) 2015-02-05 2021-02-16 Cardiovalve Ltd. Techniques for deployment of a prosthetic valve
US10426610B2 (en) 2015-02-05 2019-10-01 Cardiovalve Ltd. Prosthetic valve with radially-deflectable tissue anchors
US11672658B2 (en) 2015-02-05 2023-06-13 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10758344B2 (en) 2015-02-05 2020-09-01 Cardiovalve Ltd. Prosthetic valve with angularly offset frames
US10610356B2 (en) 2015-02-05 2020-04-07 Tendyne Holdings, Inc. Expandable epicardial pads and devices and methods for delivery of same
US10888422B2 (en) 2015-02-05 2021-01-12 Cardiovalve Ltd. Prosthetic valve with flexible tissue anchor portions
US10357360B2 (en) 2015-02-05 2019-07-23 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10667908B2 (en) 2015-02-05 2020-06-02 Cardiovalve Ltd. Prosthetic valve with S-shaped tissue anchors
US10524903B2 (en) 2015-02-05 2020-01-07 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US10390952B2 (en) 2015-02-05 2019-08-27 Cardiovalve Ltd. Prosthetic valve with flexible tissue anchor portions
US10864078B2 (en) 2015-02-05 2020-12-15 Cardiovalve Ltd. Prosthetic valve with separably-deployable valve body and tissue anchors
US10722360B2 (en) 2015-02-05 2020-07-28 Cardiovalve Ltd. Prosthetic valve with radially-deflectable tissue anchors
US10736742B2 (en) 2015-02-05 2020-08-11 Cardiovalve Ltd. Prosthetic valve with atrial arms
US10449047B2 (en) 2015-02-05 2019-10-22 Cardiovalve Ltd. Prosthetic heart valve with compressible frames
US11534298B2 (en) 2015-02-05 2022-12-27 Cardiovalve Ltd. Prosthetic valve with s-shaped tissue anchors
US10973636B2 (en) 2015-02-05 2021-04-13 Cardiovalve Ltd. Prosthetic valve with tissue anchors free from lateral interconnections
US10682227B2 (en) 2015-02-05 2020-06-16 Cardiovalve Ltd. Prosthetic valve with pivoting tissue anchor portions
US10463487B2 (en) 2015-02-05 2019-11-05 Cardiovalve Ltd. Prosthetic valve delivery system with independently-movable capsule portions
US10463488B2 (en) 2015-02-05 2019-11-05 Cardiovalve Ltd. Prosthetic valve with separably-deployable valve body and tissue anchors
US9974651B2 (en) 2015-02-05 2018-05-22 Mitral Tech Ltd. Prosthetic valve with axially-sliding frames
US10695177B2 (en) 2015-02-05 2020-06-30 Cardiovalve Ltd. Prosthetic valve with aligned inner and outer frames
US11801135B2 (en) 2015-02-05 2023-10-31 Cardiovalve Ltd. Techniques for deployment of a prosthetic valve
US10849748B2 (en) 2015-02-05 2020-12-01 Cardiovalve Ltd. Prosthetic valve delivery system with independently-movable capsule portions
US10507105B2 (en) 2015-02-05 2019-12-17 Cardiovalve Ltd. Prosthetic valve with tissue anchors free from lateral interconnections
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
US11065113B2 (en) 2015-03-13 2021-07-20 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
CN107530177A (en) * 2015-04-09 2018-01-02 弗里德曼德科技公司 For pre- anti-stroke 3D filters
US20180064525A1 (en) * 2015-04-09 2018-03-08 Frid Mind Technologies 3d filter for prevention of stroke
US10667905B2 (en) 2015-04-16 2020-06-02 Tendyne Holdings, Inc. Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves
US11523902B2 (en) 2015-04-16 2022-12-13 Tendyne Holdings, Inc. Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves
US11850147B2 (en) 2015-04-21 2023-12-26 Edwards Lifesciences Corporation Percutaneous mitral valve replacement device
US10441416B2 (en) 2015-04-21 2019-10-15 Edwards Lifesciences Corporation Percutaneous mitral valve replacement device
US11389292B2 (en) 2015-04-30 2022-07-19 Edwards Lifesciences Cardiaq Llc Replacement mitral valve, delivery system for replacement mitral valve and methods of use
US10376363B2 (en) 2015-04-30 2019-08-13 Edwards Lifesciences Cardiaq Llc Replacement mitral valve, delivery system for replacement mitral valve and methods of use
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US10470881B2 (en) 2015-05-14 2019-11-12 Cephea Valve Technologies, Inc. Replacement mitral valves
US11617646B2 (en) 2015-05-14 2023-04-04 Cephea Valve Technologies, Inc. Replacement mitral valves
US11786373B2 (en) 2015-05-14 2023-10-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10849746B2 (en) 2015-05-14 2020-12-01 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10143552B2 (en) 2015-05-14 2018-12-04 Cephea Valve Technologies, Inc. Replacement mitral valves
US10555808B2 (en) 2015-05-14 2020-02-11 Cephea Valve Technologies, Inc. Replacement mitral valves
US10314707B2 (en) 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11324593B2 (en) 2015-06-09 2022-05-10 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11471280B2 (en) 2015-06-09 2022-10-18 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US10226335B2 (en) 2015-06-22 2019-03-12 Edwards Lifesciences Cardiaq Llc Actively controllable heart valve implant and method of controlling same
US11083576B2 (en) 2015-06-22 2021-08-10 Edwards Lifesciences Cardiaq Llc Actively controllable heart valve implant and method of controlling same
US11844690B2 (en) 2015-06-23 2023-12-19 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
US10842620B2 (en) 2015-06-23 2020-11-24 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
US10092400B2 (en) 2015-06-23 2018-10-09 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
US10695170B2 (en) 2015-07-02 2020-06-30 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US10335277B2 (en) 2015-07-02 2019-07-02 Boston Scientific Scimed Inc. Adjustable nosecone
US11654020B2 (en) 2015-07-02 2023-05-23 Edwards Lifesciences Corporation Hybrid heart valves
US10456246B2 (en) 2015-07-02 2019-10-29 Edwards Lifesciences Corporation Integrated hybrid heart valves
US11730595B2 (en) 2015-07-02 2023-08-22 Boston Scientific Scimed, Inc. Adjustable nosecone
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
US11690714B2 (en) 2015-07-02 2023-07-04 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
US10856973B2 (en) 2015-08-12 2020-12-08 Boston Scientific Scimed, Inc. Replacement heart valve implant
US11576782B2 (en) 2015-08-21 2023-02-14 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10820996B2 (en) 2015-08-21 2020-11-03 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10117744B2 (en) 2015-08-26 2018-11-06 Edwards Lifesciences Cardiaq Llc Replacement heart valves and methods of delivery
US10758345B2 (en) 2015-08-26 2020-09-01 Edwards Lifesciences Cardiaq Llc Replacement heart valves and methods of delivery
US11278405B2 (en) 2015-08-26 2022-03-22 Edwards Lifesciences Cardiaq Llc Delivery device and methods of use for transapical delivery of replacement valve
US10575951B2 (en) 2015-08-26 2020-03-03 Edwards Lifesciences Cardiaq Llc Delivery device and methods of use for transapical delivery of replacement mitral valve
US10034747B2 (en) 2015-08-27 2018-07-31 Medtronic Vascular, Inc. Prosthetic valve system having a docking component and a prosthetic valve component
US11253364B2 (en) 2015-08-28 2022-02-22 Edwards Lifesciences Cardiaq Llc Steerable delivery system for replacement mitral valve and methods of use
US10350066B2 (en) 2015-08-28 2019-07-16 Edwards Lifesciences Cardiaq Llc Steerable delivery system for replacement mitral valve and methods of use
US10350047B2 (en) 2015-09-02 2019-07-16 Edwards Lifesciences Corporation Method and system for packaging and preparing a prosthetic heart valve and associated delivery system
US11051925B2 (en) 2015-09-02 2021-07-06 Edwards Lifesciences Corporation Method and system for packaging and preparing a prosthetic heart valve and associated delivery system
US11690709B2 (en) 2015-09-02 2023-07-04 Edwards Lifesciences Corporation Methods for securing a transcatheter valve to a bioprosthetic cardiac structure
US10779940B2 (en) 2015-09-03 2020-09-22 Boston Scientific Scimed, Inc. Medical device handle
US10842606B2 (en) * 2015-09-09 2020-11-24 Frid Mind Technologies Bifurcated 3D filter assembly for prevention of stroke
US20180228590A1 (en) * 2015-09-09 2018-08-16 Frid Mind Technologies Bifurcated 3d filter assembly for prevention of stroke
JP2018527087A (en) * 2015-09-09 2018-09-20 フリッド マインド テクノロジーズFrid Mind Technologies Bifurcated 3D filter assembly for preventing stroke
US11318012B2 (en) 2015-09-18 2022-05-03 Tendyne Holdings, Inc. Apparatus and methods for delivery of prosthetic mitral valve
US10327894B2 (en) 2015-09-18 2019-06-25 Tendyne Holdings, Inc. Methods for delivery of prosthetic mitral valves
US10765517B2 (en) 2015-10-01 2020-09-08 Neochord, Inc. Ringless web for repair of heart valves
US11484409B2 (en) 2015-10-01 2022-11-01 Neochord, Inc. Ringless web for repair of heart valves
US11096782B2 (en) 2015-12-03 2021-08-24 Tendyne Holdings, Inc. Frame features for prosthetic mitral valves
US10357351B2 (en) 2015-12-04 2019-07-23 Edwards Lifesciences Corporation Storage assembly for prosthetic valve
US11273024B2 (en) 2015-12-04 2022-03-15 Edwards Lifesciences Corporation Storage assembly for prosthetic valve
US10610358B2 (en) 2015-12-28 2020-04-07 Tendyne Holdings, Inc. Atrial pocket closures for prosthetic heart valves
US11464629B2 (en) 2015-12-28 2022-10-11 Tendyne Holdings, Inc. Atrial pocket closures for prosthetic heart valves
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US11298117B2 (en) 2016-02-16 2022-04-12 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
USD815744S1 (en) 2016-04-28 2018-04-17 Edwards Lifesciences Cardiaq Llc Valve frame for a delivery system
US11033390B2 (en) 2016-04-29 2021-06-15 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US10265172B2 (en) 2016-04-29 2019-04-23 Medtronic Vascular, Inc. Prosthetic heart valve devices with tethered anchors and associated systems and methods
US10470877B2 (en) 2016-05-03 2019-11-12 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
US11253354B2 (en) 2016-05-03 2022-02-22 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
US10245136B2 (en) 2016-05-13 2019-04-02 Boston Scientific Scimed Inc. Containment vessel with implant sheathing guide
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
US11382742B2 (en) 2016-05-13 2022-07-12 Boston Scientific Scimed, Inc. Medical device handle
US10201416B2 (en) 2016-05-16 2019-02-12 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US10456245B2 (en) 2016-05-16 2019-10-29 Edwards Lifesciences Corporation System and method for applying material to a stent
US20170325938A1 (en) 2016-05-16 2017-11-16 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US10709552B2 (en) 2016-05-16 2020-07-14 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US11039921B2 (en) 2016-06-13 2021-06-22 Tendyne Holdings, Inc. Sequential delivery of two-part prosthetic mitral valve
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10588745B2 (en) 2016-06-20 2020-03-17 Medtronic Vascular, Inc. Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis
US11786371B2 (en) 2016-06-20 2023-10-17 Medtronic Vascular, Inc. Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis
US11090157B2 (en) 2016-06-30 2021-08-17 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
US11701226B2 (en) 2016-06-30 2023-07-18 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
US11065116B2 (en) 2016-07-12 2021-07-20 Tendyne Holdings, Inc. Apparatus and methods for trans-septal retrieval of prosthetic heart valves
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
US11224507B2 (en) 2016-07-21 2022-01-18 Edwards Lifesciences Corporation Replacement heart valve prosthesis
USD800908S1 (en) 2016-08-10 2017-10-24 Mitraltech Ltd. Prosthetic valve element
US11779458B2 (en) 2016-08-10 2023-10-10 Cardiovalve Ltd. Prosthetic valve with leaflet connectors
US10856975B2 (en) 2016-08-10 2020-12-08 Cardiovalve Ltd. Prosthetic valve with concentric frames
US11103349B2 (en) 2016-08-15 2021-08-31 Valcare, Inc. Devices and methods for the treatment of heart valve insufficiencies
US10646340B2 (en) 2016-08-19 2020-05-12 Edwards Lifesciences Corporation Steerable delivery system for replacement mitral valve
US10639143B2 (en) 2016-08-26 2020-05-05 Edwards Lifesciences Corporation Multi-portion replacement heart valve prosthesis
US11504229B2 (en) 2016-08-26 2022-11-22 Edwards Lifesciences Corporation Multi-portion replacement heart valve prosthesis
US11510778B2 (en) 2016-11-02 2022-11-29 Edwards Lifesciences Corporation Supra and sub-annular mitral valve delivery system
US10758348B2 (en) 2016-11-02 2020-09-01 Edwards Lifesciences Corporation Supra and sub-annular mitral valve delivery system
USD846122S1 (en) 2016-12-16 2019-04-16 Edwards Lifesciences Corporation Heart valve sizer
US11633278B2 (en) 2017-01-23 2023-04-25 Cephea Valve Technologies, Inc. Replacement mitral valves
US10828153B2 (en) 2017-01-23 2020-11-10 Cephea Valve Technologies, Inc. Replacement mitral valves
US10368990B2 (en) 2017-01-23 2019-08-06 Cephea Valve Technologies, Inc. Replacement mitral valves
US11058535B2 (en) 2017-01-23 2021-07-13 Cephea Valve Technologies, Inc. Replacement mitral valves
US11090158B2 (en) 2017-01-23 2021-08-17 Cephea Valve Technologies, Inc. Replacement mitral valves
US10568737B2 (en) 2017-01-23 2020-02-25 Cephea Valve Technologies, Inc. Replacement mitral valves
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US20200008936A1 (en) * 2017-02-17 2020-01-09 Cardiovascular Diagnostics Inc. Transcatheter heart valve apparatus for calcific mitral stenosis
WO2018148839A1 (en) * 2017-02-17 2018-08-23 Cardiovascular Diagnostics Inc. Transcatheter heart valve apparatus for calcific mitral stenosis
US11166801B2 (en) 2017-03-06 2021-11-09 Edwards Lifesciences Corporation Humidity-management packaging systems and methods
US10631968B2 (en) 2017-03-06 2020-04-28 Edwards Lifesciences Corporation Humidity-management packaging systems and methods
US11576779B2 (en) 2017-03-17 2023-02-14 Valcare, Inc. Mitral or tricuspid repair systems with multi-directional anchors
US11589989B2 (en) 2017-03-31 2023-02-28 Neochord, Inc. Minimally invasive heart valve repair in a beating heart
US11654021B2 (en) 2017-04-18 2023-05-23 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US11737873B2 (en) 2017-04-18 2023-08-29 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US11389295B2 (en) 2017-04-18 2022-07-19 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US11786370B2 (en) 2017-05-11 2023-10-17 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US11559398B2 (en) 2017-06-02 2023-01-24 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US11464659B2 (en) 2017-06-06 2022-10-11 Twelve, Inc. Crimping device for loading stents and prosthetic heart valves
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
US10828154B2 (en) 2017-06-08 2020-11-10 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10813757B2 (en) 2017-07-06 2020-10-27 Edwards Lifesciences Corporation Steerable rail delivery system
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11883287B2 (en) 2017-07-06 2024-01-30 Edwards Lifesciences Corporation Steerable rail delivery system
US11877926B2 (en) 2017-07-06 2024-01-23 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US11123186B2 (en) 2017-07-06 2021-09-21 Edwards Lifesciences Corporation Steerable delivery system and components
US11154399B2 (en) 2017-07-13 2021-10-26 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
US10898325B2 (en) 2017-08-01 2021-01-26 Boston Scientific Scimed, Inc. Medical implant locking mechanism
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US10537426B2 (en) 2017-08-03 2020-01-21 Cardiovalve Ltd. Prosthetic heart valve
USD841812S1 (en) 2017-08-03 2019-02-26 Cardiovalve Ltd. Prosthetic heart valve element
USD841813S1 (en) 2017-08-03 2019-02-26 Cardiovalve Ltd. Prosthetic heart valve element
US11571298B2 (en) 2017-08-03 2023-02-07 Cardiovalve Ltd. Prosthetic valve with appendages
US10575948B2 (en) 2017-08-03 2020-03-03 Cardiovalve Ltd. Prosthetic heart valve
US10939996B2 (en) 2017-08-16 2021-03-09 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11191639B2 (en) 2017-08-28 2021-12-07 Tendyne Holdings, Inc. Prosthetic heart valves with tether coupling features
US11395726B2 (en) 2017-09-11 2022-07-26 Incubar Llc Conduit vascular implant sealing device for reducing endoleaks
US11819405B2 (en) 2017-09-19 2023-11-21 Cardiovalve Ltd. Prosthetic valve with inflatable cuff configured for radial extension
US11304804B2 (en) 2017-09-19 2022-04-19 Cardiovalve, Ltd. Prosthetic valve with connecting struts of variable size and tissue anchoring legs of variable size that extend from junctions
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
US11304805B2 (en) 2017-09-19 2022-04-19 Cardiovalve Ltd. Prosthetic valve with inflatable cuff configured to fill a volume between atrial and ventricular tissue anchors
US11318015B2 (en) 2017-09-19 2022-05-03 Cardiovalve Ltd. Prosthetic valve configured to fill a volume between tissue anchors with native valve tissue
US11337804B2 (en) 2017-09-19 2022-05-24 Cardiovalve Ltd. Prosthetic valve with radially-deformable tissue anchors configured to restrict axial valve migration
US11864996B2 (en) 2017-09-19 2024-01-09 Cardiovalve Ltd. Prosthetic valve with protective sleeve around an outlet rim
US11337803B2 (en) 2017-09-19 2022-05-24 Cardiovalve Ltd. Prosthetic valve with inner and outer frames connected at a location of tissue anchor portion
US11318014B2 (en) 2017-09-19 2022-05-03 Cardiovalve Ltd. Prosthetic valve delivery system with multi-planar steering
US11337802B2 (en) 2017-09-19 2022-05-24 Cardiovalve Ltd. Heart valve delivery systems and methods
US11304806B2 (en) 2017-09-19 2022-04-19 Cardiovalve Ltd. Prosthetic valve with atrial tissue anchors having variable flexibility and ventricular tissue anchors having constant flexibility
US11648122B2 (en) 2017-10-19 2023-05-16 Cardiovalve Ltd. Techniques for use with prosthetic valve leaflets
US11065122B2 (en) 2017-10-19 2021-07-20 Cardiovalve Ltd. Techniques for use with prosthetic valve leaflets
US11872131B2 (en) 2017-12-13 2024-01-16 Cardiovalve Ltd. Prosthetic valve and delivery tool therefor
US11382746B2 (en) 2017-12-13 2022-07-12 Cardiovalve Ltd. Prosthetic valve and delivery tool therefor
US11633277B2 (en) 2018-01-10 2023-04-25 Cardiovalve Ltd. Temperature-control during crimping of an implant
US11872124B2 (en) 2018-01-10 2024-01-16 Cardiovalve Ltd. Temperature-control during crimping of an implant
US11246625B2 (en) 2018-01-19 2022-02-15 Boston Scientific Scimed, Inc. Medical device delivery system with feedback loop
US11191641B2 (en) 2018-01-19 2021-12-07 Boston Scientific Scimed, Inc. Inductance mode deployment sensors for transcatheter valve system
US11337805B2 (en) 2018-01-23 2022-05-24 Edwards Lifesciences Corporation Prosthetic valve holders, systems, and methods
US11684474B2 (en) 2018-01-25 2023-06-27 Edwards Lifesciences Corporation Delivery system for aided replacement valve recapture and repositioning post-deployment
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
US11439732B2 (en) 2018-02-26 2022-09-13 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
US11051934B2 (en) 2018-02-28 2021-07-06 Edwards Lifesciences Corporation Prosthetic mitral valve with improved anchors and seal
US11612389B2 (en) 2018-03-23 2023-03-28 Neochord, Inc. Device for suture attachment for minimally invasive heart valve repair
US10588620B2 (en) 2018-03-23 2020-03-17 Neochord, Inc. Device for suture attachment for minimally invasive heart valve repair
US11786366B2 (en) * 2018-04-04 2023-10-17 Vdyne, Inc. Devices and methods for anchoring transcatheter heart valve
US20210228349A1 (en) * 2018-04-04 2021-07-29 Vdyne, Inc. Devices and methods for anchoring transcatheter heart valve
US11173030B2 (en) 2018-05-09 2021-11-16 Neochord, Inc. Suture length adjustment for minimally invasive heart valve repair
US11253360B2 (en) 2018-05-09 2022-02-22 Neochord, Inc. Low profile tissue anchor for minimally invasive heart valve repair
US11229517B2 (en) 2018-05-15 2022-01-25 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
USD952143S1 (en) 2018-07-11 2022-05-17 Edwards Lifesciences Corporation Collapsible heart valve sizer
USD995774S1 (en) 2018-07-11 2023-08-15 Edwards Lifesciences Corporation Collapsible heart valve sizer
USD908874S1 (en) 2018-07-11 2021-01-26 Edwards Lifesciences Corporation Collapsible heart valve sizer
US11554015B2 (en) 2018-07-30 2023-01-17 Edwards Lifesciences Corporation Minimally-invasive low strain annuloplasty ring
US10966709B2 (en) 2018-09-07 2021-04-06 Neochord, Inc. Device for suture attachment for minimally invasive heart valve repair
US11491011B2 (en) 2018-09-17 2022-11-08 Cardiovalve Ltd. Leaflet-grouping system
US11026792B2 (en) 2018-09-17 2021-06-08 Cardiovalve Ltd. Leaflet-grouping system
US11883293B2 (en) 2018-09-17 2024-01-30 Cardiovalve Ltd. Leaflet-grouping system
US11534300B2 (en) 2018-12-03 2022-12-27 Valcare, Inc. Stabilizing and adjusting tool for controlling a minimally invasive mitral / tricuspid valve repair system
US11241312B2 (en) 2018-12-10 2022-02-08 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
US11723783B2 (en) 2019-01-23 2023-08-15 Neovasc Medical Ltd. Covered flow modifying apparatus
US11376126B2 (en) 2019-04-16 2022-07-05 Neochord, Inc. Transverse helical cardiac anchor for minimally invasive heart valve repair
US11918468B2 (en) 2019-04-16 2024-03-05 Neochord, Inc. Transverse helical cardiac anchor for minimally invasive heart valve repair
US11712335B2 (en) 2019-05-04 2023-08-01 Vdyne, Inc. Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
US11931252B2 (en) 2019-07-15 2024-03-19 Cephea Valve Technologies, Inc. Disk-based valve apparatus and method for the treatment of valve dysfunction
US11793628B2 (en) 2019-07-15 2023-10-24 Valcare, Inc. Transcatheter bio-prosthesis member and support structure
US11648110B2 (en) 2019-12-05 2023-05-16 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11931258B2 (en) 2020-04-30 2024-03-19 Edwards Lifesciences Corporation Steerable delivery system for replacement mitral valve and methods of use
US11707355B2 (en) 2020-05-28 2023-07-25 Medtronic, Inc. Modular heart valve prosthesis
US11678980B2 (en) 2020-08-19 2023-06-20 Tendyne Holdings, Inc. Fully-transseptal apical pad with pulley for tensioning
US11931237B2 (en) 2021-11-08 2024-03-19 Edwards Lifesciences Corporation Humidity-management packaging systems and methods

Also Published As

Publication number Publication date
EP1850796B1 (en) 2015-12-09
ES2558534T3 (en) 2016-02-05
US10583001B2 (en) 2020-03-10
DK1850796T3 (en) 2016-01-18
US20140039613A1 (en) 2014-02-06
EP1850796A1 (en) 2007-11-07
WO2006089236A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
US10583001B2 (en) Methods for replacing a cardiac valve
US20060259135A1 (en) Apparatus and method for replacing a cardiac valve
US20070038296A1 (en) Apparatus and method for remodeling a cardiac valve annulus
US9114035B2 (en) Apparatus and method for treating cardiovascular diseases
US8652201B2 (en) Apparatus and method for treating cardiovascular diseases
US10631983B1 (en) Distal subannular anchoring tab for side-delivered transcatheter valve prosthesis
US11071627B2 (en) Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US10111749B2 (en) Prosthetic valve with flow director
CN107405197B (en) Valve prosthesis with integrated centering mechanism and method of use thereof
US20200093589A1 (en) Side-delivered transcatheter heart valve replacement
AU2009219415B2 (en) Infundibular reducer devices
US10245142B2 (en) Multiple orifice implantable heart valve and methods of implantation
CN102740801B (en) Support system for bioprosthetic valves with commisural posts with heart-shaped openings
US20200237506A1 (en) Collapsible Inner Flow Control Component for Side-Delivered Transcatheter Heart Valve Prosthesis
CN108156805A (en) Mitral valve component
US20120283820A1 (en) Endovascular prosthetic heart valve replacement
CN102869317A (en) Stents for prosthetic heart valves

Legal Events

Date Code Title Description
AS Assignment

Owner name: CLEVELAND CLINIC FOUNDATION, THE, OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAVIA, JOSE L.;NAVIA, JOSE A.;OBERTI, CARLOS;REEL/FRAME:017865/0257;SIGNING DATES FROM 20060308 TO 20060427

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION